var title_f22_4_22592="EKC";
var content_f22_4_22592=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F80243&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F80243&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Epidemic keratoconjunctivitis infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 276px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patient with right epidemic keratoconjunctivitis infection. Note the lid swelling, red eye, and absence of purulent discharge. Patient also has right preauricular adenopathy (not visible). Note the early injection of left eye, representing sequential involvement.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Textbook of Pediatric Emergency Medicine, 5th ed, Fleisher GR, Ludwig S, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_4_22592=[""].join("\n");
var outline_f22_4_22592=null;
var title_f22_4_22593="Intrauterine adhesions";
var content_f22_4_22593=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F64518&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F64518&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Saline sonohysterogram image, transverse view, demonstrating adhesive bands between anterior and posterior uterine walls",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 307px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marcelle Cedars, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_4_22593=[""].join("\n");
var outline_f22_4_22593=null;
var title_f22_4_22594="Immunofluorescence findings I";
var content_f22_4_22594=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F65429&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F65429&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Immunofluorescence findings in urticarial vasculitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 306px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Direct immunofluorescence of a biopsy specimen from a patient with urticarial vasculitis, demonstrating IgM deposits along the dermal-epidermal junction as well as involving blood vessel walls in the dermis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_4_22594=[""].join("\n");
var outline_f22_4_22594=null;
var title_f22_4_22595="Methicillin-resistant Staphylococcus aureus (MRSA)";
var content_f22_4_22595=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Methicillin-resistant Staphylococcus aureus (MRSA) (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?22/4/22595/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/4/22595/contributors\" id=\"au225\">",
"       Anthony Harris, MD, MPH",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?22/4/22595/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/4/22595/contributors\" id=\"se2060\">",
"       Daniel J Sexton, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?22/4/22595/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/4/22595/contributors\" id=\"de1811\">",
"       Elinor L Baron, MD, DTMH",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?22/4/22595?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      ANTIBIOTIC-RESISTANT STAPH INFECTIONS",
"     </span>",
"    </p>",
"    <p>",
"     Staphylococcus aureus (Staph aureus or \"Staph\") is a bacterium that is carried on the skin or nasal lining of up to 30 percent of healthy individuals. In this setting, the bacteria usually cause no symptoms.",
"    </p>",
"    <p>",
"     However, when the skin is damaged, even with a minor injury such as a scratch or a small cut from shaving, Staph can cause a wide range of problems. These problems can range from a mild pimple to severe illness, especially in young children, older adults, and people with a weakened immune system.",
"    </p>",
"    <p>",
"     This topic review discusses the signs and symptoms, diagnostic tests, treatment, and prevention of a particularly dangerous form of Staph aureus called methicillin-resistant Staphylococcus aureus (MRSA, pronounced \"Mursa\").",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      WHERE DID MRSA COME FROM?",
"     </span>",
"    </p>",
"    <p>",
"     Initially most Staph infections were sensitive to penicillin. In the 1950s many infections became resistant to penicillin and methicillin (a related drug developed to treat these germs). Thus the term methicillin-resistant Staphylococcus aureus (MRSA) was derived. Staph that can be treated with these drugs is called methicillin-susceptible Staphylococcus aureus, or MSSA.",
"    </p>",
"    <p>",
"     Unfortunately some strains of Staph have become resistant to methicillin and other similar antibiotics. These strains are known as MRSA, which cannot be cured with traditional penicillin-related drugs. Instead, MRSA must be treated with alternate antibiotics.",
"    </p>",
"    <p>",
"     Initially, after problems with MRSA were recognized, most cases of MRSA infection occurred in people who were hospitalized or lived in nursing homes. However, in the 1990s MRSA infections were recognized in people who were not hospitalized or in contact with people in nursing homes. Since then the frequency of cases of MRSA in people who live in the community has greatly increased; in 2006 more than one-half of all cases of skin infections due to MRSA occurred in otherwise healthy people living in the community [",
"     <a class=\"abstract\" href=\"UTD.htm?22/4/22595/abstract/1\">",
"      1",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     Today we now realize that infections with MRSA occur in three specific groups of people: 1) persons currently in the hospital (hospital-associated MRSA), 2) persons with recent hospitalization or ongoing contact with medical clinics, dialysis units, or those undergoing complex outpatient treatments, such as chemotherapy (healthcare-associated MRSA), and 3) persons in the community (community-associated MRSA).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      HOW IS MRSA SPREAD?",
"     </span>",
"    </p>",
"    <p>",
"     You can be \"colonized\" with MRSA, meaning that you carry the bacteria on your skin or in your nose but you have no signs or symptoms of the illness. You can become colonized with MRSA in a variety of ways:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       By touching the skin of another person who is colonized with MRSA.",
"      </li>",
"      <li>",
"       Through the tiny droplets that travel when people carrying MRSA breathe, cough, or sneeze.",
"      </li>",
"      <li>",
"       By touching a contaminated surface (such as a counter top, door handle, or phone).",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     You can develop an infection from MRSA if your skin is colonized and the bacteria enter an opening (eg, a cut, scrape, or wound) in the skin.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      MRSA RISK FACTORS",
"     </span>",
"    </p>",
"    <p>",
"     Anyone can become colonized and then infected with MRSA, although certain people are at a higher risk.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Hospital care",
"     </span>",
"     &nbsp;&mdash;&nbsp;Risk factors for becoming infected with hospital associated MRSA include the following:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Having a surgical wound",
"       <span class=\"nowrap\">",
"        and/or",
"       </span>",
"       intravenous (IV) line",
"      </li>",
"      <li>",
"       Being hospitalized for a prolonged period of time",
"      </li>",
"      <li>",
"       Recent use of antibiotics",
"      </li>",
"      <li>",
"       Having a weakened immune system due to a medical condition or its treatment",
"      </li>",
"      <li>",
"       Being in close proximity to other patients or healthcare workers who are colonized with MRSA",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     In hospitals and other long-term healthcare facilities, MRSA can be spread from one patient to another on the hands of healthcare workers. Hands or gloves may become contaminated with MRSA when healthcare workers touch a patient's skin, wounds, wound dressings, or devices such as IV tubing.",
"    </p>",
"    <p>",
"     Healthcare providers should wash their hands before and after touching any patient and change gloves between patients to decrease the risk of spreading MRSA. (See",
"     <a class=\"local\" href=\"#H14\">",
"      'Prevention in the hospital'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Hemodialysis",
"     </span>",
"     &nbsp;&mdash;&nbsp;People who need hemodialysis for kidney failure have a substantially higher risk of becoming infected with MRSA compared with other patients. In one study, 4 percent of hemodialysis patients became infected with MRSA; only about 0.04 percent of people in the general population become infected with MRSA [",
"     <a class=\"abstract\" href=\"UTD.htm?22/4/22595/abstract/2\">",
"      2",
"     </a>",
"     ]. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/57/40852?source=see_link\">",
"      \"Patient information: Hemodialysis (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Community associated MRSA",
"     </span>",
"     &nbsp;&mdash;&nbsp;You can pick up MRSA outside the hospital, especially if you:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Have skin trauma (eg, \"turf burns,\" cuts or sores)",
"      </li>",
"      <li>",
"       Are an athlete",
"      </li>",
"      <li>",
"       Shave or wax to remove body hair, particularly of the armpits and groin",
"      </li>",
"      <li>",
"       Have tattoos or body piercing",
"      </li>",
"      <li>",
"       Have physical contact with a person who has a draining cut or sore or is a carrier of MRSA",
"      </li>",
"      <li>",
"       Share personal items or equipment that is not cleaned or laundered between users (such as towels or protective sport pads)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Community-associated MRSA infections may occur more commonly in certain populations, such as daycare centers, prisons, in the military, or in athletes who play on a team. Spread of MRSA within households is common.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      MRSA SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Most people infected with community-associated MRSA (CA-MRSA) have signs of a skin infection. Such skin infections may appear spontaneously and, in some cases, may be mistaken for a spider bite. The skin may have a single raised red lump that is tender, a cluster of \"pimples\", or a large tender lump that drains pus (called a carbuncle). The area may enlarge and become progressively more tender, red, and swollen. The center of the raised area may ooze pus.",
"    </p>",
"    <p>",
"     It is also possible to develop an infection in areas other than the skin if the bacteria enter the bloodstream through an opening in the skin. Infection can then develop on a heart valve, in a bone, joint, or the lungs, or around devices (such as an IV line, pacemaker, or replacement joint). In these situations, symptoms may include fever and fatigue, as well as pain or swelling in the infected area.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h1\">",
"      MRSA DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     People with skin infections can be tested for MRSA with a culture. Results of the test are usually available in 48 to 72 hours.",
"    </p>",
"    <p>",
"     People with infections of the lung, bone, joint, or other internal areas usually require blood tests as well as imaging studies (eg, x-ray, CT scan, echocardiogram).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      MRSA TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     If MRSA is diagnosed, you will be given an antibiotic. The antibiotic dose or type may be changed when the results of the laboratory culture are available.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      At home",
"     </span>",
"     &nbsp;&mdash;&nbsp;Treatment of MRSA at home usually includes a seven to 10 day course of an antibiotic (by mouth) such as trimethoprim-sulfamethoxazole (brand name: Bactrim), clindamycin, minocycline, or doxycycline. It is very important to carefully follow the instructions for taking the antibiotic; this means taking it on time and finishing the entire course of treatment, even if you feel better after a few days. If the oral antibiotic is not effective or if the infection is making you ill, you may need to be treated in the hospital (see",
"     <a class=\"local\" href=\"#H12\">",
"      'In the hospital'",
"     </a>",
"     below).",
"    </p>",
"    <p>",
"     In addition to antibiotics, your healthcare provider may drain the infected area by inserting a needle or making a small cut in the skin. This is done to reduce the amount of infected material (pus), which will help the tissue to heal. You should",
"     <strong>",
"      NEVER",
"     </strong>",
"     try to drain a boil or pimple on your own because this could worsen the infection.",
"    </p>",
"    <p>",
"     In some cases additional strategies may be used for management of household spread",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     recurrent infection. These may include use of mupirocin ointment, chlorhexidine soap, and other techniques. These strategies are not always fully effective.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      In the hospital",
"     </span>",
"     &nbsp;&mdash;&nbsp;Hospitalized people with MRSA infections are usually treated with an intravenous medication. The intravenous antibiotic is usually continued until the person is improving.",
"    </p>",
"    <p>",
"     In many cases, the person will be given antibiotics after discharge from the hospital, either by mouth or by IV. This may be needed for a short period of time or for as long as six to eight weeks. Intravenous antibiotics can be given at home, by a visiting nurse, or in a rehabilitation facility.",
"    </p>",
"    <p>",
"     MRSA infections can be very serious and even fatal. One study estimated that in 2005, approximately 20 percent of patients with serious MRSA infections died; about 86 percent of these infections were acquired in the hospital [",
"     <a class=\"abstract\" href=\"UTD.htm?22/4/22595/abstract/3\">",
"      3",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H13\">",
"     <span class=\"h1\">",
"      MRSA PREVENTION",
"     </span>",
"    </p>",
"    <p>",
"     A number of prevention strategies are recommended to avoid becoming infected with MRSA.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Prevention in the hospital",
"     </span>",
"     &nbsp;&mdash;&nbsp;In the hospital, MRSA is commonly spread to patients from the hands of healthcare workers. To minimize this risk, patients and family members can help to ensure that anyone who comes in contact with the patient washes their hands or uses an alcohol-based hand sanitizer before and after touching the patient. Patients with active infection should also wash their hands frequently.",
"    </p>",
"    <p>",
"     Hospitalized patients who are colonized or infected with MRSA should have \"contact precautions\". This means that anyone who enters the patient's room, even family and friends, must wash their hands and wear gloves and a clean cover gown to prevent contamination of their clothing.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Prevention in the community",
"     </span>",
"     &nbsp;&mdash;&nbsp;The best way to prevent and control MRSA in the community is not clear. The Center for Disease Control and Prevention has made the following recommendations [",
"     <a class=\"abstract\" href=\"UTD.htm?22/4/22595/abstract/4\">",
"      4",
"     </a>",
"     ]:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Keep hands clean by washing thoroughly with soap and water. Hands should be wet with water and plain soap, and rubbed together for 15 to 30 seconds. Special attention should be paid to the fingernails, between the fingers, and the wrists. Hands should be rinsed thoroughly, and dried with a single use towel (eg, paper towels).",
"      </li>",
"      <li>",
"       Alcohol-based hand sanitizers are a good alternative for disinfecting hands if a sink is not available. Hand sanitizers should be rubbed over the entire surface of hands, fingers, and wrists until dry, and may be used several times. Hand sanitizers are available as a liquid or wipe in small, portable sizes that are easy to carry in a pocket or handbag. When a sink is available, visibly soiled hands should be washed with soap and water.",
"      </li>",
"      <li>",
"       Keep cuts and scrapes clean, dry, and covered with a bandage until healed.",
"      </li>",
"      <li>",
"       Avoid touching other people's wounds or bandages.",
"      </li>",
"      <li>",
"       Avoid sharing personal items such as towels, washcloths, razors, clothing, or uniforms. Other items that should not be shared include brushes, combs, and makeup.",
"      </li>",
"      <li>",
"       Students who participate in team sports should shower after every athletic activity using soap and clean towels. Athletes with skin infections should receive prompt treatment and should not compete when they have draining or active skin infections.",
"      </li>",
"      <li>",
"       People who use exercise machines at sports clubs or schools should be sure to wipe down the equipment, including the hand grips, with an alcohol-based solution after using it.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h3\">",
"      Care for family members of infected person",
"     </span>",
"     &nbsp;&mdash;&nbsp;Current guidelines do not recommend that family members of a person with CA-MRSA infection be treated with antibiotics [",
"     <a class=\"abstract\" href=\"UTD.htm?22/4/22595/abstract/5\">",
"      5",
"     </a>",
"     ]. Careful preventive measures, including washing hands, keeping wounds covered, washing bed sheets and towels, and avoiding shared personal items is recommended in these situations.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h2\">",
"      Basic infection prevention measures",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are a number of other measures that may help to prevent the spread of infections, including infection with MRSA.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Use a tissue to cover the mouth when sneezing or coughing. Used tissues should be disposed of promptly.",
"       <span class=\"nowrap\">",
"        Sneezing/coughing",
"       </span>",
"       into the sleeve of one's clothing (at the inner elbow) is another means of containing sprays of saliva and secretions and has the advantage of not contaminating the hands.",
"      </li>",
"      <li>",
"       Use of disinfectant (antimicrobial cleaning agent) on surfaces (eg, counters, door knobs, phones, computer keyboards) can help to reduce or eliminate bacteria.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Should I be tested for MRSA?",
"     </span>",
"     &nbsp;&mdash;&nbsp;It is frightening to think about becoming ill with a serious infection such as MRSA. Many people wonder if they should be tested for MRSA, even if they have no signs, symptoms, or risk factors.",
"    </p>",
"    <p>",
"     Experts do not recommend widespread testing for MRSA because of the small risk of becoming infected; currently only about four out of 10,000 people living in the community develop the infection per year.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H19\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1785057126\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5515590\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/47/31473?source=see_link\">",
"      Patient information: Methicillin-resistant Staphylococcus aureus (MRSA) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/23/4466?source=see_link\">",
"      Patient information: Cellulitis and erysipelas (skin infections) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?12/12/12483?source=see_link\">",
"      Patient information: What you should know about antibiotics (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/1/19474?source=see_link\">",
"      Patient information: Hospital-acquired pneumonia (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5515598\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/57/40852?source=see_link\">",
"      Patient information: Hemodialysis (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30042?source=see_link\">",
"      Epidemiology and clinical spectrum of methicillin-resistant Staphylococcus aureus infections in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/53/8026?source=see_link\">",
"      Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33290?source=see_link\">",
"      Evaluation and management of suspected methicillin-resistant Staphylococcus aureus skin and soft tissue infections in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/55/22387?source=see_link\">",
"      Folliculitis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/10/26792?source=see_link\">",
"      Prevention and control of methicillin-resistant Staphylococcus aureus in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43831?source=see_link\">",
"      Skin abscesses, furuncles, and carbuncles",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/6/29802?source=see_link\">",
"      Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/48/21258?source=see_link\">",
"      Treatment of invasive methicillin-resistant Staphylococcus aureus infections in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/7/4216?source=see_link\">",
"      Treatment of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/2/16425?source=see_link\">",
"      Vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus infections",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Allergy and Infectious Diseases",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.niaid.nih.gov/\">",
"      www.niaid.nih.gov/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Centers for Disease Control and Prevention (CDC)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;Phone: (404) 639-3534",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;Toll-free: (800) 311-3435",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;",
"     <span class=\"nowrap\">",
"      (file://www.cdc.gov/mrsa/index.html)",
"      <br/>",
"      <br/>",
"     </span>",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 28, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?22/4/22595?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22595/abstract/1\">",
"      Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22595/abstract/2\">",
"      Centers for Disease Control and Prevention (CDC). Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients--United States, 2005. MMWR Morb Mortal Wkly Rep 2007; 56:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22595/abstract/3\">",
"      Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Healthcare-Associated Infections (HAI). file://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca_public.html (Accessed on March 14, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22595/abstract/5\">",
"      Jones TF, Creech CB, Erwin P, et al. Family outbreaks of invasive community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2006; 42:e76.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f22_4_22595=[""].join("\n");
var outline_f22_4_22595=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           ANTIBIOTIC-RESISTANT STAPH INFECTIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           WHERE DID MRSA COME FROM?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           HOW IS MRSA SPREAD?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           MRSA RISK FACTORS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           MRSA SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H9\">",
"           MRSA DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           MRSA TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H13\">",
"           MRSA PREVENTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H19\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f22_4_22596="Keratosis pilaris 2";
var content_f22_4_22596=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F50290&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F50290&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Keratosis pilaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 271px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEPAYwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5cdm3N8x6+tJuYnqfzof77fWp7KEzSgY4rSlTdSaihN2V2XLJNke5s7z93mtaHzLmEoWJGKrunygAY4oty0UnJIP86+hhFQSitjz6kufXqUrBmt71lfOR6mtm7XCrcKd23tWZqke2ZbqM9Tzz3qyt9GbRzzyMfSnCyTiKpedpx+Zs6bBPcWTqkLMCNxPYCuX1YJa3hVJldfRWziprrVbrUE+y20rQWSgKwBxv9z6/Sp7TR4PL/eKWbGcGvNxWYwXuU1drqaYbDTi3OXXoZ0GopGTuBb09qry3rs5aJmQEYODXQy6ZaptAiXeeMCq8mmwKp3JhscD04rinmFSStsdSppO9jntzf3j+dOjEsjYj3MavvbJHIBnOemRUtorifO0cHsOtcjqLc2UWyO20q5mK7mKA9qvNoqJH8zvnuwNblhDJJgAYHoemKstYysQdhVAdoP4dalSb1E49DkX07af3UsnI4GadaT3unsW2SFF/iQ7WFdzp9vaxxvJIhdh8qqo5LHoM/wA60Gt7SO0VJLVZJCMllojOSd0W8M5x2uR+HPEUWsac1nd3qQW0aiWcINstwR6sfT0HWmX9y1zm20+Y2dqVzI7E/IuMnn1IHSvOde2Werl7EmMHnAPQ1pXPilz4f+wQp5byf6zjgnu2fU19Lg81jKm1WeqW/f8A4J4VfL5xmvZ/8MY9oqzajIUY+WGJXJPTPWrd7dPeyLZ2zBreJ8nHHmN6/SsyEuiCOI/vZeOOwre062SKaOFF2serjqB3Oe3868OUr3b6npNPm0NTSLAwlAp3Sn5s+vt9K7HTYsBW+duckNjqe/0qlp1kY+GjQHA5b+E54X64rq7W2LBYo1IBXdlhtP09z/hWLdzenSaFtIC8iGRQqrlScnjjgAfzNasEEUUscVwyxqD8xT7p/HP6U61tZ1YtcRqkKHcCMHgc9fXNblnp9uku6+RCEwyo68L7fXtmpZ304WWo61jRQ7QwvGuMnIJPoOPTjpUukNc3UayT2bW6BixMg2nHXOB+oq4Vc3CEOfs7kKECgmM8/MT12/XPNadsZpmaOVNyooYSYG18k9B1yMD86SNlZLYguYAViVTuaTAcq4XcO5Pt7dzUtjbD7KIniZYkO1Ekl8wt1GSTz+frVt4yyBGkCp0O0cqPalRPs8SlXaOOMbN5IJPPUn19fSq8xq9hmySCE/ZYt0vKrtwqgdepz/8Arp66eZ7ZoHOYSQCnOXPU5Pfn09qr+Htd07XFujpU/npby7JHC/xY4wenrU19qS6cN88EpDkkFELBVHUtjt6ntxUp32LUJ83LbUpS2928zrYbbZYlG+OU7iTnGSfXH161LZ2UO9z5kpaRdzxElkDNwSP896WWKW4MFzG0JE37twYyGRMnJBJGRwBj3z7VXttQlt7qS2u7MWscjBogDuLrjPboe+3imze0pJ26GiYFsbZooBgAcqG79sD/AA9aVnkkAVGHmNgxlum0YPQducU5lF5tktdzcAlWyBtPUn/PWnqkLCSNlJKrgqf4RjgH0pGD7vcR1eDgOqZyCGHQgZwP8fSo5DJ5Kyb9s4IDDHOPYevt/Wm6gro0Nuiq0aLhm3EcY4x7fWoI8XKqRIYnQYbC5J45B/Lg/jQw5dLk5ZMtjB3SD5icZHHPtUEsoCupeQxOQMknrnue2f61DIJppshEEUiAneTkcDj6YzzVOCZLmdo2VtkcuTz1b6exwali9m9y+xbAdWI2EKig8deKrXIJuWVeMHcZGbAH4e5qwgbzSpZVXIVcjknBySazry4SOGW7t45ZmX5vLPV9vXHp3NJkWGy3cQllMRJuSxUJ6jH8NJIxE7STsxbHyhecFR0/WpGhjkw21fNVeGLfd3DOM9qqsSkiphdhUbfm+6erE/XHWgl2HTMQVTe6qSQQeOvYcd6w5CRNKkjlWbMe5myGJOc/gK0JZla4VpGcjBOAeS3p7VkTSxNcxKhQKuW6EBXII5J5J29aZBDfzkNLGXbCKDnPHGOv8vxrEurrfESFXfgFsjHzdPrjBzV26l84MWQAE4AweNoxn6f/AFqwr6VZGkfPIGWJPc44/IfrVLUxmytfyuhUebkMeSOMDj+XSo9Gtv7T1mC2ZP3O7e+XCnyk+ZupHoPwzUWqSqPL3NkzLuVfoTxWx4FtrS6vbh7pI2uF8hI1cEoQzneMj+I4UAYPQ9Otd+Bo+1qxXTc8nHVfZ02zt7q9g0XRry5UC61m9sEvpbaZsiO3BIYRSgcAyEH7xJA6Vy3wx8P2uu6Jealc6fcyefeyGM28eVCgKMc89Qf0rofHniq31Gz1KHUUhuLiwjhnZljITd5TFQZAxAbP8IG09+eKyPB0N9pXhbTIbeO7likhE4eIiMEvljwAc8k859OmK+sjCTjd6NnzrlaLt5f1+R83EbpCB61s28K20IfI3EflWVGD5p+ta6/vlBOQOw9K8HAU1GDl1Z9NXey6E1tidj8wI9u1MnkRSVJwR7YpsMZj9sdqmvIgbfcBlj1r0Fqcuil5FWF/NYJwVPGDzxUOolrS3MAAxJ/Kr1nFGqEr94etYuo3H2m5ZgfkX5V+lcuLqezpPu9DamuedlsjS8PQBld5E75UmukSF4wNpwT61haHJiFUAGR1rr7JA6oCoA7fhXzM92d8NdBsGms6Fy4Mh/GobjTCZSDktjkd66Kz2oCmMD0PNFyIWB8qRWfn5QeaV7m3s7HCz6Y6SknOQav2Ol7Tlhz71tSiAKPNxubgk9vemLcRgcYGDQzSNjZ0myiPGF8sY3HuR3FWLu0QWqtCSVBJ+Y+v/wCoVlWN2IwxXO0+/Aq22ocMmz5cjH+FaRkrGcormH6WiW91AZQqhWbc3bnrXSeNbfTI7WGawZZQwCgxnGCPvE/mK4u9vVZ2K4Ugdu9Z+p+IEg0ySF3ONpAJqbpaFTWikmcB4gcPqk20jCnAqlOnlsAc4+lS4Mt0XxuLndUkCpd3mG4jQcbj19K1j2OSo7PmZY0i1LKZnXcTwq9zXoHh+yEQfyxmTHzOQBgAZ6/X06VkabZFbAyxqGkxlQDzjoT7V21rZGOKPZvLuuVU9R6cen1pyZFJOTuT2Onuy2scTYzIArEkkN3Prnvk119nYkyNyw4+UsACRg8knoOtYlrbMqL9kkxc9XlZd2WPYDv6eldTp9vMsZHmAlBhy2Mg5zz6emOelRc9KNOyJo4kltFSSBwjlkw4wT9c8kH/AArSgtY42EaI7lwCwB4wOg9u9RWUIgm3XkwYscxKOMnrx6nv9K0LXYWyCvTAYjnHfHbqaLmq00Q+3RShniAdnXIkQht2D0/wrRtVgnjKh2IbPPKngYPP51XcRxmMAOqp8gQYCk/SodFubySeczpB5TcRAMcn3z0x1ppGig5Rcl0NyKFREEMRZk+7k9uxzUcESFXxCESRnyrIApznJ/H/AAqO4leOYRoXzt8wkNwPQH0qxbx3G2WWWWLlsIBHghcDg56nrzSIUXa7KmnWtrpamLTYIbWyz9yKPCse9TSNFAxd+YQp6jPJxwB6fz4pxSVXBZ/LhzjC4yvTAHcnPFNt1Erlo0cokgAWT+Fhnn8zQlbY2trzNkG9Y5CqHIKEojjG0jvj16VPFHnyXlUArnCgZJ6k/jUjWyyTeY8YWQjC7jnHJ/z+NJdHzYVTIjf+HHQnrj3z6UXC6eiOc1LWrXTr2U3LJAiIGRmfYBnsfX6+5FaTTr5JuTHHHCy7mkLdxgCs7WNKjuFQ3gEhkBgdXXhweRg9iCOD+dTW+nNDpUaQ3PEBGwdTgAevHAJPvzRodMoU3FNPUspPFOjzrIZUPWTr+g9KfvjmkCq5jYNgkDbzxz79f51meH7UWVqLYfJbQsrR7ThmXsxHY+1MuNYgiujA6yxl2xuIOcZ5boePakZype81HUnv4/MEMTyEpkSKd3Bx249vWoVMCzzvazyPMDtckHgAAnngAYPX1py3W9kRFO/gCXGQQc/jzVS5ubhbiERpFIjTGFo1Of3eAQ5PQc8Y7VIrSehZtLwsha42sTIABjA+o79O9LMvlQiQnauASQcHJ7A+mKxYrS7El9HPKsjAMEUjAPzZB9uCPyp8xkm0iSLzBHJLw7DuSOQPbB+tJmU6avoyzPNb/ZZXQqhySSw4AHHP5k5qqfJcuVLo20bOCRjrk/hVS2SN9PSIIWIHlEOOCB/TinM21XDMzKoAJB5bA6UK5hJWditcTxrMwSVipjwAByeR7dDzWJekW8Cyyn59wz2J44PsM9zWrJNL9nZWwMIQBG3Xk4A71haqSFSIMyboSWd13AnpjnqPf/CnYzlKxHcPIsiL/rIckMAOw68e/rWBqE8cc7FGD5QFsjG3/Iq/LMy4BOxVAQqvOeM9e/qe1YV8ElcqERT3z1PpVxRyzlbchluFmlRmTf5cYCBePYY+vAr1C0tB4U0XyREty11ETHcMyxhwxDKitncGJ3cj65xXEeFNKfVNYjjV/IjhAuZZCA2zacJ1IH3vftmug+LWrpdSWtjax4tEkijt3VtzXL5IZmIOARtBAxya+jyijZOpLr+h85mNXnkqaMvxC0uv3Wk2ccfn/bJ5GkbaESaNSDsQDAO4ptByeQeldtPqei2d5dQ61ZobgSfJDE+Y4EwAsa4xgcE4x1Y9etct4Fb+1Nc1PWr8RxWulxfY7VHRpBCcDc2F5JX5QflI+97Vhak6ajrWqXBnhtpGunDrKh3Mw43HYdoz7V7cbSbZ5sk1aPb+vyPI7fBkwRnk1pEYUbRyKy7dws+T2NbKuVyQvHWvEwrUqSPpa90yKMkyMOox0NTx72jIweuKrwsrXBYZ69Aa3LeaFSPNXAx96uqKv1OWtJx2Rzd7Mba3eNch5fwwO9ZSgsQqAsx6AVa1GYXupO0IwjNtQe3auy0XRYVtkCL+8P33PQf4189jsRz1NOmx6mHpNrze5iaTZvCoZsiugs/NDYCnJGCa300VFhAjzgclsdatQ6asYQFWHPPPWvOab1OxUXbQzbZJ1bAkz6Ej86gvNPkueGYK/HK/KRXTrpzRkA5GRkY7e9QiMxbsqrEEZLdfWnZEtSRyJ8NXlwdpv5wB6cnFWYvBt1g+XqF0XPc4IrsbSPcAdwJxkgdMetaMMIRS+3KDqD0/OjluLqee/wDCM+IbcMILmG4QdnG0mqd5JrNkCLvTZ9vUmL5xXtEECuinbuLdBjGCfen3GnRyMQw4C45XGT/Wq5OzKTXU+fLnWtxKyrNCTwDIpFMjgiukDyTiYf73GfWva7/QISAZEB/2ducCuN8SeDrKNJJ8i1ZFLs6fLtA6k1LpyQX8zzrU44rWHhT5knEeOPxq5oemiN/3mS4646A+lZ+nI93dPK8jMq4VNw5xnj2FdzoNmECO6qVwWz6e5/zzW691WOCpLnlZG5olsBsjjAYA/MMbQuBx7nvx710OgwGNmtZ41VmbMZY7d5HI69vrUGnWMsiJ5LDaCS7D5dx7gE8/iK2rfT1jXM8aKWxgYJ2ehz3/AKVN9TqowNTT7cC4OG8slgcjhh759/Qdq2JIoLe0dpJTFGzEhVOzj8P5HrUVnAs8MUnzvNGTtYNwVxj8Tx1rWkt0MCSvG0qBceUejE+vrSaO2MRlrAkqCQDco+aIN1Ix1z24/Grd7ZG70+W3yY1kXYGiyGBz09qba2eG+0TKwl6hd3oOOOn5VcSFQkjhWEjjsxOMduDwaLGtrS0JVs7WDTzGsRAC42hjn0xn0p1vBGtzyi7iu1Aq4wuOTnp+FOWN/PhZ3IiZQvldMt149D/hWnt+YbCo6Dj19cUtgba67lR0812j27TKdrA9CMVK1q42gMA68x5XO04xkep6/nU5Qeb94Erjb9e+fbpxQ86IyJOcSONiE/xHrgfzoJTfQjKkDBBIjHyZ9ahhliRpFyI2U7pOcdc4P8/1qxK0iOT94x8hVbk5HSomEUc68DPJT15HIz600WnoRb2kYtC7gc7ty8EdOPx9PWoFnZWlEkTou4AOSMPg9R7D3x3q1JKAyxxjJA3BeNx78CqN5M7yqyx+Yu8b1Zgvy9zx1wOg7+tGhcdehAt7JJdSxsjxCMAlQAQAehB7D602RMlckkDd82c7eR09qlK7pNqwnEh3NJI+7Azyf/rUyZwhSJICQQFaQcY7Z9eaC21fRECPFCZPNieMs4YFeWcE449gc1Q1eJJJUmnwqgGKL5s4ZjyBjscVclOMPuHL5Abtx/j3qrch4JU8qNAxIEjMRyOcAf4daC4uzuRi8js7dFdHKo4GcZBOO1VIPKQyLIVVZnZyp+UAVeWEvsljlZolLYDgAZH16CsbWYlvnV0Zx5VyHLAAAYB4H+zzyKQKze5Y1BwYfOtlCxs4CgthcDg5P19PasSbU47a8uYRKZB5KSxsTkcDBOT0LHkAcVdv2cRSxy+VLhR5Sr0LAdM98n+VYGomKe2MvlrFJAnzE8CMgcADufakVCMWrM1IJzPBC8qbUdSfmPO3IxgfjWdqt+0UMsC/v5No3KuDgE4OD9O9TG7W20y1VSvnyxKUBxk88sf/AK9VJEF1O0jOyIBtOBjOBkY+mcUkjkaUXdkF1dCYcZjyAoEYycn/AOsMfrVO6kV403jA3HJZtxH+fSoUmMltI8ZEZGVQKOnXnH4dapTXbPEzEiJtmG6ccfzNNHHUuVryZWDqso3Hrj688j8hWYWjL7mKxooYs+fT/P8AM06S42qQHCnHJ9T6+3t+dL4b0uXxBr9lo1sm8zky3DDgpbqN0h/EDA+tb0oOTSR51eoopt9Dt/CMMVhpCaje286y3kc14ItrKqwoB5O5e5Y4IGDnfn3rjPGOq3P9q2EEK+Q2m2rwu6dPMkXEmeMFiXK8dB7iu0+I3iae2F/aERiKNI03mMOsZAUgKcbeh4xxgeled+FbcXl7GWlEP79TNJgh2mlB2gMeCyLk8Y5PHavsaVNUoRpdT5tSc5SrM7zTbe58LeBGvYrlYXghYgxyDdOWfchB3ZVgS33Scg4IFeeSWd7O3mxzu/mDe77Qdznlu3ZiR9Qa67xxfTPYWmnx3cUqsqTyQmI5jlzsJJyecL0IH3ie+a4u+u5VuTDYLH5cIWN97bCXwCen161pXcYR97by/ryDDKUm2t33/rzOC+7Kc9Ca27GQGLAYk46YrOvVTcETqOv1qWzk2NgtjHrXiYam6LcN0fQ1Vzxua1jbCSdegUd6TxK32S28pWyZeAfbvVvTA28479/Sub1u7N5qDsDmNPkXnsK2xdX2VF23ehx0YyqVtdkQ6ZtF7GX6D9PevQtKvuFTIyCAPUYrz/TFD3gB9M59K7K0ULtYEqc9cV8vVdpHt0XZncJLGYtxO5mHb+tXIbpplKMpI6bs81z1nICgDcr3Fa1ldKjuhidRtGHDDBz1Hr/+uiLudftUlY2Wk3Ly244BIyM/jWbdAbXKbjnhWJ71IdsgAVSWOSCRgY9K0bTTWkI+RgevXNUlc5p1LlfSElaARuMNsY+n4ZrZtFKnZ5ZbaAeTyfb3q1aaQTMwDZzxnHOa2LSwby1KopYfxdDVqJknbcrQuBbOBHLtAIICfdqxbs6oBKpwFypX09MdjWpHa78rIpyBzjjJqW4ijjjOFcZwD3xWiQOXc5a+3yFAu3n5sEdePWvHvinrckLHQ7WVWmmwbnbyVXsuffr9K9h8caxp/hTwzcalcyf6WwKWsTdZpMcLx/COp9q+bNPhuNTv5by8YvPO5kZmPU85pvREVKtlZGn4e09d0YZQSOfY49q9C0a0fEbMCobG4Mcgj1x2+lY2haerKpIxuOBlgGwOv8v1rr7OJtsEccZOWG18Y3N3z+FYtkUqZq2duY4FQhkZDvDlhk89lxwPyrZWXybffcxsqOQnOCxY/h1NZk1rJHBGFKvITvAwdznsB6jtVjwdHfXstx/a0UcC52QqrlnIyM5z26jOc5B6VNz1aOHvFyfQ39MgWGXz4ZMgvyjSEKFHYA9Pwratdsz7o4wsyjAbdkNnPGf6VVgsjBI2wCSRscMcYGe3bNP02L7NGYom8ufe0g3sXPJxn/61NGyiuhLqtrK9nmzneCYkKHByVPU4yDyM8VPplhLBC0s6s8scRiWV3wME9wDyT3PtWj5UN4NzFfPVQNhONxB7Hp1qdg0RKsG3D5crzt5z06f55qio1Hy8iCRY1eJnO0hcgZ4Jx0xUdzdywSxeVCzyO2wjAUDjOcn0/DrRCBbQxm8kUzM5VGHuThfwGMn1rRUqJFfI6YXAyfxpEaR6XM+8mu0XdHamUAD90hCnv1J/yKmWAS2zDy8NnKZPT0IqZRIqEkKCTyRyCcfnUaiTzju4j6AjoePT+opCv2GAtLKmRGVy25ycFemBwMEdeaZfSF7YNAfklO3OduO3B5+tNuRGImMcp2bWHVcE++Rzzx+NPtomitIYozhQqjGM8DHQf56CkytFZlCK2gN0tzEZWby8Dc2fx9jUssZhgXZtyB90n15Iqw9v5cIXzJZUjIKu5G5uep9SDVO6nk278ELt4Lj7vHWnuNycmMuJHDrs25KtkkY2k8j+Zqg3mBN4lfzJD820Alj049R/hU9xeRvZQTQBt7gYTPIU8YI9OvFUtPkWRWAyq5IJLY2gdMe39aNjSMWo3sWVlVFMZYblO0FQDk98dqo3MWXc5PlBjucckjHQfjUsMYiR4jIY4gSQyDp2Jz65J6VBZzmOwButrBRwRySBwB7+9DYtVqgguWcjCNG7MSokH5Aj6VkJEgvLyaWRtgCKV6g4yM47Mc9BViXUNlyXmdEVm2gAnv0Of8KlljhZHEZ65JHHXHOf89ql3tYG3H5mPdFJGZwfLfa2xABkY69PUYrKtY0tbFPMaEtK20bhwuTk9etXru7DRTmNWCqSmBzuA7g+nasu+kaSKObMQeNMEOM7TjoB2JH59sUJXYK70exVdWk1GSZJd4tgVGVwMMMZPrjioo7xLiWVBIHjj+XzI2yrcdM8evIpdPinttOeCVgZpTv54weSAB2HQVTVEeWPBWIsvJXtnk9e5pnNVmtSK4YwRNHCfkkPJHJK8/z/AFrk9YvZYboGNMxSSeWWLdX27sH8O9dDq9y4VgAFAOAQenavP7pAt1JeSkttGBvbC81SV7HNOrGFNvqaU9xuyzbRkZ2heufb8hivSfhXHDovhzxDq+o26CSWNlnuT5b/AGfCkLEFPU5OTyBnGa4n4VWtrrPiR9QvHf7LYyIIFHG6Vgx3sOpVVRjgc5K1r/EbxUVtrjRbBDEkz732SM0YGAWbDDO4tkZPY45xmvfy7CxUPbz+X9fgfM42tKpP2EfmcX4i1VNW1F5fKkhiMgdbVc7ZXHyjaMkKDjJ6gdvWu00mAWfg+G1sZVfW5LgyzXIQKY3Y5wHPfaCeeOevFc54O0pJnS+vJXijSPMG4FuTxvPTAIztXPT179b4xuXZrWN7I21nYHfcXMDjJL7coNoGSOgBGRn617GHi3++n1/L+v8APqcWImrqjDZfn/X9aHK6pdTCNbi3DeUn/HuHxulxlUBXv8xJ/Ditvw4iadpaR3F1bxTyMZZBLI2WY9SMDpWf4bszrXilbthFa2ELRkJcBjGG4EaORkgqvzV3v9lzXJN1epbSTXBMhSchWjGcBQAeAQAw9mrel70nN/L/ADMazUUqf3/5HztMSLpmP96p76LbskQYUjt2NQTKRITg9c1r2Pl3MCxSY4GMtXjU4Xck+p9JUlyJSEOpSWelNsI3SDYp7+5rnR0qa7YGdlRsxqSFqKvKxtd1Z8q2WhrSpqCbXU0NEUG5JJ5xjFdhZxttAUDvn2rH8J6aJ9rE4L8g12sNikRPIPOPpXlT1kdVKLY2CIiMN3q3aPtdWYliT2ou4jCuQ3C/eUdKqNIz/KGxzzg80noaPQ6O3vYYdsjZDDrST+NP7OOy3tmulHTyweBWEqncAyYHv0rQt7eNmGVXOD0/nTV+has+gi/E9o5CDpd+gz1CVs2PxRjxmW2uUB4wYz/k1UhsrdvlZMufQ1fj8OBgTCVYj5ip/wA/rVrm6MNFujWsPiTpMqkNcbWJ48z1/Gtq38Z6Y+We4iEUas8jbsAKBkn34HSuC1DwykzjfCJQeNoXOfx/OvKfFxtY9QOm6W5MSnbcMhypb+6Pp39/pWsXPqY1XFK5p/EPxZP4+8TrcpC0GnQfubK2B52jqzf7TdT6dO1W9F05QFEuHb5mYjr9B6gVn+H9N8rLrjd/E3Uov90D611ulW5aTLIq4UGNJCQ7KP4j7Z/lRJ3ZzU4czualosaW0BLGNpDtA2gnB9PU111pEkYSIKyzSAcr8xC+g9M96wNPCtqtrEY444WJMczAhpG6EJjrgZrtrLw7ax3TTBp1ynlRgueM9ce+D79Khnp0qSik5aEtlFcWswdpjHZqu3a4yyn6/wAI6nHrW7bwo9uJA53KOsQPzA89afa2YhgSJmfZj7j4OQB79fxq7p8EkUjNncrAHbjBHYk/pUm6kraD/I8yEpIGIK9VJDJkeo//AF1b0m0W0txBDvwqgAt82BioooDC8cULABQCQct7D+tWRJFbsBkdf+WjZK5oFrayJ0i2yZJO8nIOOfrU8eyZvnCrdOcEN/y0x2x60B8gLjLZxgHp+FIoJkUucspOGAwV/wDr4pkLzKenTJdy3EOJS8LOPnQKSASOADnHB54JHPerfKK75ARsBWU/M3t7elYuo69btqj6dBFKdWiQHcIzskGDgZHfimWetvJDcQzPaPNG7QmSMEIR2UBsEk+gq+V2udboTa5krI2VumVyZ7ZkQoGGSMZJ6E+o/KpPNYGQHaW9MYxz2/D8qhgkk8uNiMORjaOe/p6cVEC64bho+cqTnP45/H3xUGTiJeRxusgLZBXBYfeB9F9OKcpKQohYdhkZPy44/wD1/WqFtcieFJ2iCBxnyiTkBSf5jB/GprxpYIfOAaRkA+712k44HfbRbUpwd+VkkriJFJ2LC2A0ZXg8ng/oaz7tkml/0WKQ3TxE7myE+ntyfxGTUNxey+TL5bW8nllfkVsBF6kkn2qNr5YZIxPMyQvIoDcFS2OFz2Pemk0WqbRFLDfeWPtfkBwoULs4LAdfp/KqWiaa9jE8spyXJYrnjOeuTXQvdxzusE5BYuQG5wABzwfcDP1rEuvtltqzzSSMLYqEjQplMk9WPYgHj1pWdio1JNOOxTknlOs+S7J9jMZEYbdgOpyzZ7DnsDmoba/W8sUZonggX5duB8w6cHr6np3qe6l2MY4ZnldIyMZAypPPPpxxXJeKr14dOZYGMNuQAQhBJxyVB9D6+4zTWu500aXt2o7Gq8sFzd4TYJgC0b8ERqfrxmodTmlSFI4GAkAy4JyMcfr7e9cNpEdxKs12ZHRI9zojyAnb/dJxy2OOAOa6iymOoRW8qxAwhDuYr95gOD7k5B56YFSveVxYqkqMtHdIiu7lLYstujAhgsaY4ZDncx9MVD5CQ27RISDIfOdguTn09utPv7dXsHvE3hkXy0lbhWJ457DqBnvxWd57i3aHZkRuoHzYKkDLAqc5zxyao46mquitfSmNyjFn3yAE5BIGP5daoC5l8536R7jsBOc4449qs3LlIQ2GA6uen5/4VlXk6Q2kshcqFX5AD83Pb+pNCWpwV6uhT1W7Yx7ScEqTyOue+P0H1zW38CI9L1XxvcS6qmFtUj+yOWBBmLfcTdwZGAIX0wcc4NcHqknmozEkKRggHGRjoD3rovB1p/YHhK98Xar5n2SWRY9KsVO1Ly6jOFmYY+ZYizEepBB4yD3YWF6i/r+rHiYqfNBo6LxR4qvYrjUYYJLaXV7u6uDdSRottDGn+qiGANz71VpCOD8w/Hh5vD+poF8+6sb5b6SNnaObLzGQ8LkgFehz/UVQtxe3UdxqF+Zpd7M7spDO7NkuSe+RknnHp0rs/hjZQX97eSNHJEktqUtpSqyNGwK5lEZ5HA2qQRg5Oa+jhFTSi7/8D7v6/A8qf7lNxt5+v9f11OlsoLbQtJRtXllnnnU3CW8MO6GIKQixMQfnjyBjBK5C4wciuM8Va5cancqscU8glmzBb5DDzjxkk9fu/e9/au1+JVyLTTbf+14LkXiOY4RCERPJBJDlVyQxjYktgZORyVzXIeD9NfXfEQmjnLSQRiS3WJsBXYbnY9RhUGzkjJI9xXTKV48sXq/wRy01a9SS0R3HgTQoNDsFbVrh4Z7hX86VpVUyuwO45weOoyedoyRg1xvjfxVDH4kufs1oChCHaR5RT5QNpUHA4A/DFdL421m6gE13axQSW7/u4MMRPLI/yIir1HAOQe2awINQg8PQR6ZpFra34gUC5uZYgxkuCMyYJ7A/KMen1q5XhpB2dvu/4f8AQmn7zdSavfpt/Vv1PJnnEnG0DnGaLlhbRFY3yXGPoKp7irtj1prEscmvl5Y5unb7R9X7PXyEpD0paSvONDvPCMgS0hxjdt4NdUI2YEq4Oe2f0rgvDEhWBFJ2hTxg9a7Ozl3Kcc8Ywa5W7No6aTsid1eT7/QVnDKSEA4KnjjrWshJBBUAdM0xYULkABTj7xp2uE2yAS5XGG5XOAOc1ZjkbIySVwBx2+tPFtGhcAqvGeD09qtWyKgIAyzc81XIxKVmXdLDBlMeCxUMoc8Hviup04/v1zhnkx8i9F/GubsYd8nzdF+6Cc8/hVHxn4tHhSwFtYqr69cANFkBvs6n/loR6kdAfr6Z1hEqdRJXZD8U/Fv9jRy6Jpb41adMXDg4Nuvp/vEfkD78eZaBp0kskYC/JjLNil0+zmvLuS5vZZJLqYl5ZZG3MWPJJNdtolnGEYAFEXIDDnt2981UpdEcV3Udx2l6XiWGB0JJbLA52oo5yT3NdPDZrLODGZCm8I4jBz16n/Z9hRpds08cIRmMYBPzD8yV74966TT44lLQQM64IBkl6Oc5+UdcetZ6noUadlsWvD+mS2tykrpEXRj5akcxoeo5+ldYLX7RcrLMJVMJJTIBC57j34yP8isyztfOvV2SSwpGMkB8ByfX16davwXG+9UyiRdgykeQUzng5HfFS0dTjKWxsLExYbmZWJwWJBB9cVdUMZWcorqvy57Z/wAKit1Lou+MKmDhWHLHPoO1W1t5HicxbfM6qGPH6UtzNLuI8DLI235M/N9D059senpVS70y2vLqG4vwkiW7eZhidh9CwBGcEdK07d3WIBnEjnhn6c/SqcF6NQu5rdraYJHK6FpMBWIxwB1xznnr+FUjanzLVdCWAugeZMbDt2MAPmJ6fTrSrHK115xmaOPAJiYYHuTj3x/k1ZjGMqoY49ABioL6G5ZUS0mSGQMCWZSxPPp0p+oJ3fYfPBA77vKjaUsDvOBjByOaZPGLmSZHVkmbaQVAJkPoc9MevXk1MNzQsC5Qk9SuPyFUZJVWA3GC6A7lVBkt9KAjcRJkkuZIA5Mlvt80FTyDyQM9uagLxRxxedE5VH2pn5ipbIA4/D2FTRyQhlguHZVUDa6435zkDPUgf1plgEhaafYSd+Czbl3Y7n/OKDTYbcxMjLGrOJSp46BSeh9OvNVpfMkhkhkdsINqkkHfx95j27nA9KnvneaFmd1kyDtQcAKDnJPfpWTdwveXZYMqqI8FYhnOSCuffr+dNdy4aq7J1hSRWF0gAdSGwvbHQ+vB/GoLuzV4VjICxpxhhyCcYP1qcI2n20sk8pmEeWBCgEjOcAD04FQ3F0qW0c8ikW8hCqSMnccke/r9aQuZt3iTSKxQNAA0m0AmQk4HfOPX2qilyUV5MyNDkgocqhbPP4/TtT/tgWONGaNQrYUKcZ7EewrO1CaK20lA+Y7YZdDKDnr0I7UIUYNuwy6ktJoIFjjlZZFIcoQVU8+nT6Vz19bW18rmPczQPsdCp2BiM9+o6EkfStG5lKeUbVVjtwQWH3QzEAkj/PNJdRhVLMPLVVKLmTcC397H17dcUXN4ycNUzldUshFbw2cGQXJYyAEnaBk9Ohzn860orZYgsbsycY2bsZz3I/z6VZIdlGCNyqBuQBQM9iPxB+tKGWNC0aM8vl4+cHcM9sfrz7UtzCrUcn7xi69F9pknhJbyw6E7lIUE8gcHAGAT+FUo40NyyhFK5UoWJx05ZvYkZFTzQBbUuEMrnnZuyST1z7e/0qneZ3Okr55yyKeSe4z6VW5y1qvToZk9zvtHjXCo5O8nuc965/UJg+AqtKBzlhjPpnPQVr38qxIVVj5fJO3u3oPr69hXH6tckuQQWZ228DcSenA+pwK1hHueNXqGl4c0Q+Kdbi03zfs9mAbnULo9ILVTlmz0yeAB3JAqPxjrq+MPFdukFrJaaJaKlrb20QLC0gXhV+pAyeeTmtnxM1x4H8K2nhq2UjxDqpF1qw4JQDiG2OD0VSXIIHJ9qpeHNPlXTxo2j3cyXF2/m3lxljCsC/8ALR1A+6MnA6kivcwmHsrPfr6dEvN/lY8upVt7/wB36v5dCW30mPUtYltg1xP4ftGiWScr5QhVn+UlecswBIGcD8K6nxj4iumnisdKhhs0CnC2kOxnjIULGVBJ+XbneT/F0qe713w54Z8PCz8P2QfYm46ndNtaQ7id2zPzMTg4OTtwO1cHp8es+J76YWMEy6duzeXF22xADzsLgEquB0GWwK9dzVL4l772S3/4b+rHnRi6r5vsrv8A1v8A15jItVu4NUga1e9vr6GVPL8lGLGbd913PfOOOenbmvQYrO58EeHbovara67dXSeec7lhyMuCwI3EtnIAwFHU1Z8GeNLDQPDi6X9ieOaONtwsogIpSvXdL12nCkkfN6muN8QXs99cyyamk8VnIFdWfMn2nJBWMMx3DP8AGVznApwjOLc6jv2/4ff7/wDgEylzvkSsvz+W39blO4nuby8XUxcLJJMsjIked8AY44J4LPnt/Dnoc13fh3RdEsdFtE1kTSXrp5jnyywAPQAnHasnw34ZZtt7qdvdQSSSEAD5Wj4yTns2D0GOgFd5bLpcVpBs02+vlZAweKNcL/s85JPfn1rRKy5pdf66mdSd/djsj5Rf77fWkpX++31pK+FPsAoopKAOj8OswgXOCM5/CuutHK8kbQR1rlPCzgxFZB8oPpn6CuzgeLiPGTxk+prna95m1JXLUbFmDAEKRwDUsjssbNhjnsozTYTGjApgjGef51sWk0MYwWz8uSAOn40rM61y7HI3WtwQRsHDBumSh4qmni22WTbv2jsWyD/+qvULbTrK4jzL5bDHQAcetcz8RtS8P6BbLZ29nb3msyp8sbqCtuD0Z/X1C/ieOukOZmNWEUr3MS5+IAsbF47D9/eSLiPA+VT6n1+lchp9vcXl29zdSPLcSsWkkfksf8+lR6ZpwaRZJsDccDjkn/Gu10bTChDTRLGgG1ePmY+wHOK1cuh59nUeg2x0tmRooRhTjcAfvD69q63T7TzmikYKyxfIIgMKG9fyo0vT1YOY98hIw3zcLjt6c1taZosr3Er73ULGflXpn0z1zjvU7nfQo2WrH29ncXFrGkM3lSBtoKqQOvOB3roVt/skcczRxyNEuPOX0+nuc1JpVjJMn70mIxgbFRiAAcdz3reghSNJFjhIVedp/jPcipO9NLQzopZrTTWuYlad9uF+UDv0x+NamlXHKIlwhdfnljx8wz91RjgYP1qSTT7KWOKa6cmRFLrngjjH3ehxS2hhs71YnQq0o+/j5nwORgduhzT0sbRUZJ2WpqG6KQzv5c8rxIXARRyR/CM9zVyzuJZUiM6NbyOuWU4+T2J6Z6VQtEOotBJsdIIiXy+VL9Rgr6dDzWtCY2mMZID4ztzzg+351LMJxUdLakwZRuJGARgccg04EPjao3kYwePpTVxuOSpBGMr6Uhy8cqIdhXOCT098UJGZVtYXDMXZpLhTyFzwDyAPX8amLN5brGSQxAG7qMnr/Wow3koFkMjIuVLngkn17dKdHOsip5IJbaeoxj0/HtT1Lab1II0W1SQEBizGQ45HbOT2qITo4/0QBwg3Fgc/Nk4+oGRVfUPMuNMlVUYS4G4ADIOc4xnqf/11gaVDqFtPcm5uw8CNsiJURsyAkgtjoB0x6VVtLnVCipRcnLU3ZrYG/a4uZQVUcDAJHqePX0qJNYgN9PAkjK8OA4Izg4z34JxUELXMt46y/NbxgFD2wewx26c9arXZSG4kCAeYeCoGDnOPm4/I+9Kwcl9HqXxAk/mEtv3DJ2gd++Pw71BdTw24Z9wW3AO7vk46n6fpUlpJHMHIb5h/yzPBC+n1qvfJLPbTBMKGAAY9Dg8fU9aWzJS960iG7n2vGyBJG3qo3EnI284PT3Oara3dRoYoQdqoPNZWyM46EYBPtxTrciK5n8xX+YFS8rko2BnIH6fhVZnaR3YxI8i8sSOeufwHOaqxpGKT16GZcatGumTXiRO06JxETgkMccDqM0xYnvbOA3u4RtHtaP72XPqTwMcc98VYuLVbi5Dxgs0Sb4xwo5xnI9P5VZhaVZYwVjcDJIPRTnOMd/TNI1nOMY+7uVZreOBEZDlnALkjPIPGPTp/OqF9NHLK0MsyNO8x8uPd94gDOAOpznmp2g+0ai01xL5UK/xAZCDGSM/XnA9qrx6fYw6m19BZuJ2BbcWIWMAcYHZjnrzzmkznlJLfckjt3UnaFMBzjLDovTp/Oswmc2xVwY2klbARgSVBznHYc9OtaEcjCGVlXDM+SyHHsQD6Y4/OsPULpIreaXapZI2C4PDnpn/OKdjkbbvcqanN5Oy3jKxrJGWYdflGOD6D+dY17MYwz/6uBTtADdT6E980kU3nJ5swIlZAZMHaB6D6+3pWJq9yjAYdPLPGVGBge/p9OauMbnnYiolsUNYv1RWKNmQEBSBj64Hp70vg6a10tr3xdrCb4rBWj0yGQYFxe8YOO6xhgx6c7ayLOCXxJrcWnW7rBG7+bPcH5UgiH3pGPZVHOO5wPQVD4716LXNWttN0NXGg6aPsunW+DhlB5kKgcvIfmJ6nPtXdRSh78l6eb/4HU8uV6suX7/Jf8H/MrG9u9U1C61/VrnfdTSZEszElpD1OMcj1x0zXRQatquP7A8L2dzcX12xllkMG2abI7qCfkAzjOAMk4ySa6Twx8PL7+yV1fW5jpsCqqIEKPOxYgeWoztt8g9Tls+ldJEng/wAMW0UxZLUlfNjS3uTJdlwSCzEHPzYK47H2Ne3h6NTlunbu+t+v9dOjZ51fEU3KyXNbZdPL+uvkcbpXgLzNVV/iDfzWyoCZIbbBMIxwN33QScLtGTzniu3fVLTQdDSws9VtoLd1KpFOjbI0YEHcSMZPPOeTnpxTbrxZrFzod00GlLDpQcJHeam/lkq2MHyxy7DHVR0Brm9Y0i7inLXZa7csfs73UWz5COqQdVbJ4ZvYiu+hSjC/Krt/O/m2ziq1JVGvaOyXRf5GHqkqX7STWVytrp74KnyzuuHGBiGLJOD13NgdfpXW+CPA8tm9tq2qXdvFdDbNFbM3nvg84OeFcqMZxx6VZ8N+HGcrcMWaRYy0i20TZUnPDuQGPYMR07V1kVnDZXdveQ6fdiO3ZI2jK4hQsNhYO2MkcDODx6USgubmk7v+u5Mqz5eSGi/r+v8AIztd1e5a0tjpchuGkmcsGwHwBhl9xg/pWbZa9rdvbqtppvlqfnblSWJ5z+WPyrT0XWZDC1jANN8+GR0HkwNIwAIyQw44UZGeCauWPiKCzjeK7MFxIHJEjhQxHbIAwD9K3s0rKNznVup8pv8Afb60lK/32+tJXwB9wFFFFAGt4duxBcGN+FPIOe9dZagSKSkrFwM8nk156CVIKnBFa9nqjRjDNg+mKzlDW5cKjhsdzDcSYVdhC44JOatJcMjFkbqO1cza6sWX52GD0NF/rxtlEdpGk1yeAWBIT39CfY1KiypVkzpdW8YrocHl2Q87U5VIjBPywg9GYd/UD8+ODxVjYz315LeXk0k1xI5aWUjJJPOcmpdF02SR3mmy0hJLu3Jyenua63TbGJQofBQHLKWyT9cdPpWqVlYycpVmM0rTo4EWRlBYdOfuj1rqLCz1CSHfZRDzMlR5mAfb6evNNsLSFwm4OySNvA2kkf4D2rtYYIooEaGEySFMBFzwPqe9B00qXK02iPQ7VGi2NG0sikEyLwsjdMD39+ldLp0Qs5nYsg3EBsjPPJ57VVgDT27rG4iKZV9pwYx6ZHQ1c06ykkWVpPLIDYDAn5lxwD656VLOyMPkEqySt51tKZShz5AOBn+8e59qvwWF1LeBmkiWBQ26NFwz56cnoO9WtNt4kR5kVFdvlkZV5yO3PpVu1Zbv7ko8phgMr8Njr/8AXoNvhWiIkFxcXj+UsJtI/vGVvnJwcgDpjtmte2hj2qHQFwcAnsO+Pb2qvBaGOExxtuXJdlUbP5e9WYFMsX+kFVJIYdQc0mRKXYhGlR/bjciSZmB3Iu44QkYLY9SOK0EhCMjBFzjAcDqKVV3bMMVGOB0/XrUrqsTAEMQOwHJ460iHNvchEEsFwXEuEYZWPAGPx7VTsmSLznKMZWck5QqTk8HnoP8ACtNtwUgDnPO09Kxr+0VrxZEb94jFlJyAcjBORycVSNKdpXTLIeVrTYQjSY6IMKfb6frUTROsbIZNzF/MDYGRznb+FMld58IAQqyYYFMbh7H09/ao9VvDawecsJkWMEhE5LHI4Ud+Ov0p2NYwbaS6kkrNFA7A4AwSMc46niqN1LFBBI+0/vB+6XODIR/9b1qRAt1BJHcT4LkAMeMtwQPemMqi2Pm8sWzwPm9yo9aFoWkloxFljvRExUbmO4jJCjPGPc57VT1jd5ZS38wSphxk8ZBxj378fSrMluGjMMMzABfuqOw5PI6fUc1jXD3t3JEsUJjtonZZA7YLgAYAJ6+uTinbqaU4q91sg8OXVybS4N9EI2WZtkgY/vE6bwG59q0bm9Ejw2r+b83JOMcD1/XmoniEpDOB5irsUDgFagnVkKOxRlG6QE8/KOn60rahPlnPmsY2sxX968LO8cMdtOZAAuAw6Dk84xnI6HNVNSur77K1nYxjzpI9/meYQRk42njg9D34FdFJdfaU+eIFZflDBTuz1xj2+tRyIItOZ/JVpFR2ALZ3BT1/HiqbNFW5bJxM6K2mVIGwftKhUkByoHHzc/XnB71I6BY4HtCx25Pyn75+o7e1SwvKbGGS8aIXRUO8atgZPLcfU/yqSQMkccsZMeTuAGO5xnFRe5yzm76mTubnyh5jy8SEn7rj1qnqDFpmabf+7i8tgM/PnuassRHIwyFbAcDgFASOvv1+nvWdf3axOFWPY+4kfNg57nP5UJNmUpWILm6YBkmm2jr5YHQdeP8AHtXJ6k/2i/JBDJJIoVOQNoHBx7np9K0b5i00gjcb2XauARuJPzEj0GKw9ZuUti/O2YevPykcn3Jq0rnHWqWTsV9QuImRw5IU5wAOvbj/AD+lcVrWqRy3RUdOEXAzgDt7c1c1rU8QuqsVQrhieTnHt1+lcZdXLPICrN8uMEnnP4VulyK7PI1qy8jTv7+Wws5tOtpj5l0FN66N97HIi46qpwT6n6V6F8GvBl5e3X9o2mp2WmXUURZJZj5jHJ6KoHHAPOaz/ht4Dt72xfXPEFw9vaIcW8EaB5Jm9QCemcdj6HGc167dadcLq++1uplso7cRSRoEiKxkDK7QOCBkZ9c17uBwjf76pp/Ku3/BPIxuLjFOjT17s5jZZLFDFLqWoa6b2cxSxAiCGU5JAKKcsflzjNSaD4duNPtWv3tdN0bh7nN1FvkOP7q9VwCeSQDxWkuoaRp11LbaPZyWzxkM0qwh5I1OPvMcn5srgj16Vma1eyzyrHqU5h89zIBJOrPNjJy3GEX5lGCOQK9tRb/4OrPK5nt/X3DlvbE3tyUllvJdjCOeZTJLtYnDjkRoASB68Vr+GtFmeM6xI8UNw6L5U12m8qzchgBwT0P4Y4pNJ0iM3cUHlrezLEZZZW3eTEwHAUYx2xjHcGte/Wz0mEz3NzdRxLGiQ20D7FQMQCTxjOMD9amc/sR6k+ZakfT9Cgs7vUdamuZggEskR8tBkfMqgDPJ59awdSis1jmmmu5r2GZyyKJn8w+YuVbbjG4HoCOO9TaxqsNpdpcQW0X2ZYVUWzIWUvnhsY5cYOSOwqreajdwz2VzJ8kNx5jRSFRCQx4LALkg4XuevpSpwas2DY1INTttKS0WOSNvMZk8wiLyQ2QcheFJ9P0rP0/TL0wFJI7dWjdoyHiTIIPPU5PPeluL0yRB4roGMLgMsxKnn75GOSM1uHR7OZI2e2izsX5mcbn45Y89Sc1u3yrXqStz5af77fWkpX++31pK/PD7kKKKKACiipIYjK4UEDPJPXFAm7bjrZpWkCRvjPeug0bTQVjaYtgEk89T3x/jT9D0p9yhc4J+Zh3/AM+ldnY6QhhAZolPOC5wAPrRe2xCXOw0jTzcTxRjy035IAGcgf56101jbwW00UWFMsjBFB789fxxnn0qfTrdPKSWMHygyxiReh44HvXR+HtOWCV7uaPezEBVb+Dnt7n/AOtSO6nTS9BujWi28syqswkYeWSG2ggHPToBXQvBO6iAyKeMsMYAH86gUzQ6lNPPMXhwqLFEoLuxx0P9K1tOtIrzyZWkSWRExIY3+XdjlRjipuddtmwhtojH5dp5Yy3zFcEhiPSpYAUuXgLzySBVCgJxEMdfTJxU2l6da2yypaW7hmk8yRsnljxjNaUkTHanloArDkHrQaJpOyMnSZ765up/t9rFDbRkLGPM+dlPfH8vrWzb6ZapBFbKght0JZY4lCqD1578fzqKa4tnvhZXLx+bMgbyyuWwD1+maspdJHdQ2c00Kyyh2iQZyQO/PXFGprO8tYq39bmmkK7yVHAH3u3TvUoRHIBjyTnaSc49eazZRcwWXJkmmLhCyYUgZ+8c9B6/WrcTu7YEW0dQzEcj/Dt+dTY53B2vcmdWYrsJQo3UL1A7c0+RWkB3DLA4UFuo9Mf56VCt7F5GWYIzcASsFOOn50j3ojnjgYSb5PurtyP++ug6GiwuWXYcJZEDfNvDEkbB049f8apXVwVmSFo2ZZcAlcccZ57/AI1JdrFbM8mWDN1wx+boM9eByKVQSQBjCnjjPAHQHvT2NYpLUSSeJWQuVYuMKq8n3xWRcWrW93aybJHbdsYIcD5s8n6YHHbIxmtF4g1xHMEBQrtyMdPUdx6Uk8akMjqRuPIzyff+VUtDSEuTYrm2SeILLGY1RiybT2HQ596gliV42WOQeZ8y7+o5HOO/H9K0osRpJASxUD5iBg47Y/WqFvbIjzSQxiOJmJwxzlucsaaHGdtzF0/7al8ZHJa1aLYMgg7x/FVm5WRlXbLvIIAVVBBHfJ9B2/WtJpVlZY3lBAAYuCByM8Z/wqmkYSRio2xheEzwp6kk96G7s1lU5ndohXEa48xvlPUgnII4Jz9aawjuA2drLkALIfQ+vfp0qC4eVk/c5Dv8qOy5zxncMdj60qRxRMfMd3aRty5OevJUD/OKBPv1C/jlkhfY4Z3KlFBHIJwf0/DtTbuGKBXmSN24wFJJ5BH5D/Co2nMd04jGSF3Fz83rgL706W43xIsySb5AF29Wz6H34osYybVkZ14qxXFpJPIqyDCp6SMSfx7H2qvNdCK4iiPyNjfgclRk/pjJyapajcwzatELhZCIRxKTwjngAZ6nHf8ApWdf3e+8nu44nCsApZvl4Bxj1Oe4FO1yajXUnln/AH7SPtZkUklRn5eoJ9h2/OsaW6aVjcYcvKNoYrg7eenUZ6kn2p97dSfZXEh2u4+cH+6uen+e1Yt3cNgp5oEYyuT2/D86pI4qtVLRCTXawiU4yix7Occj29v515zrOsG6ufMSYtGoIOAQQ3THuOh49QKveJ9WeXzLWGQBcEMwHJPpXGXcoSFI0ZsdFGMZGeWPvmtUuXVnBWr+0Xs4ialdeYVUEkAYAP8ACP8AGu8+F/gJtUjl1zWnis9JtsENcceax6AA/wA647wxpJ1W/HmFRChBYs2AeeleyXFxpdzatpahL1Lf5mWEsoI6YPtjGcc16+WYL2z9vU26I8fMMV7Jewp/PyO4ub1I7YRyQQWyqiQm7thhEU/8s1c8DjuPzOK5rWLqEXzbZL5oVWOM28Cr5m88BP8Aaxkc+xPNZ3iWe5v1is7iO3hgiCQxxpETgdiBnDDqcnoTRoGi3l7bRPYb4xEwAn6GQ55+YYCgevvX0UYqGr0PCsW7yXTbWAQB2sHmDs7GUyzyD+4VxndnHzE9Bir3h7QXka2vIJDI00gU3U67n2g/L8vZeMHv09a0H0OwtppN1s10d5dBGxCuQBvAJOSoxnJ6kGt06hBKiyDy7O3tFXeLYnlnO3Gc8tn04HX2rKdXS0Bepn6xf3ZDW329maMlUt4YshlGM5wPvcHBPv6U+5lt8rAttJPLJGE8yUbto6ky4wpOAR9aoPpyPfQWbW0txbuGkMksrCR5g2WOfu8cAccj3qjf6drDz3k94k0UIXADhEiXA45JAJIwMHoeaIxhor2EST6ta2usQWUTNMAmdsGCsYI2gFuinGckemKzbu+2yeXJG88Vz8sUCJuKxZwCo6evU1CslssKCe/mZmjIk2Rr8mOgz2Of51LYvbpHPdx3sdwCwAEzncCeoCnGevQHvXVGHKIuSapMLWB7KyjayOFRCgLkcZ7YAHHeoXh1t55hYwQNAjlRiNiAR1GQeec1CLuzOrMVvUKwYLrEjSRyNjdhuxAOOB0PWoo9bvgpDiGdsk7/ADAmc8/dPTrS5dPdQI+en++31pKV/vt9aSvzs+5CiinRRvLIscY3M3agAjQu4AHWuj0XTHKqQhaV/urnj2JpNI0zk4XzJQpz6f8A1q7fTNPAYrw4KgM+cAetDdjK/P6E1lYQWtmqxoGkA+dwTg+wH+etbujWX2mweVo/LV32hZfvY9fal0q1EmoqXVTax4wRnJbn9frXQ29oy3OVUpCw3tuOcjpjPf1qdztpQt6jrbR4ZZLaLy8ohDIqN+7HruPvx09K6yK13+YHZiZSSWVvm7bTjt/9aqcfkx2DSxebFHGNhZE3FjnAwPWtPTbVvKgWLzY4VOCsi5c46HPrz1qbnYk2h8gisbGNJUYxY+aQLk8cDtx9ateHYc2/EwNtnMUcYABBHc9ST1q3pdl9mjKvO8iZJy77jk9vwqzb6cltqH2mEybAgRICcR9yTt7k+vajQtSVnG4xN53SQwrLOcIFLbFHJOfy709LxvIxB5UzkZUE5AY9enp6VFqcMr6axwsckvBWMHbnBx+Gf51k+D9OkgGFYGFck8ELnn5RnGfw/Ohao3jTi4Obex1tvCpQPLGDLt2Mepx9f89ajj0xRewTpsaRUZN3U7Mg4yfcVaVH8l42ZgrbSSo54xgDvyR/OpyGUsI0ITbkcglj1wPamjFVGnoxUl7Mck9WAGKR3UZERD5HJH8OR0B/D8KWOIyMmQdoGRG3UH+opkO2ItGu0BiSBjH4Y/WgmyM3UNDt9RuIriRH8+DGyQt0GOduepPuD+FaaRmNd2QGbADZPH+fenS3CI67yuQR1Ix+FQ3cgO2RlDMgLAg8Z9OP88Ubluc52i9kMldpNu1WbccMhAJWmLNtklgELGKL5lOOoI7fjkUs1wY4C0URLnDbSR82fr0xS7wpV1EhyMDHv1oDpsVGK222JIykcQ+TB49x/hmgTxy4Z8sd5xnqSB/Kn6jDvgc8BTGflxnPGMH6Zz9aqWto1vbwIJy0m0jzsZAyM5I7dKZouVq99RYn8xZZoZHO48E5xjPQD0qK9fawiYSyEMoBXgKD39/fPrTYnuFUPc+WjZ2rH645zgcE4pfK3/MJAJGbYxKnJUeuePyoK0UtRkt3auuyVID5ZZHfjCMOo9/zrOurmNrfzVPnK6l9u7bvHQkf19ar6rFb3cX2aPbEUlExwMdD0GOoOaq20TbUeJGDOxViSWGcff8AQY4/rTWhvGEUuYltJVsYoLdpjJcSxCSKMjgDPPHrUcMEv9tLfsGYNtGwNn5VB4A6Drn3NIbKaW6F3K6kwqY2wDyzf3R24xmprTBit32hAoIEafdYd/x4ptkVKqV7PfcjtDKqO1/IS0h+VioHyk8CobhzHLM7BsJjAXtgcc1YluFIULu4fcCR7/pzWRdzwSxt5wPlLIZ/LRuZOdoz7k8YoRxSm5O5CHJ3XV5lpZGIEQOEUjuMjn8a5+9kZZJTI24Kwwm7J3e/tkgVcurgzeTJM5RmnwwRvu8nKD/PrXN3967+WMKpLFihOQCOi/QdapHJVq22GaxfSQNJtkDuAIwevPBJ9gOlcnq+ohITg4eX7ucdB/Fj37CptUv0UXDyHMQjOOxfPOB7Vwmr38kx81xkuNq+2P8AIrVRS1Z5tSo5vlRW1G7LSyRqeM4JzVOCGW6mWKFS7twAKjALMFUZYnAFekeCPC4+zm4uC0cjMCshHHHOB/8AXroweFnjKnKtupniK8MJTv1NTwlplvp2mGRIY31KIj5QhkJzzg9h0/A967Oy0Z7aEXb287si7p/KkAihBwAjn7rE+2cda0Dp9lp9qzaU8V3dnEcKOpMRYjnd7foOKnu9LvZNKtYr+a5mJhbzIVyBuGDhEAwP4gCfrX10XGEVCOiPlpzdSTlLdlTTbO4nntzPBLNbNmNonkAijYsQDkcu+BkdhWzqcE1lPL517dW1sI1jWOXGdpOMJGBtUngEcn6Va0u0naMHToDZRmMD7Z5aloAW6CHoGIP3jzViLyjPPbStILYlpGnuGIcnPOT2OQMY46VjOo3JtE20GMlveaWiQWtzaOh8tY3fazxgfeYAcK2c8c1Fb6akbzWkc9s0NqRPHZWVuXlKtjBaRuAc56dueKu3n222Nu0IuN5QqsjqC1yOoQADO7GSOxqPUIrbSJHN4s2yOMeRbjKRkfeYPt75PT61lGTekXv8w9Tn/EOr6bLdCIasjXeCPLswXaAjtxwoxkE9/wAqyNUupkjMP72B512hZmEhYYGWCHhMZ6nkAetSa7qFtHYibQTZwTAuCQBujRh825j13YGBjsK5NrxL2/kDTSl1cgrIxOOeuO/0716FGHKkmRa+x0mmxQ6dFvazjvbaTGQ7n5F3YVm9eR1pdTa3VrSOO1slCMrL5MRzI3AC4HqeuD261HbQw3MCXD3FxeNEBGsRzGm3PHPUnntxxT7u+1WOeOaOG2iaFjGmSN6gHghfcdDV21v1EVksrie7a4ubu0s2I+XTiTEzdjwOcdCe5NSulyreVbaUZ0iAjMsKMFcgDJ+bBP5Co53vrm9lZ9s12WZuXTeo4GG54BGR14zmrttq13FCGh04OkpMgaaUux5xyfwptSBM+b3++31pKV/vt9abX5yfdDlGWAzjPet/TdNZljQKC3Vz3OTx+FQ6LYAhbiVd3dVrutI03a25sK4PJHUfT9aL2Mm+Z2Ww/SNOESNgqpY4AI6exrq7GyTzYwiMSWCgZ56f554qHTNOvEMckVsmGOUDct0O3PYdyc9q6S2tWiCPdCNucvz0Of4RUas6KdPWxVSyNlOqWtoJCFDcnAyTwBnv3rotFZJRKrxsJYDtkTb/ABZ7nHQD0p1i1vfzG4VSsbFUHmDbnng1s6X5Rt2j2PGjsxKngk5xn68frQ30PQjG0dVqTi1KqfKAxs+XI43YPOKvaeJPJCTSMZEHzsBj8qiC/wCkKkZO3HzAjOfXNXNPmJmkwjssbkZP/LTgYIPoM/pRaxoovlL0aR28Cqm0KmGwMdz/APXqQyNG6kspJO0fj0/Ko1ZgqCRAI2XlUOSevTHakG5ZVVju2HafVsjqR26VNxRhfcsqQwO5cykcK3IGDwfqeuKsxKOMksM8E8gewpkMZbO1CobnIGMdj+lWuExHGDuxnpnpSSFLsglUF5CWwo+YkdOKpTpeJdrJAyGHbxk9PqPxzV4R7pkHzAJyykD5j1pwaUzv9oVflJKBecAnAyfXrVoIvl8xicyB93yAEBs8fnWdLp7y6p9okkkMTODtPbA4x+HbvVpoibnzB95l28SZUc8/L0z708l33MigAgktnPbn/wDWady4ycdUUtYhD2azJ5ZaL5vu9RngZ7VYtbgeYEmUr2Hp+PHX2qKNpPmEqYUH92GwD+I+vNN1C5kghjlSIXjM4iEakKOe4z6dcUeRdr+4XEOyZiQvzL8jd85qKQqrsw4IOVz0zj9Of0NJLM0EEku1gzDd07D2/wAKjdxsMe3BzuwfTtUmdupHPuMfmlQz7eEQ4BbHY/X19KS2JaBCVZDkeYuRngdfzqKVlVXLDrwxxxu6E/T3pnmq8EczkIoJzvUqTnsfQ55pmltCKORrjyw+24O8AgEfKV/i/A9qz9avHtZUjVEMsrLESXGEByT+QH8qtRyKnmRiQSORhDjBK+nv3zVXULF7iNuIwu8FPVVxyD7n24wapbmsHFS97Yy7aQ3I2mNoI2cSBuMEHsQOeuT+NW4INu1SQobKlS2TgngeoFPtjzJFCu5kbO9hgFuBj3x/SiKJIJHkB3NzsIHQDPX1PPSgmtW3sVbtRcRxCI70jk3jJK7yCfmx35qC5WPy/PEjCJAFyP4hgDOO2T/KrvmqogUqpmK9Dzz3GP5VlXrKtsSdpaBg3HIyD3Htmnuccqr2KrXBQ3TodojA24JCrtGeD9e4rJmvpIrpTGvLIOSeFONxx7npRezSGZlMjAFt2WYbQ2eh/QgVz2qXjgS24cllJ2vncOuTz75GatI56tXTQW6naNIfKILxPukyf4ickn3FcjrN9FGodW2CIHZjJLE/y7VJrWpqqsAwQg8jdhQe/wBa4XWtUIDqhyz9M/wj/HpWkY9WedOo5OyGaxqbyr85DBv4R29qwppXkOXOcDAHoKaTkkk9a6bwBoM2ua3EsNuLnyyGMWcbqqlCWJqKnAUnHD03OXQ3fhz4dheH+1L63jmEci7YXOGf2A/HrXruoS276QbeC1WztFfy0jUDKtnDcc7icZDdqn07QbjT7BSiLHaSTlnZG+WPHA5btVt9TttO1I2NtJbXdy3mu2WDeS46Ejp36V9dh6cKEFTpq9j5bEV5V5uch2iLqH2K6FnCglEYNuQ6q7gsDg+3B5qSzgv7KzN42o2s0wldWMeVCLwSrHHP1p1hHqGr3sMgEKRjKO7vwp2kj5QMnqfYVr/abC3srm1tbiObU45ANvJULwTn6nmlObTstb7/APBMUuo6dJhblSMO3z7W4HJ6kcDjjrWZb6mNOkklleSe/LlfM2ligwN5K9AuQcAZrI1qa/v3kmiZIh5yYZmy8hBwH2/Xhfwq3L5j2jMBHM9lOUDynYWzzggZO7PBxTjSSXvdRX10NzTdaiuxGNM80rJuzJMx5VOWJGM4Hv8AhXFeLkto9LMustIJTlIbZ7khcnJEir1bg854Aq5e6rdWcdvDqMr2xkMivJEACVCgqgPuSRuHvmvOL+8N/qLm0lF3csDEnmn7qn7wyT+VaU6Sp+9/TGk5MgEkcl4CkkMEKYLuyA4QDJwCf51u6Tq+iaXcPBpkzRuoMjXJGDJu4Y4/qMYzUKWljpsAtrvTRKZFDvKzlmifgDcRwOO3PJq+os5Ijeahb28ssOxI0kG1HOcEFQf/ANdbqMt3a5UpRemtiC2hllllW0k/dykYkXLrEBySvqQOPxqTUoUuL6MzQsk7KrXDJH5PbooznJrZm1DWJHjXSrX+zLKLiME5I+gA4BPpVP8As65iv4kvGmvZCrG5upQHhRic5U569smrU9feMy7pWkafIzpapcSsi/6qGMMoDH5A5bk898k1Y+3QRqq6leXVtMOkayEDbk8jHB5zV5rQy6gWuBp9mjQqil3zluCo46EYzmtS2MJgRb2SynmQbfMKHDDtj2rCVTvqLfc+QH+831rU0exMkiySxCRD91M9T7+1M0+xM0gZRuOSTjoo/qa7PTNNCRqQoVVxjII6/wBa+AbsfbOXM7In0jTmiRVcqZAw+TqAT9a6bSo/Ln2ARySAlyCew7+lJaWxcKZnVdvVhkDp2/StjSrSG5lMMcDLCYwjyPwMfewD/P61O50UaKerLdtdMLhUKuYUXzPNC9hx8vqa6C20+PUIoJ7u1kUZLIshw6fh9OtOtbcIEgACswz8vVR27dTWhaP505t7iJ3g25B3csePl9/Wh6nfTpqOsUJFHMyx+WiG1VzkHnZ6EAdfxresrGDT7Ty4TIZsiV9zZYknJJPv6e1RxK0coS3iK5YFYsevfP51HdwytdW7wzvGqsPMTA/eg8bSfTuaDZLm929ka/2VZvMiYAxY3EYyCRz+hAqTT4HgsE8yVpJQgLSvjLH6VBGJVlaNdqFgNuOmM4PHr9fWta3RS+11GeQfb6VLB3irEUSNGzt8obG3OwjnHf2q/BGIkJZfmdug6j3z9aJFA3IANh+8PX2PrU442kFQoGACOKEZOVxRniMZO45HGAPxpzbcOS4GD1x79/eqt5cJayxeWo33DcM2duQBx7d/qasQZZgxjI4BAPGPrVD5WlclBYJvJUdWweo70wgb1Ta21mxxyRxzz9f51LJhljDE4xzgcdO+aNqBiVG3ZyR/hSIuVrl5I0maFFd1/wBWoOM4/wDr0iRuY45dojl28r1Cn0/P+VWXP7wjsRkDsDUZbyYHbzVUnlTJyPTJ+tMpPQqCTzkeZoikikqueMY4/Kq6FLa3PnIBG0oyBk5JPQe2ec1XgtzuRhNKDJIZpBkNuJ69uBn0q8gBiZnHyrgk5xnt+eKZq1y6Fa9h3TSyrIY1bBIByGx/F/Smef580iRtv2jIOcDn37jr71nRX0geeNY2EZyyNINpPTofT3plmlyh3XOwxqxYpGc5U4wMn070Gvs2lqxiZgmvArGQvKvmAkjZkY4B4wasEyNdFGBLEsd2PTp9O34Vi6tq0tvfwo6q0UsmCyn5k5/StcyTPANiokZYhynPA/zz9KOpVRSSTfUklCP5eIgz9QxbBRh79ahu5nhgdoFRj5ZKg8BiR+nvVS91T+y9O8+cmRi+0lRy7Me3TgnmquuGaRLIwyuoWUSSuV5ZfTHbn+VNW6mEVqr7FLSZLttNmM0ZW+d85RiRtB6fhV5i+zMg81APnTOB1yDnt24p84YqvlFDKSHY5IGfT1qgdQijjf7SCgLbGjC8g9QM+/WmYVanNdoS+kljtJo4sNcGRiO5IJH9Kx7yddsskmxVwOCeAD6+5OaJ7qOSR5ostIOA27hl/ug1x3ibUGntXhRyMYLMxxnnP41SRySffQlu7xkh/dkeWGMnlsdpHUdu3tXJanqC7JGYfOzEgnt+X86TVb4ogWOXCDg7TkcdiDXHeIL/AGymJmDMFAYZHHsPfmtox6s86dRzlZEWvap+/aFXSQDAJTpnuM9/SuelcO2Qu3jHWkJLHmrmk6bNqU4WJcoD82OtJKVaXJBGqUaMXKRb8M6M+r30cZDeUWC/KOSa9x8O29t4XZodIsYp7uJQwSZRvVscuSO3PSl8A+H47GCcR6ZeQuAFNwI9ignlCCeST3xXRadaxxxl7PTory7abZNJG2xRgDdz3+n1r6rB4Snhadmk31PmsZi5YmemkewXkGpahYSTajqNg7tLljFuZz/eXA+6PbHap9P0LRtPs4JrmObz0QSFwMhz3GOrOxx9Mc0m77VZ3NsRBp9qGIj+zod8h65+bkg+tUrmTVILW0ila4klkTasd2FQKDncy46YGOT16V02k/dvY4jTiKXsM8Uc909w5XMO3YI+OEGBgHgE80to9k0ou7iRZr+FGP2ZePkHUsehY9BntWbcS3f9m3tncvHDasCkt4C0K5UAnIPLc4HHbgVYurkXy3R0yHzLZxGhuXPkxlihYhlHYAZB6/NRy9P6/ry3EVb+4W7tobWDQ43uPMeQRiRt8bFcgluAMjPHTipNQ1V7KxttPtILLTo7dPKTzphKzGQHl+TnGMZ7VBq3ibSNLZ4EWW+kiRVCw7sIfRnPdQeOorhbjxPbpp8sUS5jzx8nAIz1b7zdvarXJvPRLu/+D+nzHGEpfCivrGrQHN1a4kkmLbhONxJwAdg/u8cVf0jTItLktpbuKWee4XcwI8ts4yFUAH5QOM8Vm6PNC5OoanHcyzELFFH5XyxR9iSemfQVvm7u9k84spriAIESK4Gcrn72QeO+K1p+++d/L/P5l1PdXIv6/wCGNBdRtPtcGpXnh6ZN6loYjcMgdum5lwc9qiudV/tCOBLLQbCxnicsGEe5WOBknscc1YvLaCSUNqMH2BY4lQRorSeYpJIK5PAzTtV1CKZks/D0ks9sy7ZHRfuso9DjI/rVJRutPzsY3KNxHLdQQvdXNz9quI3jG+TeVychOyqpxnPpWy85ZFtY7+NIo1G9YFBG4rgKw6Ng9DWfqF0sltbWTIJJDxs8thub3AzjoB+NXLyOGOP/AECymiSRhJInlhdgyMqSeewAFN20QmXdIuVEdtCbUSXMwKI8/wAoYAgng5J6de9MudNnkndvI+1KSSrhC+AecZz2JNWBbP8A2bYQz6fczg78zwyoDEDggeyH19RSS6lFYsLe5ljhkUfdKsSB2yVGM+vvWF22+T/MLdzxXRrM4DEeUqnAOMD/AOvXV6faD93uJQRsTkjJHYk/rVeCPyGjLqzyu309ecd+a3LSykYNEqhd/Qkg5/I9fWvz0/QKVJMLe2SSdIBklwpxuPB6jd7Yrs4LGIWm2FcAHcC38IPXH1xWZp9mlorSEw+YTueRzwcnAH1rpLE7pzvI8sn5iU/gA4pXsdqiklYi0y03w4E+QeWYjGccYH5GtTTLU2o3MX3zscIpyVHb9PyqRI/IYzIhYTtjLvnB+nfj8OKuRMrymKPzPNQkBB93HHzH1/8A100+p0RbsFtG6KiK4I3Ycg8+w9gOnvRILoSW8UDIbhmHmgp92PucdvQVclKwzMWACHJLR88jtj3FNO+3njBLklQpZAA3tluvemaQfUuW9syXpO8OqIVQAep7+4/rWqCQZCcAAkkk4zgc1n/vIRJhmZom6L1x2yKeIma6sx5pKh8yB2I8wc4Bx0ySDipZnJc2rLyhyA5Iwo+4gz+AqxHKJF80A9cHjrzUQYAfvAMg4HuT/wDWp0bYjYyOcszgOnYdB+PrTsY2FaMO+505jJJznrjp9cU5pgkkQI+YjHXpx0+nvUkMbtHncrMv3S3UjoCexNRXYjgG4+VkMAD2yen61SGtXYeLnzHbaGZRgA5yD/8AqqRiq7s/dwSFJ6/WqsMK2xbyQAzPv68k9T9ahMWCm5y4HIDdySO/tzQx8qb0HPduj7yyAnC4bpn2NNm8+S3cx3BSXblSoBCn8eoqhdXELXCRPMhZ4y+FP3QGxg+nIPWrbThAJm+VHwuQOfx988e1Hoa8vLZpGZ4csbiwU2/nSyRR527u+ffqAMdO1XPNggRLcyeRGepA7k+p7/0qrYX0c800SFcxSFCVz8p55H+TxQ9nBFfLOrM6SfIcnIHHGB3zzSZpP3pNz3FSEzEvu2wq27AGS3PfPQ9MVU/tKKHUHsGcC7aLzRu5Az0U9gxA6VNN9oZ4RCkbwqf3pJ5O37uB3qO9sYbq4hmz5jo5lXaeCegP0FMm6+0UdRtxdKEkUKGTDNHxhevB9fekE6hJXOYd424JxuIGOfQcdajuzP8AboYYSIohHlkHC5HGW9QeeOlOubqG2JV0Lbk+ZcZ9sD/A+tPqTKTskRGVWmc3oVplVdwBJCZPynHrxUm8lJlJy5wqA9AQOv581UmcLFLOVUjqi54BHT6cE1n3d/FZ2ayXTrDJ02cYB9j3qtznm+bYr2Uc1p+61G8lvZVdnExBDbmPKhR0UcYFV7ycSRyAyHY6ndkbc47ZPTvUF7eOjqiu5aVC7sVz8vbisG8vCwDGQ5A2jkFR/nrxVKNjjq1eo/W9Q+yW8gt2MatwRGOMdDn+WfWuF1G8LKGuVAVBgAnr+HepvEWrCRQEYMrZOc9s9a4jVdT82QB3BOcf7PWtoxPPq1JT91Euqak8oYKpVEBbnt2rlmO45NOkdpHLMxYnuaaql3CLyScCs5z53ZGlOn7NE9jaTX11Hb28bu7kDCjJr2nwL4Xawt4mKiOcuT5ezezADrkdsisn4e+F5oLWW9W4iTbD5gAAYvXoOn3HlpZWAvxBHOrsrg7Tk8bRjquOtfT5bgfq8PaS+J/geBmGN9tL2cPhRvW2qXBzp8Zn1G8dFZyMeVCM/d3DBOOap293aafqLad9j8o7/LL7sq5JyHPPQ9OOeKi0+xurLXCsOpYuZpVQRRZZFG0DDDt0zWpqv2WysZPsphuL2ZyIQyH5WXqSf4RnJwK7Xyp8q6/1c8xjLm5FtdzLGYoZWk3C6lRZGZMjKgdEXjAptiLfVmhby55523svm4AVerBcnp7mqUVi7XRbUri3W4dUZ1VDucZ4UnvwPSry/wBlzi2+0xl5MkK0fyxBE+baTnk8dMUNJLTcQ9La2lM7ztHKyEgShkkCk/wqDxwPxrC1W5kk1hooLl5UDGOAORkKw4QA8KvoQM+tXookL3F2kc94GYAK0ghjj3DI+VfbjJ5rLuoX0+yimUeXayqXeLzFZ4yxPCjqccY5rWlH3hM524LSaTBJL5UYgDQnyF2+cSf+Wh6lh1zwMVzViov51hhSOPT42ZsK2fNdRk5PVh3IFWr177WNSGn6eZIBGp+0Tbg/loeMkDgMegArqk0z+ydGSGSx2W2FWKSaVUcduvJGc9hk1d1UnZbL8fLv6m38OOu7/Dz/AMinp01/deVFc20CxMmGnY7CFAzg565+netE3tsunSxX2qM2FVURThXbJGCoHOMjp2pkml20SRgxwSSPwkjzsjjBOSBzn8fwqpPLcxf6JaQyzuxErL9nABG3aMuecc4GK16asx0b0KVwJWs/3zLcwttUwhjx/wACH6Va0yWNXtAEtjFDJ+8WQnk+jjqR1ORUbRM80QuxDFcqwi2Rxs3mN0x2UY6ZFalq0ErtdvcRxFAYwskQzgdCOOoPbnNW2nqBfuzcymOxg1B/LaMN9ms4vLYjORg9R0zVywgM2rHbZXM0fmBJTHKW2P3c569PwzXPQ3k1lq7XFpdG/uSpAWOE7pOMHgDjJPr2roNMGsgS3W0aWrBcKwyeMZf3PBB9sVhUXKrK2v8AXQR0j3enF4ozDfB0DwyFIgRtJ+XaOhOc1R/tK3kRHutL8pmHyhpcEr2OOMfSqf2kzRxXt1a39xKJSkYFwsIkx0yB0THc81zurxXN5d/avPS3EyBgvmcemR7cVhSoRbs/zC5nadbu0AmZ42y27cMcYz610ljahfJyjyPnAAHcjJz7+tZkc0TQFJF2DOB8u0HnOAO/TrW7BIwmERAYeWSDn7v1PvX5/c/SoU32L4hkKQKERw0mx1IwACpGR9K0rKJyBDGFAJ2uTyRg9Ofrz9RVG2+V0HLOvOzGOP8AA8c96uRNi5ECyEynDFh1U+mOnrUtm8Ymmu9VDtEkaxEbctnr2FaERS3CynDDJHuPYfzrGnmul1FIxsa0cZ3Aln8zOOn05zWhDCzW6gKzqPmMj4JYZxn/AOt2pmnLomy0pzIZ0RlxlBuHUE5yPQnH5VoRwebGfOK+Wy5ZNxOCevPfrUNvIWQyM7eUwAyRhs/3iPpU8IYSZZyUxwccdc81Qm+hJAFWeXaqqvBHzFicdc/0p4ime6aZW2q0exQy8Bs53Y/T+VOgYGXey9OQcbcc4pdOeebzPNDFVc7cE9j29Rx3osK73LaIVGWALHGSAOeOw/z2qM+bbyXM25pYtu/yQvzKMdvc4P8AkVLp0dylur6g0Cys5+aIkjGeozz0x+OabFfNK7bYXV87T8u4ryRweh9fpTWhCvd9RdF1JL+COQK0WOGSQEFTjgfSpb8qZI2kVX+YEcZ7dfrTyiCJo5E3vHySvHbt29TVLUbgQWzedE2wqAY17Z45I6AnimFlKd4onJDrLIjq0DEBcc9x0qrekSW7RRblVxsPk/e2+h9On5VLEscKpsCBFXJReewxj9f85pt05DHcNpxuUdAT2P8A9agFo9CqLcphgBuDY2kZGR/h+VN1SCO5tzAAAzrh3XghQc/zqwxEMAZiXkA6k4znr9OtMmmWIfNtOcEAdCM+g6AcUFKbvchVTFFBEgJjJ45wRxwM+venS7F+RgTn7+DwnHHPpVa+u0tLSSeR1VEG5ucgDGf8getVraczIrXCARvGQHbksp5yR9MUA7tcxJOyXUCM7Oq4B8rOAf8AOahfzfkW2YPggfeABGPb39KW52TQRyRoV2HA5xx3H05qvJMIJJGVQ4HDKRtIwPWhGbn2Kl1JDbRqJFM8jsRnZ2xyBnp/jWQ0kks4McrjcqY389s5HHLc4/8A1VoyzwSwbzuaSRcswySvtWbK6+VMF8yRX2pnPEmONoPpxTSIdTlEu7xTG+Czsyg7YxwPfj8yc1ga8XuvJF0RiM7xFHxux0GOc9Kk1WeS3RpLlohPKdoQA7e+cfpXN3s/lM5MZeSX5mYHgL3Gev5Y+uK1SOSpW5dixfXqhVDnnGGTf97vjPXAzXIaxqSBriVyhB+WJAOGP0HYdSTSalqCxs8vlhgq/wCr3cE56EjoK4rUtTMg3S/PG3AOMbjjt6gf4fStYx7nnzqOWiE1rUlkUFSruM5z+Vc/PKZCPqST6mknlaR8EggZAx0qOonO/uo1p01HV7gAWYKoyx4Ar0D4feFZbq9WeSNWQEAuyhlGQe1YfhfR/tE6tJG8rnGI1GSvOOa900mxktrWW1sMNPGNhjQjaj9CGOPzr28rwCX76p8jysyxtv3UPmT6laGXT0S1tbe3kcqsZGPLQEdDj6cj3q/4dhWLdd6hDb3U8EhhBtgCsOBjC1QtrO6t7cJefuLUSeYUtMyStxgKT0H4elakinStMR1t7C3jLGWYKzZbPOSOpbFe3N3XKup4RcnuJ50liuJZLeORWcyrjcndVXjr6ZrnrXUp7++e10gJcTLCxEpI8w4HO5jwPwpZNcfULl42hVBOu6PzI95VccYXPPAP5imI8NrIY7aQqqgJJ8hb92eclQMDrwPXFOFPlVrf5CNuz04x28E8sR81SQyow84ts++zE429KqaZ4dK2y3dvBJdTs5VZZWAO7OSMcAAcninackDXEaMk9mIxJJObwZKJkhSynqzHoB+VR3HiFn1GWx8P3N3eRSIssxli2xJgbSQOBx17ZPrUe/e0WBW1O/AldLy7ljt3cKkMUBQvnq/rKRjIPTkV5v4h1BLZCLW8nvHkk2x+aQ0kkhPfHAHriuj1bXER2F3dpLJGrJHyQ6HAzknouPxNcroNnLrU1xq10YorLYYoFkyBtA+9xyCe1azbjanTfvP8O7NaUftz2X4+R0fhzRdI0LT7SfUb+CLUZZTJcI/JJHQAD+EHNbMk1vJPDeCf7dEZ2DQSuVVQORyBjGOlR6NZxamsbSaRaW9zBtjWWVmcs395gT+Nasun3azExtbqqncizyDYwzyVVRnJ7ZqoctNci0SMpyc5c0tzNh1CKC/mOpW0UBVhItsOWUEcHnqPxouxpLapDfWV9OSJcP5jhEj2kfKqdSea09TktL+Z9yJHd2uYxIYVCyNnoMndgDqfasvUZrkqrSWDySxBibmOEJjdzuJxxVR95p7E+hnSzzvMq6fdXOoRsdqA/wAI/ujPUnn6Vpvpt/I9slqscUMDCR5J8Mkbv6Z46YHfmqqa3c3h0+0S3htTFKQryEJuXHYnqfxFbFl5tuxub63LWkw2rKh80RnPO0D5QfzqpSaQPQkT7Jp8hRr24knAYXEqSiOSP5gDtUe36VSv7qUahGZdTku2e4YtCmS7KuAoOP4QCOe5rR83yr6CaGEuGTzBLNb9UY4+Y98fpmrmo2GixalPHBHKwnXBCQfebvjByAMA+9Y86i1f+v8AIRn3cFo1sLy1hMWwGJAfuk85BGcY4Oee+awLZrgoXjiDq53/ACwNIFz2BxwB2HpWvZ2t1JBHZz3VuLW1JcxtAVzyfXjmlgsmniEtjEv2d+VZ791Lds4GAK0UuVNX/r5jW5E+l+fJa3M+cQk5w+OSf5mt2KAeayqMW4wAMjHHrVGNkjtrZmVnCFSuTksc/wCNa8MZQjLhpGPXACrn0r81ufqrbtYvRYcFBGv2lh1Hue/0xin6SN1tGPL3SynzJOCCOeM/lx3pbCF2lkhZdqlcK4Uk+g59etaFnaMF8pmDxs5Yt3btg+vShXE0kidBCZEwiMq8HaQeCP15xVi55t4yFjEKswbnggDrnvUWn7RIyLgoMhwBgj0qzFaPLfeYZ28uNQPKHQ49RjmqsJKz1JLSDZCjRHk43AnBbP8ATnpWgsZkjKEphQdzAHkjrj8ahNvhZAuEUZYs3J/KrMalY0REJwg+XPH0/LnmqIk76jkRJCWU5ZBwSME8ZJzjpULa3Zw6iLXcTMwZ8MDtAA5J/wABnpWgI/MMY+XcQVGBwR3A/CqGoaLaXWppOI1ae1ziVv4SwwRnqOPTr0q42KpSg3aoaqSGRkZixjUZBIweaE3SAPIFC5xnZ09vekibZCpmDJld3JAKnjHNNEhkDBBwWxlhgDPekzJi3ZTyysrYjbliDj8KznNrqkEMvlebEGzHkY5GcNU81wVlSOKJptxJeR8AL3GB3/8A1VEgKbQ5BZmLEfdVTz0HvQUnyrzJtzC5wX3HABHoaxNY13T9Eikub+dY8NgCQli7d1UAHt64FaayYAjBJYjJx1TPP8qztYitr+NIZbVZxglfMGQuCOT+P9aEXSlHm99aeRaivftcCyLGUVsbUPXnk++RVNwYLsPIzyRsvlxwhR8pzyeKfJDGsXzOVjAwoC4444/H9ajmlWRJER9vlFcHuD2+vWm9CLpPQZdQtOjNI0flIThSmQueufWmXO+eEJujEHBk74HUj0GKWZ0ZAD5hBAA+bAwPVazL7UYY7WQuWVV+RiicMx7D39v8KVu5Km3oTJq0d0Mxo+wuYgyrgFV6tj07Z/Kq5kwg8oSDewVm469DnPYetQCYqHlucKq4J2nA9AC3c5xWXquoraWzNJEVjb5AFbh27D6c0WZDetoos3Uwhj2W4TAdmUocIB/eJPUn096wNTvvKxHAuVjzjCYyevTtjjjPWqOpXl0kzKg++4YwA8IAOAPQd6y769EVwZLiXy1LMzYb5SvqPxI+laRictSVnuLqGo3CW7NKyS3DL1HXg8+3HrXJ6xfxiOQb0YM2GYMR+A9ieM9abqOrrJFNcspjj4wpPJ78D0/+tXEavqkkjtliC3P+76D61vFJK7POnNzlyxH6pqhUSiMEq3GAPlH+elc9I7SNuckmlkkZ+CcLx8o6UysZ1ObRG9OmoLzErc8OaX9tmDyK2wei5x+HeqOlWL3twqAdTgZOAT9e1e2eD9Cmgt47vyHKRx+aTGnBA6Ybv9BXq5ZgfaS9pPY4cwxnsY8kd2aHgjw+LVozLOskDgyBZCEKkchWxyfxrqpXs2SSSEyr5GZXlA8tAoOSgx97+uaxzcPb6XPfXli6kS7lQoEyD03fjWlG017bQ29zeQKka4meAny4s9AxI96+jlG22x83Jtu7HPeyQaii2yust2wYkkIqEddrH26ijxFf2q+UiwxPLMTsLtuLAYyxqlqN1KxuItFtIwADEkrHcc9NwPbPWsJFknvlRhC7BwpZRtH+0x7AZqoU02pPoI0J0ja4DWcOyW7yWu2bcyKByAP4Rn8auCD7HcNHaTTWe+ELJOjZmkz8zIq84PPXA6YzS3VlvsLxfOZgjDywEZDvBB2Z6DgdTxU0H+jXFzeSIbWeXBuSrhR5Z+UYyd5PXJHrTbutBFfUTBHqlpLZWrxaiVWLdqG4LsjGd5UseSBkZ65rJ1zW7lmupBcSSmZ8hVhEZCAcZz0XJxk9PeqervptpqF5Ibi4Nws7TQ+RkMR0VctnKDHU45Ncj4n1y7kvFjskLX99gqmfMcE/32PUj2GM/SiU4UI88v8AgmlOlKrLlRFJbXniS/m0+LfJb25D3twMBUH8KZ6deM16G6WWn6bai2tYJFUhSxYmPcBxn24rK8D6VJY6W1pbht5UzTTYx5p9WJ4IBrZSO6v41aeCyjg3bElkm+Qvn+6Ovf606MHD36nxPfy7L5fmFaopPlh8K/q/z/Iz49as5Li5mu4QlztMhFrllDEYBJJyqjt9a09OkcW9skamO4lAkE1xIFUDoGUY6j9anuLcXWowJqFraxeZCWLw7V80I2BuC9jnpUmqaTpdqsT3kyx3GzP7iZmKjHCcD5SR+lXzrRGLsVzdw+ZafZl027vXYxS3bKQQ3Y5z35GPWs+7vHiu5otRaaR2kYSssmxVVc4UJz7c09LLS4raE6Sq+fG5VYnQOxfGSApPQVHYx3Q+z3V+8UsMinykK53hTgqSOQc+tXFJANtklkhlWa0iSDhzMT5kigDI4Pb2rbuJpNTswbm41N4EALQwRFIgF7fjk9qk0eV7S2kNxBZQLLn5ZFIZ8cp8x7npVu7voblLERzXEDbP3qkYAyehb+E54rKcm5bfMVysL3R5Lz7Fb292IFj2tsLEnplR6YzzWjfXRn0xylpf2VtkJbmMeXkgY257DPU09pZraGH7JPAftDhgI0JYgk5yR3GOcnmsjX5TPbBTc3skCSiSGMkKZmA5G3tzmsUueSt+oyhL5cDboLjz3LsrwFyQxA6Et79/yp2js7We+SC1uS7EgsW+THBTj0IIqrcTEYNml1HdAmTyguQynAQ7ucYG49K37LxHDBEUfYcHjFn04HoOvXPvmt581tFcES2cAnkeGePJCFfLH3SeO/c1q2sSIriQLKofzDhu3HSooiIWJEeGLlxwSAD3A/Pk9vSrNsxu43Pl7eTgluM9hn9cV+bH6pruaVoEjuXkySQoIP8Ad9TVi0nZ7XDfIM4xnpz0qpDGZXeQJ8qr88hGd5HXHoOozVyKNY5PJiaTAHAHzAnPb+ppryJVupJbzJDK0h4hLld543Y43fn2rTso2a4lkxkphVG8ABeuT/npUNusRgWJlyB8vPVfx9aurCzRl3AQNz5RPA9CfX3qhSaJbJ/MRhEvyh+ZNuA+e+fTNWBIN8iKp8w8DCggD1+nf86hiWInbG2YmH7x9zEsT1x+P9afJ5KsyxoAm7BKnAJ74P5VRnZXJl8snYnzBOGA6ZPv2pjIhEiom2JuWVPlz+PUH3oixHGWVVjXOY484L9+R+dH2gpE+xDIxOWZjgD+tAvQaTiIbwhZlC4Bzxx3pqy5Uru3lMgN2DH+dNafasrLKSycHaBgE4yAKjZnKRhhhRyExyeM80wHseAPNcjkE9fTnFV551ZpEdyI3UldrFWGDgnNQLMxiLs5Ks6sB0JHpjrj/PFEsqSFltiI1YgmQjPI9qAtYJAEhcgYjI/eOTjGByefwrCa+33zQRrOWdV/eKPkwegH8z9au6lcRyFbYtHISgzE+MdeuPc8ZqPfGlwdgDLjYSDnAAAKr7cY/CmjSMlFaogvxFd3FobqaZXiYeVDk4LHocfQc/hU0oiVYl3A5YvluQec7j6nP69Kqtcq05ztaUA4DnIXB+mfaqX2l4YCGL3BDfdbGTk9fYenpimyZSuXbtpIflbBmGGKKfvDPygE9B1JPtVTU7lvKEfmRF2/jP3VJPPy96zp0itpp5ZCztOQzkSH5fQZ7HA/Wsi61CO45CzeepBAU8IMnj3J45osZNq90X5rl5oGDyA7GwTIflU9ckfliua1q9SQwpcuFaFwWQc4cY6kcZx/Wor+/ldIw4iLYG1AeB6cD04PNYVxfKVm814/LRvmAyQT3PTtiqS6HPOry6k91c3CQOlxcACdzIT1bnjnHPToPpXL6lfxm1kE2CqDbtU5wc8A5/E/iTVXUda82faijhCxcEfMTkj8QMDr1965LVr47vKVcOeWBOcf/X9a1ilFXZ59ScqkuVEms6oZyEXGxTxjsPT/AOvWKzMxyxzSEknJOTRWU5uRtCmoKyCrem6fPfzKsMZKZwW6D86rwxmV9q4/E4r03wL4Tk1BUiKyMQSxIwqAAdMmu3AYN15XlsjnxmJWHhfqbXg7RXtZtPYWNtObkhUWTBRcepPc+levtLO+npbh4bFYE2AImNg9h04rktGS8so0uQsT20BCASsqqj4wGIq9qKXFxdWxe3eYMC7xovDgDGd3RQTX1LppWitkfLTk5ttjLS7JmZRC93aSYj3SruYlTySPepfEHlSPBFLGke5tzGQkKpI4AHrxnmq19q6vctFbwqjRAQyMj/LFkZxk8Z461mXWt+VPJKMsqFCjSAMCx6gDqGA79K1UW2pWIItUDwOyvN5CNk/KpJI6BT7njNR6TkNcRC3XFwv755X428DIHUdxWvoFpe3iExmN7ZW3SyH5mY56jvuxz+FaBt9O027ktk8l5Awc4ZS7H1b1+Xt75q3UXw7sRGbK9uI7qyt4LRbVPLkkjXIDYOQQ2STwBnPNPn01tNibU9ekW4vJC2xLRdxKlMKRu6AYz69az9ZudYjsnhs7n+yrQRoqQom9UbBP38ZZmyCcelczq+oSW2kWcrRCW5ZC1xJPLyF/vEA4+g7VCUnq3ZeQ7X0RmeI/ErQaU7zLHGh2o/lDDTY6KzdwM9KpeE9NvLeWLWb5LmCe9Pl27KVURxHptJyQT9KzNEgl8Ua19snhkfS7PARUjJVzn0rsZLqxEpsit5d3gYLAEtwqxjpx+P51nTf1iarP4U9PN9/8vvOqovYx9kvie/8Al/n9xtT29jJPDZ2V1exCQsgHnMV3kdOmMZ6/WrEvhq+GnWX2y9tSiL+5iMqIu7OQc/40yxsYbhcapJfo0SsYxAmzg9B6sevSq9rPb2c5SJLiSKQBQjFUYlcZIByR1rqbb+F7HGT2wazEkV7YTTgPlBbNhyvqHI5APJ7Yptv4o/s2G1jSO6S3jlPmRyoWklJH8RAwBV25v7mxik8hxqO08KyhyFY8gn9c1j6jYyW7Xc+sW1zcWsjEIjyYVpCPk2jP8+Km3N8QG3pqFr8XFq8URkBkjQxhnXjDDjt/OubvvtYkjhGpCyluAXMk0nIKtnomduR61mT2gN4qixlLTqRuSVtoOOnB9RwK6Tb/AGXp6izKW2wrHIssYzIxxnk54xVNNNoNtTQ0e2jvZLq6s76W9u5WMkccULMN23Azv42g9+1RSQzm8ulu9N+wy/KY3kkQiMgAnHO1iTgY96lsp3t7++hjJhSFPLH74v8AM3IGB29fanvZXlxGQWnkIchY7hBIoPGQpbj6E9Ki7Ut9P67CHXMrR6dLa3GnTS3shxHMWKsT/urwMVj3VlNDJObtUVWT95IuTsJ469j7D1rqtVnltfIkhuHSWTKNZxrny3xhQzDtn161zUupX2+4RYbVLVAsl1+6LkEdsng8/wBaKUm1dAR2LiyvpVvQl3KEBRWnO5QVwoKg8YBz+NaVvqFqqbbTSrhYwcENmI578Z/XvWBZi3vhdSRNJI0ZRpVliWMq5JOOB1745zjtV+6jsvPYSazfIwx8vLbeM4ztqpWbux21szsPL3xyOHUckORxuGDx/nrVuESeXEgGNzffY/wY547dvwp8MCriO5DCMnACHBJ7Zq0tmWullucZiKkbOhwDjP0zke9fmyR+pcxctJY1gAJUYXGByABxn9OlXLWGQSBsuiH5CpPIB7ex4qDy0ILkkLE3zrgdT/QdfrVmy88MmbRiSvB80FguevPH61aVjJ6Fy3jIZnCnrlABgr6k/wA/yp9yFk8tHw8knymRQQUBHXA6fT3pyrmFUCtglvvYAJB74J9qbD5jtLIMlTnD5HTH3gP8aaJvrcmigQRoiM8gYdCx6fy/+vTVLeaRM+F+7tBySfTjp70iuII1ZDt3EHpyT6//AFqaZMTNEkaryuM85ByeaLD3JDE7sSZ/nJ++v8K+mf5duaCo81xkbiPmc8sAR/U96jFwd7OcBFYg8dv61mWokMs29Q3mOC/zfwgnAGfqKEBYWYRsUj2tIBklSNq88fifz5pJ5omiMb7g7jlV+Y4A64/DHvVHCsyxMPkjO7KjaevA/nVZr0faLiQPuYD/AFaoFwATt+bH1/wzVW0GaNxMojV5OGJ2h2GCoPXP4Cqn2sQCZfNdnGSW2YPPQYx07VW3Ft0qKZBIoZdx9AeSOnf9KbcSMkkbsDg4LHjceOg7c96drbhdbDZR5N0qBIIWMZ2FuCRz6dv8iql+ZooX8iTaEHzJGAM8c4PbI7mse0Dyahd3QtfLkkYgM77se6jJwP8A9dSTiWIXS2pSEyyb3MmXyoHJ/IY/ChBNpOyZYgllSCWR38lMYiBTJ5Py59z1/wD1VQN3LBfsxnNwyjHlvhVRePmJ6nPP5VRu9TOonY+TbKykggfLjnp/npWeLnzGlkKpGzE8gbiAD0OepODz0/lTuZSmop3NLUtRiUvIio7L91F5Ckg7Sx6ZwDx+Nc5qd+pjltoZCCzAtIVIYgdQOeM8moLibIkZfMMD9HOMqBgHC56msHVL51kVQGWNjyONz56ZPbg0JXOSdazJNUvlUJHC+ByXfPLHpkn+73rn9Tvk2PHzgAN8zEdPQVWvdUaIfubVJGZtvOM4Hfnvz/KuZunmlErNIXbOSen4/wBK1ilE45OVTqSXV+0EwNqwDhg+QAQvcfj3rKYlmLMSWJySe9O8tvSjy29KylLmNYQUFoNp8MTzyLHGOTxnsKPKc9B+tdl4I0EXvmeajSBcMUVgMj6104TDPET5ehniK6oQc2b/AIB8Fi4khmmsmmVeXlYgRL9Sep+lek2drdRPDYaVOogmlMjhVARVBwQT1z7VVsbKODTI5Jrx45Ux5dtGpCjPQk9zxVuCW7iV7oSC3tYZNuyEfO5Yckn619fSpRpR5YHytWrOrLmkxLvT7KK6kL29wIzIMvNk+ac+nTHFXH1AXsZEYfyGLEYztQA/xKOe3ArLt7S8uWX+zZZJbZsiWS4kyVI5woPTjvWZes8VrLHcgwpuLbo5CS2ema1snu9UZWLWozWaTtbqqPI5yI+OAD1J6DNU5LiC9v4D9hRVhkCqgBAcqMkAj72aom53bAkSRRlfmOMuTjpmthbTVJ7LTp4Y4beXzN0EzPuMhz1b0Ax0ArS6QEsF9dahA39km3iMoZmIBJizwR25pJopNHiMlpMjXhjUi4IQkk8ZAwTnGM4/GtPXdIXT83LziW2lUvN5Me0ls9eTn8sVhRTrPZXP2GwgYPCH8+VjuRR0Ud+x6evNEWpK62EzM1TUpLmOVJL+SWR23u7ZkycDdg8Yz0HpXEXMl54j1AaXppIjP+tkz91M8KTVnxPqM6W0VhEq/apMRJ5fyqPU89+RXTeEdHvNA0uCOzljW8uZN80rDIUAdffFcVWTxFT2MHaK+L/L+uh200qFP2r+J7f5/wBdTa8ONN4YuFsT+5s/ICgZIDHuRgHJ9Ktwx/b7fzDqLIynZmO1YO/UgcdP61pQT6jey2/2mzhuUiQm2cTFNxxglhj9KZcyahp9+v2u7W1tZ2U7Yk8wBcZI65zXWml7q0f+Rwu7d2Y+kDU1ukCTXUVxDJsUyMoYjHQZPOf0rbsYp59PukuGgjvxuD3KgFgxPyrkDp1z61X197Wz0kzwOzyoyvFMEC7ZD93j09aoQC4s7GO6aZ2M5yEjYgBweTzjvVfEAjPLaWjWkN7HbQM/lSyIG5H+0cd8nAqrpxtodPFut1cyX6sBGdhMYUHPVvwqo9zbx6aYBHK0zNudye+evJPrWlHLdSPGtkUUQSARiX5y7Y5PYAY7Vq7IRc0y9hsLi4ufLMtyroFSH55Oc/gAfbmtqC7u47WFryAWltuLMsiZO08hQPXPesC9lsYrgmVZbeTeMeQfmxn1Pvmp7nxJb3Lwx6dY+YsW4iO6csW6fMWz+lYTjzPbcLGvo9jDLql7dte3djEjsiNGuPNRly25j6e1M1SztY72N21ucrIuYgIyxkbHGew9vWqo1q4n817a2ihUWzu7tyEyQMgd8enTmqur3l9qkKGXyniVl+YqAc4+6B27e1TGE+e7f9fcAye3e1vp/JmkYI656blI6KOvXnn8KjJGp3F3Cm8m3+eUzPgnaexAxnngemaq3Eri4S8RVQwfMnlqAGAJ27vVs556UmoXFsNTaTyxbiWPc87FncE8846gn8a3C1y9NcR3EdxbaxpgZfMTyQil4kfHBJ4OMA1qWc3h21tY1v4L0TON/wDx94yPXGeM4J59a5rW9XMrQ+dMVmuNjBlUhQynG4D6cY9619K1TRBZIuo77u6UkPJJEM9egODkCspRVv8AJjsz/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Acne-like lesions are seen on the upper outer arms.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy;2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_4_22596=[""].join("\n");
var outline_f22_4_22596=null;
var title_f22_4_22597="Almotriptan: Patient drug information";
var content_f22_4_22597=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Almotriptan: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/26/20901?source=see_link\">",
"     see \"Almotriptan: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/40/32388?source=see_link\">",
"     see \"Almotriptan: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F131843\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Axert&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F131844\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Axert&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10017450\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700568",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A very bad and sometimes deadly health problem called serotonin syndrome may happen. The risk may be greater if you take this drug with certain other drugs. Call your doctor right away if you have dizziness, very bad headache, agitation, hallucinations, fever, fast heartbeat, a heartbeat that does not feel normal, flushing, seizures, shakiness, sweating a lot, change in balance, change in thinking clearly and with logic, very bad upset stomach and throwing up, or very bad loose stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10017452\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691956",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat migraine headaches.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10017451\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701467",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to almotriptan or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfa (sulfonamide) allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Some types of migraine headaches, chest pain or pressure, diseased arteries going to the legs, heart disease, poor bowel blood flow, recent heart attack, stroke, or very high blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701342",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are using this drug to stop you from getting migraine headaches.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703854",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, or zolmitriptan in the last 24 hours.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703856",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken ergotamine, methysergide, or dihydroergotamine in the last 24 hours.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10017456\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697753",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use care if you have risks for heart disease (high blood pressure, high cholesterol, overweight, high blood sugar (diabetes), cigarette smoking, man older than 40 years of age, other family members with early heart disease, woman after change of life). Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10017457\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3796262",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loss of eyesight. This can be long-lasting.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10017459\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698625",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure, a fast heartbeat, or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698599",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Agitation, twitching, sweating, or muscle stiffness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in strength on 1 side is greater than the other, trouble speaking or thinking, change in balance, or blurred eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699030",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache or if headache is not better after the first dose.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699006",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain or bloody loose stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10017454\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695208",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your headache comes back after the first dose, 1 more dose may be taken 2 hours after the first one.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694765",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take more than 2 tablets a day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698544",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a diary of your headaches.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10017455\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696572",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10017460\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10017461\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12520 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.150.3.100-EF161DC620-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_4_22597=[""].join("\n");
var outline_f22_4_22597=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131843\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131844\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017450\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017452\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017451\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017456\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017457\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017459\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017454\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017455\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017460\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017461\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?20/26/20901?source=related_link\">",
"      Almotriptan: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/40/32388?source=related_link\">",
"      Almotriptan: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_4_22598="Subpulmonic effusion I PA";
var content_f22_4_22598=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F57250&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F57250&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Right subpulmonic pleural effusion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph of a right subpulmonic pleural effusion. The right lung base is slightly elevated. A small pneumoperitoneum outlines the actual level of the right hemidiaphragm. Left pleural effusion has spilled over into the left lateral costophrenic sulcus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_4_22598=[""].join("\n");
var outline_f22_4_22598=null;
var title_f22_4_22599="Clinical manifestations and diagnosis of avian influenza";
var content_f22_4_22599=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of avian influenza",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/4/22599/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/4/22599/contributors\">",
"     Iain Stephenson, MD, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/4/22599/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/4/22599/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/4/22599/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/4/22599/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/4/22599/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been five influenza pandemics during the past 100 years, and each has been caused by the emergence of a novel virus. In the 1957 and 1968 pandemics, the new viruses contained components of previous human as well as avian influenza viruses. The origin of the influenza virus responsible for the 1918 pandemic, which killed more people in a single year than the bubonic plague, remains uncertain, but it appears to have been an adapted avian influenza strain. The emergence of a novel H1N1 human-swine-avian reassortant virus in 2009 in North America started a new pandemic. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/2/31786?source=see_link\">",
"     \"Epidemiology of pandemic H1N1 influenza ('swine influenza')\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sporadic transmission of avian influenza H5N1 to more than 600 humans since 2003 has prompted concerns that conditions are suitable for emergence of a pandemic strain [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/1\">",
"     1",
"    </a>",
"    ]. Two features of avian influenza H5N1 outbreaks are striking: the predominance of children and young adults; and the high mortality rate [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Estimates of potential global mortality related to pandemic avian influenza are as high as 62 million deaths [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical manifestations and diagnosis of avian influenza will be reviewed here. The epidemiology, transmission, pathogenesis, treatment, and prevention of avian influenza are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/48/14090?source=see_link\">",
"     \"Epidemiology, transmission, and pathogenesis of avian influenza\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39032?source=see_link\">",
"     \"Treatment and prevention of avian influenza\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35320?source=see_link\">",
"     \"Avian influenza vaccines\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of avian influenza are variable, being determined in part by the virus clade.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Avian influenza H5N1",
"    </span>",
"    &nbsp;&mdash;&nbsp;More than 600 human cases of H5N1 influenza have been reported to the World Health Organization, with a case-fatality rate of approximately 60 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/1,5\">",
"     1,5",
"    </a>",
"    ]. Most patients with H5N1 infection give a history of recent exposure to dead or ill poultry. H5N1 infection can result in mildly symptomatic illness to life-threatening disease. The clinical presentation may depend on the duration of exposure and the clade of the virus [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/6-10\">",
"     6-10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Incubation period",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following exposure to infected poultry, the incubation period for human H5N1 infection is seven days or less, and is often two to five days [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/11\">",
"     11",
"    </a>",
"    ]. In clusters of human-to-human transmission, the incubation period is typically three to five days, but was eight to nine days in one cluster [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/9,11-13\">",
"     9,11-13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory illness is the most common manifestation, but patients with solely gastrointestinal or central nervous system involvement have also been described. A striking feature of the avian influenza H5N1 outbreaks is the predominance of children and young adults.",
"   </p>",
"   <p>",
"    The following observations illustrate the range of findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the 1997 H5N1 outbreak in Hong Kong, 8 of 18 affected patients were less than 12 years of age, and all but one had relatively mild disease [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/7,14\">",
"       7,14",
"      </a>",
"      ]. The most severe infections occurred in those older than 12 years of age.",
"     </li>",
"     <li>",
"      Among 67 hospitalized patients in Vietnam with clade 1 H5N1 influenza infection between 2004 and 2006, the median age was 25 [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/15\">",
"       15",
"      </a>",
"      ]. Common presenting features were fever (75 percent), cough (89 percent), dyspnea (81 percent), bilateral pulmonary infiltrates (72 percent), lymphopenia (73 percent), and increased aminotransferases (aspartate aminotransferase [AST], 69 percent; alanine aminotransferase [ALT], 61 percent). Diarrhea and mucosal bleeding at presentation were more common among patients who died. The risk of death was highest among individuals &le;16 years of age.",
"     </li>",
"     <li>",
"      In a report from Vietnam, two children from the same family presented with diarrhea and encephalopathy without any signs of respiratory compromise and later died [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/16\">",
"       16",
"      </a>",
"      ]. The presence of H5N1 infection was later established by isolation of the virus from cerebrospinal fluid, as well as from fecal, throat, and serum specimens. The capacity of H5N1 to cause systemic illness, including central nervous system involvement, has also been demonstrated in animals [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/17,18\">",
"       17,18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Respiratory symptoms may be accompanied by gastrointestinal symptoms, headache, myalgia, sore throat, rhinorrhea or uncommonly conjunctivitis or bleeding gums [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/7-9,11,19\">",
"       7-9,11,19",
"      </a>",
"      ]. Diarrhea is a prominent presenting symptom, along with respiratory distress, in several case series [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/7-9,20\">",
"       7-9,20",
"      </a>",
"      ], particularly in association with clade 1 H5N1 infection [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Risk factors associated with severe disease have included delayed admission to the hospital and the presence of bilateral pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/7-9,14,21,22\">",
"     7-9,14,21,22",
"    </a>",
"    ]. In a study of 67 patients, neutropenia and increased ALT at presentation were predictive of a fatal outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Complications include multiorgan failure with renal dysfunction and cardiac compromise; pulmonary hemorrhage; pneumothorax, and pancytopenia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/11,19\">",
"     11,19",
"    </a>",
"    ]. Most deaths have been related to respiratory failure. Patients with severe disease often have leukopenia, neutropenia, lymphopenia, and thrombocytopenia on hospital admission [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/7-9,14,15,21-23\">",
"     7-9,14,15,21-23",
"    </a>",
"    ]. Other laboratory abnormalities include elevated levels of aminotransferases (AST&gt;ALT) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/8,9,15\">",
"     8,9,15",
"    </a>",
"    ], lactate dehydrogenase, creatine kinase [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/8\">",
"     8",
"    </a>",
"    ], and hypoalbuminemia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiographic findings of H5N1 avian influenza include diffuse, multifocal, or patchy infiltrates; interstitial infiltrates; and segmental or lobular consolidation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/19\">",
"     19",
"    </a>",
"    ]. Pleural effusions are usually not seen [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Progression to respiratory failure is associated with diffuse bilateral ground-glass infiltrates [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathologic studies in H5N1 avian influenza are primarily obtained at autopsy. Autopsy findings include severe pulmonary injury with diffuse alveolar damage, alveolar hemorrhage, hyaline-membrane formation, lymphocytic infiltration into the interstitium, and the presence of reactive fibroblasts [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/8,24,25\">",
"     8,24,25",
"    </a>",
"    ]. Bone marrow examination has demonstrated reactive histiocytosis with hemophagocytosis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Avian influenza H7N7 and H7N3",
"    </span>",
"    &nbsp;&mdash;&nbsp;Avian influenza H7N7 and H7N3 appear to have a predilection for conjunctival epithelium, and may present with isolated conjunctivitis following direct contact with poultry or inoculation with contaminated material (such as feathers, feces, or eggs) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/26-28\">",
"     26-28",
"    </a>",
"    ]. A survey of poultry workers and their families potentially exposed during the 2003 Netherlands H7N7 outbreak found that 349 and 90 persons complained of conjunctivitis or influenza-like illness (ILI) symptoms respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/26\">",
"     26",
"    </a>",
"    ]. Avian H7N7 was confirmed in 83 cases of conjunctivitis, five of whom had an ILI, and in two patients with isolated respiratory symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Avian influenza H9N2",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children infected with avian H9N2 influenza viruses presented with mild, self-limited upper respiratory illnesses [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     WHO SHOULD BE TESTED",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with H5N1 avian influenza infection give a history of recent exposure to dead or ill poultry. Thus, a comprehensive travel and epidemiologic history is critical in the identification of suspected cases.",
"   </p>",
"   <p>",
"    A patient who meets the following criteria should be tested for H5N1 avian influenza virus [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/31\">",
"     31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Has an illness that requires hospitalization or is fatal",
"      <strong>",
"       and",
"      </strong>",
"     </li>",
"     <li>",
"      Has or had a documented temperature of &ge;38&ordm;C (&ge;100.4&ordm;F) in the past 24 hours",
"      <strong>",
"       or",
"      </strong>",
"      has a history feverishness in the past 24 hours",
"      <strong>",
"       and",
"      </strong>",
"     </li>",
"     <li>",
"      Has radiographically confirmed pneumonia, acute respiratory distress syndrome, or other severe respiratory illness",
"      <strong>",
"       and",
"      </strong>",
"     </li>",
"     <li>",
"      Has",
"      <strong>",
"       at least one",
"      </strong>",
"      of the following potential exposures within seven days of symptoms onset:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      History of travel to a country where H5N1 avian influenza has been documented in poultry, wild birds,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      humans",
"      <strong>",
"       and",
"      </strong>",
"      had at least one of the following potential exposures during travel:",
"      <br/>",
"      <br/>",
"      Direct contact with (eg, handling, slaughtering, defeathering, butchering, preparing for consumption) well-appearing, sick, or dead poultry or wild birds",
"      <br/>",
"      <br/>",
"      Direct contact with surfaces contaminated with poultry feces or poultry parts (eg, carcasses, internal organs) that might contain H5N1 avian influenza virus",
"      <br/>",
"      <br/>",
"      Consumption of raw or incompletely cooked poultry or poultry products",
"      <br/>",
"      <br/>",
"      Close contact (approach within about 6 feet) with a confirmed H5N1 avian influenza virus-infected animal other than poultry or wild birds (eg, cat or dog)",
"      <br/>",
"      <br/>",
"      Close contact (approach within about 6 feet) with a person who was hospitalized or died with a severe unexplained respiratory illness",
"      <br/>",
"      <br/>",
"      Visit to a market where live poultry are sold or slaughtered",
"      <br/>",
"      <br/>",
"      Direct contact with samples (animal or human) suspected of containing H5N1 avian influenza virus in a laboratory or other setting",
"     </li>",
"     <li>",
"      Close contact (approach within about 6 feet) with an ill person with confirmed H5N1 avian influenza virus infection",
"      <br/>",
"     </li>",
"     <li>",
"      Close contact (approach within about 6 feet) with an ill person who was under investigation for possible H5N1 avian influenza virus infection",
"     </li>",
"     <li>",
"      Work with live H5N1 avian influenza virus in a laboratory",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Testing for H5N1 avian influenza virus infection should also be considered on a case-by-case basis, in consultation with local and state health departments for a patient with mild or atypical disease (hospitalized or ambulatory) who has had one of the exposures listed above",
"    <strong>",
"     or",
"    </strong>",
"    a patient with severe or fatal respiratory disease whose epidemiologic information is uncertain, unavailable, or otherwise suspicious but does not meet the criteria listed above. An example is an ill returned traveler who visited a country where H5N1 avian influenza virus has been documented or is highly suspected in birds.",
"   </p>",
"   <p>",
"    For a list of H5N1-affected countries, see the",
"    <a class=\"external\" href=\"file://www.who.int/influenza/human_animal_interface/avian_influenza/en/\">",
"     World Health Organization web site",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H434682988\">",
"    <span class=\"h2\">",
"     Approach to diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of H5N1 avian influenza can be made by one or more of the following tests [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/7,14,21,31-34\">",
"     7,14,21,31-34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Real-time reverse-transcriptase polymerase chain reaction (RT-PCR) assay for avian influenza A (H5N1) RNA",
"     </li>",
"     <li>",
"      Virus culture, but it should be performed",
"      <strong>",
"       only",
"      </strong>",
"      if enhanced biosafety level 3 conditions are available (eg, at the United States Centers for Disease Control and Prevention [CDC])",
"     </li>",
"     <li>",
"      A fourfold rise in H5-specific antibody in paired serum samples",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Among these tests, real-time RT-PCR is the preferred diagnostic method under biosafety level 2 conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/31\">",
"     31",
"    </a>",
"    ]. Serologic testing can be performed if other diagnostic testing methods are not available, but should be performed only at the CDC (or an equivalent national laboratory outside the United States).",
"   </p>",
"   <p>",
"    It is best to send samples for diagnosis as soon as possible following onset of symptoms, although the optimal specimen type is not known. There is some evidence that the diagnostic yield may be improved with oropharyngeal (throat) specimens compared to nasal samples [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/8,9,19\">",
"     8,9,19",
"    </a>",
"    ]. The yield of lower respiratory specimens has not been well studied [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/9\">",
"     9",
"    </a>",
"    ], but they are thought to have a higher yield than nasopharyngeal and nasal specimens [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/31\">",
"     31",
"    </a>",
"    ]. However, nasopharyngeal specimens are useful for detecting seasonal influenza viruses. We suggest that specimens be collected from the oropharynx and lower respiratory tract (when feasible) for the detection of H5N1 avian influenza as well as from the nasopharynx for the detection of seasonal influenza. To increase the diagnostic yield, we suggest that multiple respiratory specimens from different sites be obtained on at least two consecutive days. The first specimen should be collected as soon as possible following onset of symptoms, and no later than seven days into clinical illness.",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H434682911\">",
"    <span class=\"h2\">",
"     Diagnostic tests",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H434682731\">",
"    <span class=\"h3\">",
"     PCR",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the detection of viral RNA by PCR appears to be the most sensitive method for diagnosis, initial diagnostic testing can be negative. Repeat PCR testing of respiratory samples must be repeated if there is a high index of suspicion [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/8\">",
"     8",
"    </a>",
"    ]. Stool and cerebrospinal fluid samples are recommended as well in patients with diarrhea and encephalopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    PCR can differentiate between subtypes of influenza if the specific primers are included. In the United States, throat or nasal specimens from suspected cases of avian influenza will be processed by culture and with PCR testing. In 2008, the US Food and Drug Administration approved a real-time RT-PCR assay that detects influenza virus RNA and can distinguish between seasonal and avian H5N1 influenza [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/36\">",
"     36",
"    </a>",
"    ]. All specimens (whether positive or negative) will subsequently be sent by the state laboratories to the CDC for confirmatory testing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5528?source=see_link&amp;anchor=H1018262470#H1018262470\">",
"     \"Diagnosis of seasonal influenza in adults\", section on 'Polymerase chain reaction'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24346?source=see_link&amp;anchor=H19#H19\">",
"     \"Clinical features and diagnosis of seasonal influenza in children\", section on 'Laboratory diagnosis'",
"    </a>",
"    .)",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Antigen tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Commercial rapid antigen tests are less sensitive in detecting influenza A (H5N1) infections than PCR assays and also lack specificity in differentiating between seasonal and avian influenza [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/19,22\">",
"     19,22",
"    </a>",
"    ]. In two case series, rapid antigen testing did not detect avian influenza in any of the patients subsequently diagnosed by PCR testing [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Rapid antigen tests are therefore",
"    <strong>",
"     not",
"    </strong>",
"    recommended for patients suspected of having avian influenza [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/5,31,37\">",
"     5,31,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Serologic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic testing, by a combination of methods including virus neutralization, ELISA, and Western blotting, for the specific virus strain is a useful tool for epidemiologic surveillance studies and retrospective diagnosis, but is not helpful in the acute setting [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/33\">",
"     33",
"    </a>",
"    ]. A positive test is a fourfold or greater increase in antibody titer between a sample obtained as soon as possible after the onset of symptoms and one obtained after at least 14 days.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Specimen handling",
"    </span>",
"    &nbsp;&mdash;&nbsp;When suspecting highly pathogenic avian influenza, specimens must be handled and processed using appropriate biosafety precautions. Therefore, clinicians must alert their laboratory personnel and state health department of any clinical suspicion of avian influenza so that the samples will be processed at the appropriate facility [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/31,35\">",
"     31,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Specimens for PCR or viral culture should be obtained using a swab with a Dacron tip and an aluminum or plastic shaft; swabs with calcium alginate or cotton tips are not recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/31\">",
"     31",
"    </a>",
"    ]. Specimens should be placed in sterile viral transport medium and shipped immediately (on ice or frozen at -70&deg;C and then shipped on dry ice) to the appropriate level 3 testing laboratory. For specimens that will undergo PCR testing, nucleic acid extraction lysis buffer can be added prior to shipping. Detailed recommendations for specimen handling can be found on the",
"    <a class=\"external\" href=\"file://www.cdc.gov/flu/avianflu/guidance-labtesting.htm\">",
"     CDC&rsquo;s web site",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Surveillance programs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The threat of an avian influenza pandemic has prompted global preparedness plans. A national surveillance system for avian influenza in Thailand led to a decrease in the median time from procurement of samples to results of testing from 17 days to 1.8 days [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22599/abstract/38\">",
"     38",
"    </a>",
"    ]. In the event of a pandemic, the presence of such programs should help in the containment of disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H434682540\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of H5N1 avian influenza includes atypical pneumonia, typical respiratory virus infections (such as seasonal influenza and respiratory syncytial virus), severe acute respiratory syndrome, and upper respiratory infections associated with conjunctivitis (as may be caused by adenovirus). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/49/31514?source=see_link\">",
"     \"Epidemiology, pathogenesis, and microbiology of community-acquired pneumonia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/26/26026?source=see_link\">",
"     \"Diagnostic approach to community-acquired pneumonia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38970?source=see_link\">",
"     \"Clinical features and diagnosis of community-acquired pneumonia in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/1/18456?source=see_link\">",
"     \"Clinical manifestations of seasonal influenza in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24346?source=see_link\">",
"     \"Clinical features and diagnosis of seasonal influenza in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link\">",
"     \"Respiratory syncytial virus infection: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/21/17753?source=see_link\">",
"     \"Severe acute respiratory syndrome (SARS)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39257?source=see_link\">",
"     \"Epidemiology and clinical manifestations of adenovirus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?5/58/6050?source=see_link\">",
"       \"Patient information: Bird flu (avian influenza) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clinical characteristics of H5N1 avian influenza infections in outbreaks included fever, pneumonia, diarrhea, and encephalopathy. Laboratory abnormalities may include leukopenia, lymphopenia, thrombocytopenia, and elevated serum aminotransferases. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most patients with H5N1 avian influenza infection give a history of recent exposure to dead or ill poultry. Thus, a comprehensive travel and epidemiologic history is critical in the identification of suspected cases. Patients who meet clinical and epidemiologic criteria should be tested for H5N1 avian influenza infection. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Who should be tested'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of H5N1 avian influenza can be established by real-time reverse-transcriptase polymerase chain reaction (RT-PCR) or viral culture of respiratory specimens. RT-PCR under biosafety level 2 conditions is the preferred diagnostic method, and virus culture should be performed only under biosafety level 3 conditions. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Serologic testing is a useful tool for epidemiologic surveillance studies and retrospective diagnosis, but is not helpful in the acute setting. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Serologic testing'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     World Health Organization. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2013. file://www.who.int/influenza/human_animal_interface/EN_GIP_20130215CumulativeNumberH5N1cases.pdf (Accessed on February 20, 2013).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/2\">",
"      St&ouml;hr K. Avian influenza and pandemics--research needs and opportunities. N Engl J Med 2005; 352:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/3\">",
"      Bartlett JG, Hayden FG. Influenza A (H5N1): will it be the next pandemic influenza? Are we ready? Ann Intern Med 2005; 143:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/4\">",
"      Murray CJ, Lopez AD, Chin B, et al. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet 2006; 368:2211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/5\">",
"      Uyeki TM. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Clin Infect Dis 2009; 49:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/6\">",
"      Webster RG, Govorkova EA. H5N1 influenza--continuing evolution and spread. N Engl J Med 2006; 355:2174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/7\">",
"      Yuen KY, Chan PK, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/8\">",
"      Oner AF, Bay A, Arslan S, et al. Avian influenza A (H5N1) infection in eastern Turkey in 2006. N Engl J Med 2006; 355:2179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/9\">",
"      Kandun IN, Wibisono H, Sedyaningsih ER, et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med 2006; 355:2186.",
"     </a>",
"    </li>",
"    <li>",
"     WHO disease alerts 12th Aug 2004. Three fatal human cases of avian influenza confirmed in Viet Nam www.who.int/csr/don/2004_08_12/en/ (Accessed on February 22, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/11\">",
"      Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus, Abdel-Ghafar AN, Chotpitayasunondh T, et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008; 358:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/12\">",
"      Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005; 352:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/13\">",
"      Wang H, Feng Z, Shu Y, et al. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet 2008; 371:1427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/14\">",
"      Katz JM, Lim W, Bridges CB, et al. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis 1999; 180:1763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/15\">",
"      Liem NT, Tung CV, Hien ND, et al. Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin Infect Dis 2009; 48:1639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/16\">",
"      de Jong MD, Bach VC, Phan TQ, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005; 352:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/17\">",
"      Guan Y, Poon LL, Cheung CY, et al. H5N1 influenza: a protean pandemic threat. Proc Natl Acad Sci U S A 2004; 101:8156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/18\">",
"      Shortridge KF, Zhou NN, Guan Y, et al. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology 1998; 252:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/19\">",
"      Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353:1374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/20\">",
"      Tran TH, Nguyen TL, Nguyen TD, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004; 350:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/21\">",
"      Bridges CB, Lim W, Hu-Primmer J, et al. Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. J Infect Dis 2002; 185:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/22\">",
"      Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, et al. Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 2005; 11:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/23\">",
"      Kawachi S, Luong ST, Shigematsu M, et al. Risk parameters of fulminant acute respiratory distress syndrome and avian influenza (H5N1) infection in Vietnamese children. J Infect Dis 2009; 200:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/24\">",
"      Peiris JS, Yu WC, Leung CW, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004; 363:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/25\">",
"      To KF, Chan PK, Chan KF, et al. Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol 2001; 63:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/26\">",
"      Koopmans M, Wilbrink B, Conyn M, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 2004; 363:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/27\">",
"      Nguyen-Van-Tam JS, Nair P, Acheson P, et al. Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill 2006; 11:E060504.2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/28\">",
"      Centers for Disease Control and Prevention (CDC). Notes from the field: Highly pathogenic avian influenza A (H7N3) virus infection in two poultry workers--Jalisco, Mexico, July 2012. MMWR Morb Mortal Wkly Rep 2012; 61:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/29\">",
"      Peiris M, Yuen KY, Leung CW, et al. Human infection with influenza H9N2. Lancet 1999; 354:916.",
"     </a>",
"    </li>",
"    <li>",
"     WHO disease alerts: 5th April 2004. Avian influenza H7 human infections in Canada www.who.int/csr/don/2004_04_05/en/ (Accessed on February 02, 2012).",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Interim guidance for laboratory testing of persons with suspected infection with highly pathogenic avian influenza A (H5N1) virus in the United States. file://www.cdc.gov/flu/avianflu/guidance-labtesting.htm (Accessed on September 11, 2012).",
"    </li>",
"    <li>",
"     World Health Organization. Recommended laboratory tests to identify influenza A/H5 virus in specimens from patients with an influenza-like illness. 2005. file://www.cdc.gov.tw/public/Attachment/11289223671.pdf (Accessed on February 22, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/33\">",
"      Rowe T, Abernathy RA, Hu-Primmer J, et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999; 37:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/34\">",
"      Centers for Disease Control and Prevention (CDC). Outbreaks of avian influenza A (H5N1) in Asia and interim recommendations for evaluation and reporting of suspected cases--United States, 2004. MMWR Morb Mortal Wkly Rep 2004; 53:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/35\">",
"      Majury A, Ash J, Toye B, et al. Laboratory diagnosis of human infection with avian influenza. CMAJ 2006; 175:1371.",
"     </a>",
"    </li>",
"    <li>",
"     FDA Clears New CDC Test to Detect Human Influenza file://www.hhs.gov/news/press/2008pres/09/20080930a.html (Accessed on February 22, 2012).",
"    </li>",
"    <li>",
"     World Health Organization. WHO recommendations on the use of rapid testing for influenza diagnosis file://www.who.int/influenza/resources/documents/rapid_testing/en/index.html (Accessed on February 22, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22599/abstract/38\">",
"      Kitphati R, Apisarnthanarak A, Chittaganpitch M, et al. A nationally coordinated laboratory system for human avian influenza A (H5N1) in Thailand: program design, analysis, and evaluation. Clin Infect Dis 2008; 46:1394.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7001 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-FD0A04FE88-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_4_22599=[""].join("\n");
var outline_f22_4_22599=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Avian influenza H5N1",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Incubation period",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Pathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Avian influenza H7N7 and H7N3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Avian influenza H9N2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      WHO SHOULD BE TESTED",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H434682988\">",
"      Approach to diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H434682911\">",
"      Diagnostic tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H434682731\">",
"      - PCR",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Antigen tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Serologic testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Specimen handling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Surveillance programs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H434682540\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35320?source=related_link\">",
"      Avian influenza vaccines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38970?source=related_link\">",
"      Clinical features and diagnosis of community-acquired pneumonia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24346?source=related_link\">",
"      Clinical features and diagnosis of seasonal influenza in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/1/18456?source=related_link\">",
"      Clinical manifestations of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5528?source=related_link\">",
"      Diagnosis of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/26/26026?source=related_link\">",
"      Diagnostic approach to community-acquired pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39257?source=related_link\">",
"      Epidemiology and clinical manifestations of adenovirus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/2/31786?source=related_link\">",
"      Epidemiology of pandemic H1N1 influenza ('swine influenza')",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/49/31514?source=related_link\">",
"      Epidemiology, pathogenesis, and microbiology of community-acquired pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/48/14090?source=related_link\">",
"      Epidemiology, transmission, and pathogenesis of avian influenza",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/58/6050?source=related_link\">",
"      Patient information: Bird flu (avian influenza) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=related_link\">",
"      Respiratory syncytial virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/21/17753?source=related_link\">",
"      Severe acute respiratory syndrome (SARS)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39032?source=related_link\">",
"      Treatment and prevention of avian influenza",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_4_22600="EEG frontal sharp waves";
var content_f22_4_22600=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F66248&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F66248&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 510px\">",
"   <div class=\"ttl\">",
"    Left frontal sharp wave in a patient with left frontal lobe epilepsy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 490px; height: 347px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Frontal sharp waves are frequently seen to some degree on both sides, especially when the maximum is frontopolar as here (\"bifrontal\"). The referential montage (right side) confirms the maximum at Fp1 followed by F7.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_4_22600=[""].join("\n");
var outline_f22_4_22600=null;
var title_f22_4_22601="Geriatric bipolar disorder: Maintenance treatment and prognosis";
var content_f22_4_22601=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Geriatric bipolar disorder: Maintenance treatment and prognosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/4/22601/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/4/22601/contributors\">",
"     Martha Sajatovic, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/4/22601/contributors\">",
"     Peijun Chen, MD, MPH, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/4/22601/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/4/22601/contributors\">",
"     Paul Keck, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/4/22601/contributors\">",
"     Kenneth E Schmader, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/4/22601/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/4/22601/contributors\">",
"     David Solomon, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/4/22601/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1033803\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical features and treatment of older bipolar patients differ from those of younger patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/1\">",
"     1",
"    </a>",
"    ]. Up to 25 percent of all bipolar patients are elderly [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/2\">",
"     2",
"    </a>",
"    ], and the absolute number of geriatric bipolar patients is expected to increase as the world&rsquo;s population ages over the next several decades [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic reviews the maintenance treatment and prognosis of geriatric bipolar disorder. The epidemiology, pathogenesis, clinical features, assessment, diagnosis, and acute treatment of geriatric bipolar disorder are discussed separately, as are the clinical features, diagnosis, acute treatment, and maintenance treatment of bipolar disorder in mixed-age patients.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/23/7545?source=see_link\">",
"       \"Geriatric bipolar disorder: Epidemiology, clinical features, assessment, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link\">",
"       \"Geriatric bipolar disorder: Acute treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=see_link\">",
"       \"Bipolar disorder in adults: Epidemiology and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/8/38026?source=see_link\">",
"       \"Bipolar disorder in adults: Pharmacotherapy for acute mania, mixed episodes, and hypomania\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/3/44088?source=see_link\">",
"       \"Bipolar disorder in adults: Pharmacotherapy for acute depression\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27802?source=see_link\">",
"       \"Bipolar disorder in adults: Maintenance treatment\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1033810\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1292379\">",
"    <span class=\"h2\">",
"     Geriatric bipolar disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;The minimum age used to define geriatric bipolar disorder is generally 60 years [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/5\">",
"     5",
"    </a>",
"    ]. However, some authorities use an age cut-off of 50, 55, or 65 years [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/6\">",
"     6",
"    </a>",
"    ]. Geriatric bipolar disorder includes both aging patients whose mood disorder presented earlier in life, and patients whose mood disorder presents for the first time in later life [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/1,7\">",
"     1,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bipolar disorder is characterized by episodes of major depression (",
"    <a class=\"graphic graphic_table graphicRef70852 \" href=\"UTD.htm?17/21/17756\">",
"     table 1",
"    </a>",
"    ), mania (",
"    <a class=\"graphic graphic_table graphicRef81976 \" href=\"UTD.htm?3/53/3932\">",
"     table 2",
"    </a>",
"    ), and hypomania (",
"    <a class=\"graphic graphic_table graphicRef70757 \" href=\"UTD.htm?22/39/23164\">",
"     table 3",
"    </a>",
"    ), as well as mixed episodes (major depression concurrent with mania) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/8\">",
"     8",
"    </a>",
"    ]. However, the clinical features of bipolar disorder are different for older and younger patients in that [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/1,9-12\">",
"     1,9-12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Cognitive impairment is more common and severe in geriatric patients",
"     </li>",
"     <li>",
"      Comorbid general medical illnesses are more common in older patients",
"     </li>",
"     <li>",
"      Excessive sexual interest and behavior during manic or hypomanic episodes appear to be less common in older patients",
"     </li>",
"     <li>",
"      Comorbid anxiety and substance use disorders may be less common in geriatric patients",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinical features and diagnosis of geriatric bipolar disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/23/7545?source=see_link\">",
"     \"Geriatric bipolar disorder: Epidemiology, clinical features, assessment, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1292399\">",
"    <span class=\"h2\">",
"     Remission",
"    </span>",
"    &nbsp;&mdash;&nbsp;Remission is defined as the resolution of mood symptoms, or improvement to the point that only one or two symptoms of mild intensity persist. If psychotic features (delusions or hallucinations) are also present, resolution of the psychosis is required for remission. The rate of remission from geriatric bipolar mood episodes is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749378#H13749378\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Recovery from mood episodes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1033817\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maintenance treatment is indicated for geriatric bipolar disorder because patients who remit from a mood episode are at high risk for suffering another episode:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A prospective study of 220 bipolar patients assessed course of illness for approximately 40 years and found that the median number of lifetime episodes was 10 and that the risk of recurrence remained constant up to the age of 70 years or more [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/13\">",
"       13",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A retrospective study of 26 geriatric bipolar patients found that 38 percent had a lifetime history of at least three mood episodes [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/14\">",
"       14",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Multiple studies suggest that approximately 20 percent of geriatric bipolar patients will sustain four or more recurrences within a 12-month period [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/15,16\">",
"       15,16",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Maintenance treatment for geriatric bipolar patients is consistent with practice guidelines from the American Psychiatric Association [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/17\">",
"     17",
"    </a>",
"    ], National Institute for Health and Clinical Excellence [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/18\">",
"     18",
"    </a>",
"    ], Canadian Network for Mood and Anxiety Treatments [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/19\">",
"     19",
"    </a>",
"    ], and British Association for Psychopharmacology [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H173801633\">",
"    <span class=\"h2\">",
"     Pharmacotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maintenance treatment for geriatric bipolar disorder usually includes pharmacotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/19,21\">",
"     19,21",
"    </a>",
"    ]. Acutely ill patients who remit with a medication regimen should generally be maintained on the same drugs and doses. However, patients successfully treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    for an episode of major depression are generally tapered off of fluoxetine within a few months of remission. (See",
"    <a class=\"local\" href=\"#H1861552\">",
"     'Following recovery from bipolar major depression'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Comorbid diseases, concomitant medications, and age-related physiologic changes often alter a drug&rsquo;s pharmacodynamics and pharmacokinetics, which can affect therapeutic and adverse responses. Pharmacologic issues in elderly bipolar patients are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749308#H13749308\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Pharmacologic issues'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5969178\">",
"    <span class=\"h3\">",
"     Evidence of efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evidence for the efficacy of maintenance treatment for geriatric bipolar disorder includes subgroup analyses of older patients in randomized trials conducted with mixed-age patients (18 to 65 years):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A pooled analysis of two 18-month randomized trials compared",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"       lamotrigine",
"      </a>",
"      , and placebo in mixed-age bipolar patients who were stable for at least four weeks [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/22\">",
"       22",
"      </a>",
"      ]. In the subgroup of 98 older patients, time to intervention for an emerging episode of mania, hypomania, or mixed mania was significantly longer with lithium (modal dose 750 mg per day) than placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/23\">",
"       23",
"      </a>",
"      ]. Time to intervention for an emerging episode of major depression was significantly longer with lamotrigine (modal dose 240 mg per day) than placebo. These results were consistent with those from the mixed-age patients. Among older patients, withdrawal from treatment due to side effects occurred most often with lithium, followed by lamotrigine and placebo (29 versus 18 and 13 percent of patients). &nbsp;",
"     </li>",
"     <li>",
"      An open-label, two-year randomized maintenance trial (Bipolar Affective disorder:",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"        Lithium",
"       </a>",
"       /Anticonvulsant",
"      </span>",
"      Evaluation; BALANCE) compared lithium monotherapy, valproate monotherapy, and lithium plus valproate in 330 bipolar mixed-age patients [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/24\">",
"       24",
"      </a>",
"      ]. Lithium monotherapy and combination treatment were superior to valproate alone, and subgroup analyses found the results did not differ significantly between older and younger patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1861552\">",
"    <span class=\"h3\">",
"     Following recovery from bipolar major depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acutely ill patients who remit with a medication regimen should generally be maintained on the same drugs and doses. However, for geriatric bipolar patients with major depression who remit with the combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    , and then remain stable for two to six months, we suggest tapering fluoxetine by 10 mg per week until it is discontinued, and continuing olanzapine. The reason is that maintenance antidepressants may possibly induce mania or hypomania [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. If symptoms of depression recur during the taper, the dose should be titrated back up to the full dose used to initially achieve remission. If a full-blown depressive episode develops despite increasing the dose and does not improve within four to eight weeks, the relapse is treated as a new acute episode; acute treatment is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749357#H13749357\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Bipolar major depression'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For geriatric bipolar patients with major depression who remit with the combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    and then develop manic or hypomanic symptoms during maintenance treatment, fluoxetine should be abruptly discontinued and olanzapine continued. If a full-blown manic or hypomanic episode develops despite discontinuing fluoxetine and does not improve within four to eight weeks, the relapse is treated as a new acute episode; acute treatment is discussed separately.(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749322#H13749322\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Manic, hypomanic, and mixed episodes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1861594\">",
"    <span class=\"h3\">",
"     Treatment following remission with electroconvulsive therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;For geriatric bipolar patients who remit with electroconvulsive therapy (ECT), we suggest maintenance treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    , based upon its efficacy in the subgroup of older patients who participated in randomized trials with mixed-age adult bipolar patients (18 to 65 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. However,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    is a reasonable alternative. The maintenance drug is started the day after ECT is completed, unless the patient is suffering cognitive impairment secondary to ECT, in which case maintenance pharmacotherapy is delayed until the impairment has dissipated. The dose and side effects of lithium and lamotrigine are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H1137967#H1137967\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'First line medications'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H361190867#H361190867\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Treatment resistance'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For geriatric bipolar patients who remit with ECT and cannot tolerate maintenance treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    , reasonable alternatives include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/11/43193?source=see_link\">",
"     aripiprazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    , valproate, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/39/4728?source=see_link\">",
"     ziprasidone",
"    </a>",
"    . There is no evidence of superior efficacy among these alternatives; the choice is thus guided by side effect profiles, potential drug-drug interactions, comorbid general medical conditions, patient preference, and cost. The dose and side effects of these alternatives are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H1137967#H1137967\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'First line medications'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H175101727#H175101727\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Resistant patients'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H1036587#H1036587\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Refractory patients'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Maintenance ECT should be offered to geriatric bipolar patients who repeatedly remit with ECT and then relapse during maintenance pharmacotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/17\">",
"     17",
"    </a>",
"    ]. Maintenance ECT is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/21/41305?source=see_link&amp;anchor=H24#H24\">",
"     \"Overview of electroconvulsive therapy (ECT) for adults\", section on 'Continuation and maintenance ECT'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5969969\">",
"    <span class=\"h3\">",
"     Managing intolerable side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Geriatric bipolar patients who cannot tolerate maintenance treatment with the minimum target dose of a medication are generally switched to another medication. For patients not receiving",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    , we and others suggest switching to lithium [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/1\">",
"     1",
"    </a>",
"    ], based upon its efficacy in analyses of results from older patients who participated in randomized trials with mixed-age adult bipolar patients (18 to 65 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. However,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    is a reasonable alternative. The failed medication is generally tapered and discontinued over one to two weeks by the same amount for each dose decrease. As an example,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    15 mg per day is decreased by 5 mg per day, every one to three days. At the same time, lithium or lamotrigine is started and titrated up. The dose and side effects of lithium and lamotrigine are discussed separately. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H1137967#H1137967\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'First line medications'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H361190867#H361190867\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Treatment resistance'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    For remitted geriatric bipolar patients who cannot tolerate maintenance treatment with the medication that induced remission and are also intolerant of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    , reasonable alternatives include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/11/43193?source=see_link\">",
"     aripiprazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    , valproate, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/39/4728?source=see_link\">",
"     ziprasidone",
"    </a>",
"    . There is no evidence of superior efficacy among these alternatives; the choice is thus guided by side effect profiles, potential drug-drug interactions, comorbid general medical conditions, patient preference, and cost. The dose and side effects of these alternatives are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H1137967#H1137967\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'First line medications'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H175101727#H175101727\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Resistant patients'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H1036587#H1036587\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Refractory patients'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For geriatric bipolar patients who remit with a medication combination and cannot tolerate minimum target doses, we suggest tapering and discontinuing the drug that is most troublesome and continuing with the remaining drug. The failed drug is generally tapered and discontinued over one to two weeks by the same amount for each dose decrease. At the same time, the dose of the remaining drug should be increased within the target dose range as tolerated. The dose and side effects of medications are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749322#H13749322\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Manic, hypomanic, and mixed episodes'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749357#H13749357\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Bipolar major depression'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H87479527\">",
"    <span class=\"h2\">",
"     Adjunctive psychotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest that older bipolar patients receiving maintenance pharmacotherapy also receive psychotherapy that focuses upon [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/17,27\">",
"     17,27",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Managing bipolar disorder",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Accepting the illness and the limitations it imposes",
"     </li>",
"     <li>",
"      Adhering to treatment",
"     </li>",
"     <li>",
"      Detecting and reporting prodromal symptoms",
"     </li>",
"     <li>",
"      Limiting or eliminating use of alcohol",
"     </li>",
"     <li>",
"      Eliminating drugs of abuse (eg, cannabis)",
"     </li>",
"     <li>",
"      Regulating sleep",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Managing interpersonal difficulties",
"     </li>",
"     <li>",
"      Improving self-esteem",
"     </li>",
"     <li>",
"      Age-related issues (eg, changing occupational and social roles, loss of family members and friends, reduced financial resources, or decreased functioning)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although pharmacotherapy is the cornerstone of maintenance treatment for bipolar disorder, adjunctive psychotherapy improves outcomes compared with pharmacotherapy alone in randomized trials with mixed-age adults (18 to 65 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Thus, several practice guidelines recommend adjunctive psychotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/17,19,20,30\">",
"     17,19,20,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Different psychotherapy options include, in order of preference [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/31\">",
"     31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Psychoeducation",
"     </li>",
"     <li>",
"      Cognitive-behavioral therapy (CBT)",
"     </li>",
"     <li>",
"      Family therapy",
"     </li>",
"     <li>",
"      Interpersonal therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Adjunctive maintenance psychotherapy is discussed further. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27802?source=see_link&amp;anchor=H20#H20\">",
"     \"Bipolar disorder in adults: Maintenance treatment\", section on 'Adjunctive psychotherapy'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H87479534\">",
"    <span class=\"h3\">",
"     Adherence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many geriatric bipolar patients do not adhere to treatment (although their adherence generally exceeds that of younger patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/32\">",
"     32",
"    </a>",
"    ]. A study of 6461 elderly bipolar patients found that 19 percent partially adhered to treatment and 20 percent were nonadherent, and that comorbid substance abuse was associated with nonadherence. Poor adherence probably increases the risk of recurrence, and strategies for improving adherence are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27802?source=see_link&amp;anchor=H1205113#H1205113\">",
"     \"Bipolar disorder in adults: Maintenance treatment\", section on 'Adherence'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H361191963\">",
"    <span class=\"h2\">",
"     Monitoring the patient",
"    </span>",
"    &nbsp;&mdash;&nbsp;Remitted geriatric bipolar patients should be evaluated regularly and monitored for recurrence of manic and depressive symptoms as well as medication side effects and cognitive decline. Particular attention is given to suicidal ideation and to psychotic symptoms. Older patients often require more vigilant monitoring than do younger patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For geriatric bipolar patients who remit and remain stable, monitoring can be tapered, with progressively longer intervals between assessments. As an example, a patient who is seen every two weeks at the time of remission can be seen every two weeks for one to three more visits, then every month for one to three visits, and then every two months for one to three visits. Continuously stable patients can ultimately be seen every three to six months. More frequent visits should be scheduled for patients who develop symptoms or side effects; monitoring acutely ill patients is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749301#H13749301\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'General principles'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H253436\">",
"    <span class=\"h2\">",
"     Duration and discontinuation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon clinical experience, most geriatric bipolar patients require maintenance treatment for many years, and some patients require it for their entire lives. However, the duration is not established and is generally longer in patients with:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Residual symptoms, particularly suicidal ideation",
"     </li>",
"     <li>",
"      Ongoing comorbid psychopathology",
"     </li>",
"     <li>",
"      Psychosocial stressors",
"     </li>",
"     <li>",
"      A history of suicide attempts",
"     </li>",
"     <li>",
"      A greater number of prior mood episodes",
"     </li>",
"     <li>",
"      A history of longer or more severe (eg, psychotic) mood episodes",
"     </li>",
"     <li>",
"      Onset of bipolar disorder at an early age (eg, &le; 30 years) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If the decision is made to discontinue maintenance treatment, we suggest slowly tapering the regimen to increase the probability of detecting incipient mood symptoms before a full-blown episode recurs. For geriatric bipolar patients who remit with monotherapy, we taper the medication over one month. Based upon clinical experience, we decrease the dose each week by approximately 25 percent of the dose used during maintenance treatment. As an example,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    1200 mg per day is reduced by 300 mg per day each week until it is discontinued. If symptoms recur during the taper, the dose should be titrated back up to the full dose used initially to achieve remission. If a full-blown manic or mixed episode develops despite increasing the dose and does not improve within four weeks, or if a full-blown depressive episode develops and does not improve within four to eight weeks, the recurrence is treated as a new acute episode. Acute treatment is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749322#H13749322\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Manic, hypomanic, and mixed episodes'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749357#H13749357\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Bipolar major depression'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Discontinuing a maintenance medication combination begins by tapering the medication that is more difficult to use because of side effects or drug-drug interactions. We generally taper the medication over one month, decreasing the dose each week by approximately 25 percent of the dose used during maintenance treatment. If mood symptoms recur during the taper, the dose should be titrated back up to the full dose used initially to achieve remission. If a full-blown manic or mixed episode develops despite increasing the dose and does not improve within four weeks, or if a full-blown depressive episode develops and does not improve within four to eight weeks, the recurrence is treated as a new acute episode. Acute treatment is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749322#H13749322\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Manic, hypomanic, and mixed episodes'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749357#H13749357\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Bipolar major depression'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Geriatric bipolar patients who successfully discontinue one medication from their pharmacotherapy combination should be monitored for one to six months prior to discontinuing the remaining medication. If mood symptoms recur, we suggest restarting and titrating up the discontinued drug to the full dose used initially to achieve remission. If a full-blown manic or mixed episode develops despite increasing the dose and does not improve within four weeks, or if a full-blown depressive episode develops and does not improve within four to eight weeks, the recurrence is treated as a new acute episode. Acute treatment is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749322#H13749322\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Manic, hypomanic, and mixed episodes'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749357#H13749357\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Bipolar major depression'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Geriatric bipolar patients who successfully taper and discontinue one medication from their pharmacotherapy combination and remain stable for one to six months can then be tapered off their remaining medication. We suggest tapering the medication over one month, decreasing the dose each week by approximately 25 percent of the dose used during maintenance treatment. If mood symptoms recur during the taper, the dose should be titrated back up to the full dose used initially to achieve remission. If a full-blown manic episode develops despite increasing the dose and does not improve within four weeks, or if a full-blown depressive episode develops and does not improve within four to eight weeks, the recurrence is treated as a new acute episode. Acute treatment is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749322#H13749322\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Manic, hypomanic, and mixed episodes'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749357#H13749357\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Bipolar major depression'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H361192038\">",
"    <span class=\"h1\">",
"     RECURRENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent symptoms or mood episodes during maintenance pharmacotherapy for geriatric bipolar disorder are initially treated by optimizing medication doses [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/17,34\">",
"     17,34",
"    </a>",
"    ]. This includes ensuring serum concentrations are in the therapeutic range for medications such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    or valproate, as well as increasing the dose to achieve a higher serum level within the therapeutic range, provided that side effects do not intervene. For medications that do not have an established therapeutic serum concentration, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    or second-generation antipsychotics, the dose can be increased within the target dose range. &nbsp;",
"   </p>",
"   <p>",
"    If a geriatric bipolar manic or mixed episode recurs during maintenance pharmacotherapy and optimizing the dose does not control symptoms within two to four weeks, the recurrence is treated as a new acute episode. &nbsp;If a geriatric bipolar depressive episode recurs during maintenance pharmacotherapy and optimizing the dose does not control symptoms within two to eight weeks, the recurrence is treated as a new acute episode. Acute treatment is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749322#H13749322\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Manic, hypomanic, and mixed episodes'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749357#H13749357\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Bipolar major depression'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with geriatric bipolar disorder who decide to stop maintenance treatment and successfully taper and discontinue their medication regimen, but subsequently relapse, we suggest restarting the same regimen that was discontinued. The relapse is treated as a new acute episode; acute treatment is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749294#H13749294\">",
"     \"Geriatric bipolar disorder: Acute treatment\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1033937\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Geriatric bipolar disorder does not resolve or &ldquo;burn out,&rdquo; nor does it follow a progressively deteriorating course [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/6,35\">",
"     6,35",
"    </a>",
"    ]. Rather, patients often suffer repeated mood episodes that generally remit [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/15,36\">",
"     15,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A study of 220 bipolar patients assessed course of illness for approximately 40 years and found that the frequency of recurrent bipolar mood episodes remained constant over the lifespan up to the age of 70 years and more [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/13\">",
"     13",
"    </a>",
"    ]. In addition, geriatric bipolar patients can develop periods of rapid cycling (ie, four or more mood episodes in a 12-month period). Two studies of elderly bipolar patients (N = 475 and N = 246) each found a history of rapid cycling in approximately 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/15,16\">",
"     15,16",
"    </a>",
"    ], comparable to the incidence in mixed-age (18 to 65 years) bipolar patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Geriatric bipolar patients are frequently ill with recurrent and chronic mood episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/36\">",
"     36",
"    </a>",
"    ]. As an example, a prospective, two-year, open-label treatment study found that 31 late-life bipolar patients were ill 45 percent (mean average) of the time [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Recurrence of mood episodes in geriatric bipolar disorder can be precipitated by biologic factors, eg, treatment of a comorbid general medical disorder such as arthritis, asthma, or inflammatory bowel disease with steroids [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/17\">",
"     17",
"    </a>",
"    ]. In addition, stressful life events (eg, serious illness or changes in family role, residence, employment, or finances) may possibly contribute to recurrences [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1033951\">",
"    <span class=\"h2\">",
"     Psychosocial functioning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychosocial functioning is significantly worse in geriatric bipolar patients than age-matched healthy controls in domains such as [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/41-43\">",
"     41-43",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Finances",
"     </li>",
"     <li>",
"      Household chores",
"     </li>",
"     <li>",
"      Physical activity",
"     </li>",
"     <li>",
"      Mobility and transportation",
"     </li>",
"     <li>",
"      Communication",
"     </li>",
"     <li>",
"      Perceived social support",
"     </li>",
"     <li>",
"      Social and recreational activities",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Functioning also appears to be significantly worse in geriatric bipolar patients than younger patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/44\">",
"     44",
"    </a>",
"    ]. Psychosocial functioning and activities of daily living in late-life bipolar disorder may be impaired in part because of cognitive deficits [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. Impaired cognition in geriatric bipolar disorder is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/23/7545?source=see_link&amp;anchor=H1522530#H1522530\">",
"     \"Geriatric bipolar disorder: Epidemiology, clinical features, assessment, and diagnosis\", section on 'Cognitive impairment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recurring mood episodes and impaired functioning in geriatric bipolar disorder may create burdens for family caregivers [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/47\">",
"     47",
"    </a>",
"    ]. In addition, older bipolar patients may have a greater risk of developing dementia than older patients with other disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/48\">",
"     48",
"    </a>",
"    ]. As a result, guardianship may be necessary for geriatric bipolar patients who cannot manage their healthcare, finances, or housing [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/35\">",
"     35",
"    </a>",
"    ]. A study of 266 indigent geriatric bipolar patients found that 9 percent required a guardian [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1033958\">",
"    <span class=\"h2\">",
"     Mortality and suicide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mortality is elevated in geriatric bipolar disorder compared with the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/49\">",
"     49",
"    </a>",
"    ]. In addition, the high rate of suicide in bipolar disorder persists into late life. A study of 220 mixed-age adult bipolar patients followed for up to 34 to 38 years found that completed suicide was 12 times higher in patients than in the general population, and this risk remained constant over the lifespan up to the age of 70 years [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22601/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (See",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/5/4178?source=see_link\">",
"       \"Patient information: Bipolar disorder (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=see_link\">",
"       \"Patient information: Reducing the costs of medicines (The Basics)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Beyond the Basics topics (See",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?38/55/39796?source=see_link\">",
"       \"Patient information: Bipolar disorder (manic depression) (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=see_link\">",
"       \"Patient information: Reducing the costs of medicines (Beyond the Basics)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These educational materials can be used as part of psychoeducational psychotherapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27802?source=see_link&amp;anchor=H21#H21\">",
"     \"Bipolar disorder in adults: Maintenance treatment\", section on 'Psychoeducation'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    The National Institute of Mental Health also has educational material explaining the symptoms, course of illness, and treatment of bipolar disorder in a booklet entitled \"Bipolar Disorder,\" which is available online at the website",
"    <a class=\"external\" href=\"file://www.nimh.nih.gov/health/publications/bipolar-disorder/complete-index.shtml\">",
"     file://www.nimh.nih.gov/health/publications/bipolar-disorder/complete-index.shtml",
"    </a>",
"    or through a toll-free number, 866-615-6464. The web site also provides references, summaries of study results in language intended for the lay public, and information about clinical trials currently recruiting patients.",
"   </p>",
"   <p>",
"    More comprehensive information is provided in many books written for patients and family members, including The Bipolar Disorder Survival Guide: What You and Your Family Need to Know, written by David J. Miklowitz, PhD (published by The Guilford Press, 2002); An Unquiet Mind: A Memoir of Moods and Madness, written by Kay Jamison, PhD (published by Random House, 1995); and Treatment of Bipolar Illness: A Casebook for Clinicians and Patients, by RM Post, MD, and GS Leverich, LCSW (published by Norton Press, 2008).",
"   </p>",
"   <p>",
"    The Depression and Bipolar Support Alliance (",
"    <a class=\"external\" href=\"file://www.dbsalliance.org/\">",
"     file://www.dbsalliance.org",
"    </a>",
"    or 800-826-3632) is a national organization that educates members about bipolar disorder and how to cope with it. Other functions include increasing public awareness of the illness and advocating for more research and services. The organization is administered and maintained by patients and family members, and has local chapters.",
"   </p>",
"   <p>",
"    The National Alliance on Mental Illness (",
"    <a class=\"external\" href=\"file://www.nami.org/\">",
"     file://www.nami.org",
"    </a>",
"    or 800-950-6264) is a similarly structured organization devoted to education, support, and advocacy for patients with any mental illness. Bipolar disorder is one of their priorities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1033965\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The minimum age used to define geriatric bipolar disorder is generally 50 to 60 years. The clinical features of geriatric bipolar disorder differ from those of younger patients in that cognitive impairment and comorbid general medical illnesses are more common in geriatric patients, whereas comorbid anxiety and substance use disorders may be less common in geriatric patients. (See",
"      <a class=\"local\" href=\"#H1292379\">",
"       'Geriatric bipolar disorder'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/23/7545?source=see_link&amp;anchor=H7214018#H7214018\">",
"       \"Geriatric bipolar disorder: Epidemiology, clinical features, assessment, and diagnosis\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Bipolar disorder is a highly recurrent illness. For geriatric bipolar patients, we recommend maintenance treatment rather than no treatment (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Maintenance treatment usually consists of the same medication regimen that induced remission. (See",
"      <a class=\"local\" href=\"#H1033817\">",
"       'Treatment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H173801633\">",
"       'Pharmacotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For geriatric bipolar patients who remitted with a medication other than",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"       lamotrigine",
"      </a>",
"      , and cannot tolerate maintenance treatment with the medication that induced remission, we suggest switching to lithium rather than other medications (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). However, lamotrigine is a reasonable alternative. For patients intolerant of lithium or lamotrigine, reasonable options include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/11/43193?source=see_link\">",
"       aripiprazole",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?36/36/37449?source=see_link\">",
"       olanzapine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"       quetiapine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"       risperidone",
"      </a>",
"      , valproate, or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/39/4728?source=see_link\">",
"       ziprasidone",
"      </a>",
"      (See",
"      <a class=\"local\" href=\"#H173801633\">",
"       'Pharmacotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients receiving maintenance pharmacotherapy, we suggest adding psychotherapy rather than using pharmacotherapy alone (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H87479527\">",
"       'Adjunctive psychotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinicians should regularly monitor remitted geriatric bipolar patients for recurrence of manic and depressive symptoms as well as medication side effects and cognitive decline. Particular attention is given to suicidal ideation and psychotic symptoms. For stable patients, we progressively lengthen the interval between assessments. (See",
"      <a class=\"local\" href=\"#H361191963\">",
"       'Monitoring the patient'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most geriatric bipolar patients require maintenance treatment for years, and some patients require it for their entire lives. The duration is generally longer in patients with residual symptoms (particularly suicidal ideation), ongoing comorbid psychopathology, psychosocial stressors, a history of suicide attempts, a greater number of prior mood episodes, a history of longer or more severe (eg, psychotic) mood episodes, and onset of bipolar disorder at an early age. (See",
"      <a class=\"local\" href=\"#H253436\">",
"       'Duration and discontinuation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Recurrent symptoms or mood episodes during maintenance pharmacotherapy for geriatric bipolar disorder are initially treated by optimizing medication doses. If this does not control symptoms within two to eight weeks, the recurrence is treated as a new acute mood episode. (See",
"      <a class=\"local\" href=\"#H361192038\">",
"       'Recurrence'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749322#H13749322\">",
"       \"Geriatric bipolar disorder: Acute treatment\", section on 'Manic, hypomanic, and mixed episodes'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=see_link&amp;anchor=H13749357#H13749357\">",
"       \"Geriatric bipolar disorder: Acute treatment\", section on 'Bipolar major depression'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Geriatric bipolar patients usually recover from each of the multiple mood episodes they suffer. &nbsp;However, patients may have an elevated risk of cognitive decline, psychosocial functioning is often impaired, mortality is elevated compared with the general population, and the high rate of suicide in bipolar disorder persists into late life (See",
"      <a class=\"local\" href=\"#H1033937\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/1\">",
"      Sajatovic M, Chen P. Geriatric bipolar disorder. Psychiatr Clin North Am 2011; 34:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/2\">",
"      Sajatovic M, Blow FC, Ignacio RV, Kales HC. Age-related modifiers of clinical presentation and health service use among veterans with bipolar disorder. Psychiatr Serv 2004; 55:1014.",
"     </a>",
"    </li>",
"    <li>",
"     United Nations, Department of Economic and Social Affairs, Population Division, Population Estimates and Projections Section. file://esa.un.org/unpd/wpp/index.htm (Accessed on June 14, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/4\">",
"      Jeste DV, Alexopoulos GS, Bartels SJ, et al. Consensus statement on the upcoming crisis in geriatric mental health: research agenda for the next 2 decades. Arch Gen Psychiatry 1999; 56:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/5\">",
"      Young RC, Schulberg HC, Gildengers AG, et al. Conceptual and methodological issues in designing a randomized, controlled treatment trial for geriatric bipolar disorder: GERI-BD. Bipolar Disord 2010; 12:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/6\">",
"      Depp CA, Jeste DV. Bipolar disorder in older adults: a critical review. Bipolar Disord 2004; 6:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/7\">",
"      Prabhakar D, Balon R. Late-onset bipolar disorder: a case for careful appraisal. Psychiatry (Edgmont) 2010; 7:34.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, American Psychiatric Association, Washington, DC, 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/9\">",
"      Broadhead J, Jacoby R. Mania in old age: A first prospective study. Int J Geriatr Psychiatry 1990; 5:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/10\">",
"      Burt T, Prudic J, Peyser S, et al. Learning and memory in bipolar and unipolar major depression: effects of aging. Neuropsychiatry Neuropsychol Behav Neurol 2000; 13:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/11\">",
"      Young RC, Kiosses D, Heo M, et al. Age and ratings of manic psychopathology. Bipolar Disord 2007; 9:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/12\">",
"      Goldstein BI, Herrmann N, Shulman KI. Comorbidity in bipolar disorder among the elderly: results from an epidemiological community sample. Am J Psychiatry 2006; 163:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/13\">",
"      Angst J, Gamma A, Sellaro R, et al. Recurrence of bipolar disorders and major depression. A life-long perspective. Eur Arch Psychiatry Clin Neurosci 2003; 253:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/14\">",
"      Takeshima M, Kurata K. Late-life bipolar depression due to the soft form of bipolar disorder compared to unipolar depression: an inpatient chart review study. J Affect Disord 2010; 123:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/15\">",
"      Al Jurdi RK, Marangell LB, Petersen NJ, et al. Prescription patterns of psychotropic medications in elderly compared with younger participants who achieved a \"recovered\" status in the systematic treatment enhancement program for bipolar disorder. Am J Geriatr Psychiatry 2008; 16:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/16\">",
"      Oostervink F, Boomsma MM, Nolen WA, EMBLEM Advisory Board. Bipolar disorder in the elderly; different effects of age and of age of onset. J Affect Disord 2009; 116:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/17\">",
"      American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002; 159:1.",
"     </a>",
"    </li>",
"    <li>",
"     National Institute for Health and Clinical Excellence. Bipolar disorder: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care.",
"National Clinical Practice Guideline Number 38, 2006. file://www.nice.org.uk/ (Accessed on April 26, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/19\">",
"      Yatham LN, Kennedy SH, Schaffer A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009; 11:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/20\">",
"      Goodwin GM, Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2009; 23:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/21\">",
"      Malhi GS, Adams D, Cahill CM, et al. The management of individuals with bipolar disorder: a review of the evidence and its integration into clinical practice. Drugs 2009; 69:2063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/22\">",
"      Goodwin GM, Bowden CL, Calabrese JR, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004; 65:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/23\">",
"      Sajatovic M, Gyulai L, Calabrese JR, et al. Maintenance treatment outcomes in older patients with bipolar I disorder. Am J Geriatr Psychiatry 2005; 13:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/24\">",
"      BALANCE investigators and collaborators, Geddes JR, Goodwin GM, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010; 375:385.",
"     </a>",
"    </li>",
"    <li>",
"     Bipolar disorder: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. NICE clinical guideline 38, July, 2006. file://guidance.nice.org.uk/CG38 (Accessed on October 01, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/26\">",
"      Ghaemi SN, Wingo AP, Filkowski MA, Baldessarini RJ. Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr Scand 2008; 118:347.",
"     </a>",
"    </li>",
"    <li>",
"     Sajatovic M, Kessing LV. Bipolar disorder in the elderly. In: Bipolar Disorder: Clinical and Neurobiological Foundations, Yatham LN, Maj M.  (Eds), Wiley-Blackwell, West Sussex 2010. p.488.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/28\">",
"      Miklowitz DJ. Adjunctive psychotherapy for bipolar disorder: state of the evidence. Am J Psychiatry 2008; 165:1408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/29\">",
"      Lam DH, Burbeck R, Wright K, Pilling S. Psychological therapies in bipolar disorder: the effect of illness history on relapse prevention - a systematic review. Bipolar Disord 2009; 11:474.",
"     </a>",
"    </li>",
"    <li>",
"     Bipolar disorder: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. NICE clinical guideline 38. July 2006. file://guidance.nice.org.uk/CG38 (Accessed on August 16, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/31\">",
"      Morriss RK, Faizal MA, Jones AP, et al. Interventions for helping people recognise early signs of recurrence in bipolar disorder. Cochrane Database Syst Rev 2007; :CD004854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/32\">",
"      Sajatovic M, Blow FC, Kales HC, et al. Age comparison of treatment adherence with antipsychotic medications among individuals with bipolar disorder. Int J Geriatr Psychiatry 2007; 22:992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/33\">",
"      Young RC, Gyulai L, Mulsant BH, et al. Pharmacotherapy of bipolar disorder in old age: review and recommendations. Am J Geriatr Psychiatry 2004; 12:342.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association Practice Guideline for the Treatment of Patients with Bipolar Disorder, Second Edition, 2002. file://www.psych.org/MainMenu/PsychiatricPractice/PracticeGuidelines_1.aspx (Accessed on August 25, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/35\">",
"      Sajatovic M, Popli A, Semple W. Ten-year use of hospital-based services by geriatric veterans with schizophrenia and bipolar disorder. Psychiatr Serv 1996; 47:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/36\">",
"      Kessing LV. Recurrence in affective disorder. II. Effect of age and gender. Br J Psychiatry 1998; 172:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/37\">",
"      Kupka RW, Luckenbaugh DA, Post RM, et al. Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. J Clin Psychiatry 2003; 64:1483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/38\">",
"      Cruz N, Vieta E, Comes M, et al. Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe. J Psychiatr Res 2008; 42:1068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/39\">",
"      Gildengers AG, Mulsant BH, Begley AE, et al. A pilot study of standardized treatment in geriatric bipolar disorder. Am J Geriatr Psychiatry 2005; 13:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/40\">",
"      Beyer JL, Kuchibhatla M, Cassidy F, Krishnan KR. Stressful life events in older bipolar patients. Int J Geriatr Psychiatry 2008; 23:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/41\">",
"      Depp CA, Davis CE, Mittal D, et al. Health-related quality of life and functioning of middle-aged and elderly adults with bipolar disorder. J Clin Psychiatry 2006; 67:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/42\">",
"      Depp CA, Mausbach BT, Eyler LT, et al. Performance-based and subjective measures of functioning in middle-aged and older adults with bipolar disorder. J Nerv Ment Dis 2009; 197:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/43\">",
"      Beyer JL, Kuchibhatla M, Looney C, et al. Social support in elderly patients with bipolar disorder. Bipolar Disord 2003; 5:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/44\">",
"      Depp CA, Lindamer LA, Folsom DP, et al. Differences in clinical features and mental health service use in bipolar disorder across the lifespan. Am J Geriatr Psychiatry 2005; 13:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/45\">",
"      Martino DJ, Igoa A, Marengo E, et al. Cognitive and motor features in elderly people with bipolar disorder. J Affect Disord 2008; 105:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/46\">",
"      Gildengers AG, Butters MA, Chisholm D, et al. Cognitive functioning and instrumental activities of daily living in late-life bipolar disorder. Am J Geriatr Psychiatry 2007; 15:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/47\">",
"      Martire LM, Hinrichsen GA, Morse JQ, et al. The Mood Disorder Burden Index: a scale for assessing the burden of caregivers to adults with unipolar or bipolar disorder. Psychiatry Res 2009; 168:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/48\">",
"      Kessing LV, Nilsson FM. Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses. J Affect Disord 2003; 73:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/49\">",
"      Dhingra U, Rabins PV. Mania in the elderly: a 5-7 year follow-up. J Am Geriatr Soc 1991; 39:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22601/abstract/50\">",
"      Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002; 68:167.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16645 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-7CC26F0507-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_4_22601=[""].join("\n");
var outline_f22_4_22601=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1033965\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1033803\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1033810\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1292379\">",
"      Geriatric bipolar disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1292399\">",
"      Remission",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1033817\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H173801633\">",
"      Pharmacotherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5969178\">",
"      - Evidence of efficacy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1861552\">",
"      - Following recovery from bipolar major depression",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1861594\">",
"      - Treatment following remission with electroconvulsive therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5969969\">",
"      - Managing intolerable side effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H87479527\">",
"      Adjunctive psychotherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H87479534\">",
"      - Adherence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H361191963\">",
"      Monitoring the patient",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H253436\">",
"      Duration and discontinuation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H361192038\">",
"      RECURRENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1033937\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1033951\">",
"      Psychosocial functioning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1033958\">",
"      Mortality and suicide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1033965\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/16645\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/16645|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/21/17756\" title=\"table 1\">",
"      DSM-IV-TR diagnostic criteria for major depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/53/3932\" title=\"table 2\">",
"      DSM-IV-TR diagnostic criteria for mania",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/39/23164\" title=\"table 3\">",
"      DSM-IV-TR diagnostic criteria for hypomania",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=related_link\">",
"      Bipolar disorder in adults: Epidemiology and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27802?source=related_link\">",
"      Bipolar disorder in adults: Maintenance treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/3/44088?source=related_link\">",
"      Bipolar disorder in adults: Pharmacotherapy for acute depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/8/38026?source=related_link\">",
"      Bipolar disorder in adults: Pharmacotherapy for acute mania, mixed episodes, and hypomania",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16330?source=related_link\">",
"      Geriatric bipolar disorder: Acute treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/23/7545?source=related_link\">",
"      Geriatric bipolar disorder: Epidemiology, clinical features, assessment, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/21/41305?source=related_link\">",
"      Overview of electroconvulsive therapy (ECT) for adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/5/4178?source=related_link\">",
"      Patient information: Bipolar disorder (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/55/39796?source=related_link\">",
"      Patient information: Bipolar disorder (manic depression) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=related_link\">",
"      Patient information: Reducing the costs of medicines (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=related_link\">",
"      Patient information: Reducing the costs of medicines (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_4_22602="Falls in older persons: Risk factors and patient evaluation";
var content_f22_4_22602=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Falls in older persons: Risk factors and patient evaluation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/4/22602/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/4/22602/contributors\">",
"     Douglas P Kiel, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/4/22602/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/4/22602/contributors\">",
"     Kenneth E Schmader, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/4/22602/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/4/22602/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/4/22602/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 5, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Falls in older persons occur commonly and are major factors threatening the independence of older individuals. As is the case for many geriatric syndromes, falls usually occur when impairments in multiple domains compromise the compensatory ability of the individual [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Falls often go without clinical attention for a variety of reasons: the patient never mentions the event to a health care provider; there is no injury at the time of the fall; the provider fails to ask the patient about a history of falls; or either provider or patient erroneously believes that falls are an inevitable part of the aging process. Often, treatment of injuries resulting from a fall does not include investigation of the cause of the fall.",
"   </p>",
"   <p>",
"    Significant morbidity and mortality may result from falls in older individuals. The importance of preventing falls is emphasized by a study that found that 80 percent of older women preferred death to a \"bad\" hip fracture that would result in nursing home admission [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of the physical conditions and environmental situations that predispose to falls are modifiable. Physicians caring for older patients need to routinely inquire about falls, assess for fall risk, and address modifiable underlying risk factors.",
"   </p>",
"   <p>",
"    This topic focuses on risk factors and patient evaluation for falls. Measures to prevent falls in older persons are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/12/8393?source=see_link\">",
"     \"Prevention of falls and complications of falls in community-dwelling older persons\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of falls increases with age and varies according to living status. Between 30 and 40 percent of community-dwelling people over the age of 65 years fall each year [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/3-8\">",
"     3-8",
"    </a>",
"    ], increasing to about 50 percent for those 80 years and older [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. In a US survey of over 90,000 people aged &gt;65, falls were reported in the prior three months by 16 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/11\">",
"     11",
"    </a>",
"    ]. Falls were equally common between men and women, but were more likely to result in injury in women. The majority of nonfatal injuries in adults aged 65 and older who were treated in emergency departments in the US in 2001 were caused by falls [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 50 percent of individuals in the long-term care setting fall yearly [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Almost 60 percent of those with a history of a fall in the previous year will have a subsequent fall [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Falls often result in an injury of some type, usually minor soft tissue injuries such as bruises and scrapes. In one study of women over age 70 followed for two years, 41 percent of falls resulted in minor, and 6 percent in major, injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/13\">",
"     13",
"    </a>",
"    ]. Earlier studies had also found that 5 to 10 percent of falls among community-dwelling elderly result in major injuries: fracture, head trauma, or major lacerations [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/8,14\">",
"     8,14",
"    </a>",
"    ]. Rates of fall-related major injuries for nursing home residents are higher (10 to 30 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. Falls accounted for 62 percent of non-fatal injuries leading to US emergency department visits for people over 65 years [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/12\">",
"     12",
"    </a>",
"    ]. Approximately 5 percent of falls in older persons will lead to hospitalization [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The number of fall-related hospitalizations is likely to increase substantially with ongoing aging of the population. In the Netherlands, the number of hospitalizations for falls more than doubled between 1981 and 2008, although the average length of stay decreased and offset the total number of fall-related hospital days [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Morbidity and mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fall-related injuries are associated with significant subsequent morbidity: decline in functional status, increased likelihood of nursing home placement, and greater use of medical services [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/19-22\">",
"     19-22",
"    </a>",
"    ]. Among community-living elders who sustain hip fractures, 25 to 75 percent do not recover pre-injury functional status [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/14\">",
"     14",
"    </a>",
"    ]. In an Australian study, 9.5 percent of patients hospitalized for falls became first-time residents of a long-term care facility at discharge [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A community of 1100 independent-living individuals over the age of 71 were followed prospectively for three years to evaluate the incidence and impact of falls. The following results were reported:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Those who had suffered at least one fall experienced a decline in basic and instrumental activities of daily living [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/19\">",
"       19",
"      </a>",
"      ]. Activity restriction was reported in 24 percent of recent fallers versus 15 percent of nonfallers.",
"     </li>",
"     <li>",
"      A total of 133 participants (12 percent) had long-term admissions to nursing homes. After adjustment for other risk factors, the risk of nursing home admission increased progressively for subjects with a single noninjurious fall, two or more noninjurious falls, or at least one fall causing serious injury (relative risk 3.1, 5.5, and 10.2, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Only one-half of older individuals who fall are able to get up without help, resulting in the so-called \"long lie.\" Fallers who are unable to get up are more likely to suffer lasting declines in activities of daily living than those who are able to get up (35 versus 26 percent in one series) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Death after a fall occurs far less frequently than injuries. However, complications resulting from falls are the leading cause of death from injury in men and women older than age 65 [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/25\">",
"     25",
"    </a>",
"    ], and the fifth leading cause of death in older adults. In a large study of elderly persons seeking emergency care after a fall, 2.2 percent of injurious falls resulted in death [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/26\">",
"     26",
"    </a>",
"    ]. The death rate attributable to falls increases with age. A report from the National Trauma Data Bank noted that mortality was three times higher for seniors sustaining ground level falls, compared with younger individuals with falls, and that seniors were more likely to sustain long bone and pelvic fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/27\">",
"     27",
"    </a>",
"    ]. The rate of fatal falls in people aged 65 years and older increased in the US between 1993 and 2003 [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/28\">",
"     28",
"    </a>",
"    ]. Fatality rates are highest in white men (48.3 per 100,000 population).",
"   </p>",
"   <p>",
"    A paper in 1995 estimated that the costs of fall-related injuries for individuals older than age 65 in the United States was $12.6 billion [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/29\">",
"     29",
"    </a>",
"    ]. This figure has likely increased substantially, with rising medical costs and an expanding geriatric population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Fear of falling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fear of falling, also called the post-fall anxiety syndrome, is a well-recognized syndrome in older persons. In a study of over 1000 community-dwelling women aged 70 to 85 years, fear of falling, as determined by questionnaire, was found in one-third of women at baseline, and affected 46 percent of the sample at three year follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/30\">",
"     30",
"    </a>",
"    ]. In another study of 673 community-dwelling older adults, 60 percent reported moderate activity restriction and 15 percent severe activity restriction due to fear of falling [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/31\">",
"     31",
"    </a>",
"    ]. A systematic review found that fear of falling may affect 50 percent or more of patients following hip fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fear of falling was associated with living alone, cognitive impairment, depression, and balance and mobility impairments, as well as a history of falls [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/22,30\">",
"     22,30",
"    </a>",
"    ]. Fear of falling following hip fracture was associated with increased risk for institutionalization and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/32\">",
"     32",
"    </a>",
"    ]. New-onset fear of falling was predicted by obesity and impaired mobility.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Falls in older individuals are most often not due to a single cause, but occur when a threat to the normal homeostatic mechanisms that maintain postural stability is superimposed on underlying age-related declines in balance, gait stability, and cardiovascular function [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/1\">",
"     1",
"    </a>",
"    ]. This threat may involve an acute illness (eg, fever, dehydration, arrhythmia), a new medication, an environmental stress (eg, unfamiliar surrounding), or an unsafe walking surface. The older person is unable to compensate for the additional stress (",
"    <a class=\"graphic graphic_figure graphicRef63126 \" href=\"UTD.htm?43/9/44190\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The impact of challenges to postural control varies according to the risk-taking behavior of an individual and his or her opportunity to fall. Thus, individuals who are completely immobile may not be at risk of falling despite multiple predisposing factors, and those who are either vigorous or somewhat frail may be at increased risk [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/33\">",
"     33",
"    </a>",
"    ]. Vigorous older individuals may take more risks, while the frail older persons may not be able to compensate for relatively minor threats to postural stability.",
"   </p>",
"   <p>",
"    Multiple community-based prospective cohort studies of risk factors for falls have been published [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/5,9,34-44\">",
"     5,9,34-44",
"    </a>",
"    ]. Risk factors that were found in at least two of the studies include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Past history of a fall",
"     </li>",
"     <li>",
"      Lower extremity weakness",
"     </li>",
"     <li>",
"      Age",
"     </li>",
"     <li>",
"      Female gender",
"     </li>",
"     <li>",
"      Cognitive impairment",
"     </li>",
"     <li>",
"      Balance problems",
"     </li>",
"     <li>",
"      Psychotropic drug use",
"     </li>",
"     <li>",
"      Arthritis",
"     </li>",
"     <li>",
"      History of stroke",
"     </li>",
"     <li>",
"      Orthostatic hypotension",
"     </li>",
"     <li>",
"      Dizziness",
"     </li>",
"     <li>",
"      Anemia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Studies differed significantly in the types of risk factors evaluated, the populations studied (eg, past fall history was sometimes an entry criterion), and the defined outcomes (one fall, two or more falls, injurious falls). In one systematic review of 18 longitudinal cohort studies, age itself was found to be an independent risk factor in only 4 of the 11 studies that considered age in a multivariate analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/44\">",
"     44",
"    </a>",
"    ]. The fact that different risk factors were found across studies highlights the multifactorial nature of falls. Gait and balance impairment was the most consistent risk factor, followed by medications, in this systematic review that evaluated six potential risk factor domains:",
"    <span class=\"nowrap\">",
"     gait/balance,",
"    </span>",
"    medications, orthostatic hypotension, visual impairment, limitations in ADLs, and cognitive impairment.",
"   </p>",
"   <p>",
"    The site of falling, whether indoors or outdoors, may also be a factor in identifying risk factors. Studies have suggested that indoor falls tend to occur in frail persons, while outdoor falls tend to occur in younger active persons [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/45-48\">",
"     45-48",
"    </a>",
"    ]. This was corroborated in a prospective study of falls in a population-based sample of community-dwelling seniors in the Boston area that used fall calendars and individual follow-up of fallers to ascertain the location of falls [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/49\">",
"     49",
"    </a>",
"    ]. Indoor falls were associated with disability, indicators of poor health and an inactive lifestyle, while outdoor falls were associated with an active lifestyle and average or better-than-average health. Although most studies of risk factors have not considered fall location, failure to do so may obscure important risk factors. As an example, if slow gait increases risk for indoor falls and decreases risk for outdoor falls, an analysis that combines indoor and outdoor falls may find no association for gait speed with falls. Additionally, if risk factors are dependent on the site of falling, specific intervention strategies to prevent falls may differ for indoor and outdoor falls.",
"   </p>",
"   <p>",
"    Although some falls occur in individuals with no risk factors, the risk of falling generally increases with the number of risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/5,9,35\">",
"     5,9,35",
"    </a>",
"    ]. The rate of falls is increased in recently-hospitalized patients with other risk factors for falls [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Postural control",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical approach to fall prevention in older persons requires knowledge of age-related changes that affect postural control and increase the risk of falls.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Sensory systems",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ability to maintain the upright posture is dependent upon sensory input from several systems, including visual, proprioceptive, and vestibular. Declines in all three systems occur with aging:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Visual impairments result from decrease in visual acuity, depth perception, contrast sensitivity, and dark adaptation. Impaired vision has been associated with both falls and hip fracture [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/51-53\">",
"       51-53",
"      </a>",
"      ]. The use of multifocal lenses also increases the risk of falls [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Proprioceptive sensitivity loss occurs in the lower extremities and leads to an increased risk of falling [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The vestibular system is impaired by the loss of labyrinthine hair cells, vestibular ganglion cells, and nerve fibers.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Loss of function in these sensory organs is compounded by age-related changes in the central nervous system, including loss of neurons and depletion of neurotransmitters (eg, dopamine) within the basal ganglia, causing further loss of postural control [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is difficult to quantify the age-related changes in postural control that are independent of disease. Testing of postural stability (measured sway) in young and old subjects with no apparent musculoskeletal or neurologic impairment reveals age-related differences when moderately severe perturbations of stance are administered (changing the support surface, changing body position, altering the visual input, or moving the support surface horizontally or rotationally) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/57\">",
"     57",
"    </a>",
"    ]. These perturbations stress the redundancy of the sensory systems in their ability to maintain postural stability. Hearing loss has also been associated with an increased risk of falling [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/58\">",
"     58",
"    </a>",
"    ], but whether this represents concomitant vestibular dysfunction or an independent risk is uncertain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Muscle activation and composition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some of the most striking postural control differences between young and old relate to the order or grouping of muscle activation patterns.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Older individuals tend to activate proximal muscles, such as the quadriceps, before more distal muscles, such as the tibialis anterior, in response to perturbations of the support surface [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/59\">",
"       59",
"      </a>",
"      ]. This strategy may not be an efficient way to maintain postural stability.",
"     </li>",
"     <li>",
"      There may be greater contraction of antagonistic muscles in older persons, leading to a delay in the onset of muscle activation [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/60\">",
"       60",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Balance recovery during a postural disturbance may be compromised by an age-related decline in the ability to rapidly develop joint torque using muscles of the lower extremity [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/60,61\">",
"       60,61",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Decreased muscle cross-sectional area and increased muscle adiposity are related to declining physical function and disability in older adults. A study has identified a correlation between fatty infiltration of muscle and risk for hip fracture [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/62\">",
"       62",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These age-related changes in muscle use potentially undermine upright posture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     History of falls",
"    </span>",
"    &nbsp;&mdash;&nbsp;A previous history of falls is a significant risk factor for future falls [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/36,63-65\">",
"     36,63-65",
"    </a>",
"    ]. This was illustrated in a prospective study of community-dwelling elderly Medicare beneficiaries [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/63\">",
"     63",
"    </a>",
"    ]. At baseline, 63 of 736 subjects reported a fall and 67 reported two or more stumbles without a fall in the past month. On follow-up one year later, 127 subjects (22 percent) reported one or more falls. Independent baseline predictors of a fall at the second interview included two or more stumbles and one or more falls (adjusted odds ratio 2.3 and 5.9, respectively).",
"   </p>",
"   <p>",
"    Patients who have sustained a hip fracture are at increased risk of a second hip fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/66\">",
"     66",
"    </a>",
"    ]. Among 481 participants in the Framingham Study who had sustained one fracture, 14.8 percent had a second hip fracture during a median 4 year follow-up; risk increased with older age and higher functional status. Mortality was greater for second, compared to first, hip fractures, even after correcting for older age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Systemic blood pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regulation of systemic blood pressure is an important contributor to the maintenance of upright posture [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/67\">",
"     67",
"    </a>",
"    ]. Postural hypotension may lead to failure to perfuse the brain, thereby increasing the risk of a fall. Many older individuals have underlying vascular disease, which compromises resting cerebral perfusion. One study confirmed an association between more severe compromise in cerebral vasoreactivity and increased the risk for falls [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Causes of hypotension in older individuals include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Age-related decline in baroreflex sensitivity to hypotensive stimuli, manifested by a failure to increase the heart rate when blood pressure falls.",
"     </li>",
"     <li>",
"      Normal daily patterns, such as postural change related to eating a meal [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/69\">",
"       69",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/41/12951?source=see_link\">",
"       \"Mechanisms, causes, and evaluation of orthostatic and postprandial hypotension\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Age-related reduction in total body water, placing older individuals at increased risk of hypovolemia with acute illness, diuretic use, or hot weather. Progressive decline in basal and stimulated renin levels, leading to reduction in aldosterone secretion, may promote the development of volume depletion in the face of dehydrating stresses.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Chronic diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several age-related chronic conditions are associated with an increased fall risk.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Parkinson disease increases the risk of falls via several mechanisms: rigidity of the lower extremity musculature, inability to correct sway trajectory due to slowness in initiating movement, hypotensive drug effects, and (in some cases) cognitive impairment [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/70\">",
"       70",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Chronic musculoskeletal pain increases the risk of falls, and the risk correlates with pain severity and number of sites involved [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/71\">",
"       71",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Osteoarthritis of the knee affects mobility, the ability to maneuver and step over objects, and postural stability because of the tendency to avoid complete weight bearing on a painful joint. Chronic pain may also interfere with attention and cognitive reactions to impending falls. It is unknown if improved pain management would decrease the fall risk.",
"     </li>",
"     <li>",
"      Falls rates are higher for older patients with diabetes compared to individuals without diabetes [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/72\">",
"       72",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The risk for falls increases with increasing numbers of chronic diseases [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Cognitive impairment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild to moderate cognitive impairment is associated with a higher risk of falls and hip fractures. In one study of 1600 persons aged 75 years and above, the risk of hip fracture over six year follow-up was twice as high when the score on the mini-mental status examination was suggestive of mild impairment (score 18 to 23) compared with those with no impairment [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Anatomic changes associated with cognitive impairment have also been correlated with fall risk. In one prospective study, the volume of white matter lesions in the cerebral cortex was directly associated with the risk for falls [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is also some evidence that better social integration through family and friendship social networks may reduce the risk of falls among community-dwelling seniors [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Medication use",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medication use is one of the most modifiable risk factors for falls. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/0/30730?source=see_link\">",
"     \"Drug prescribing for older adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to specific types of medications, greater numbers of medications of any type, and recent changes in the dose of medication, are associated with increased fall risk [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/77-79\">",
"     77-79",
"    </a>",
"    ]. Poor adherence to medications has also been shown to be a risk factor for falls [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Drugs affecting the CNS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Central nervous system (CNS) active drugs, such as neuroleptics, benzodiazepines, and antidepressants, appears to be the most common drugs associated with falls [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/73,79,81-84\">",
"     73,79,81-84",
"    </a>",
"    ]. There is uncertainty whether the risk for falls using these medications arises during the initiation or chronic use of these medications. In a meta-analysis of 22 studies involving multiple classes of drugs, the likelihood of falling was increased with the use of sedatives and hypnotics (odds ratio [OR] 1.47, 95% credible interval (CrI) 1.35-1.62), neuroleptics and antipsychotics (OR 1.59, 95% CrI 1.37-1.83), antidepressants (OR 1.68, 95% CrI 1.47-1.91), and benzodiazepines (OR 1.57, 95% CrI 1.43-1.72) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/79\">",
"     79",
"    </a>",
"    ]. There was no increased risk of falls with narcotics (OR 0.96, 95% CrI 0.78-1.18). The \"credible interval\" in Bayesian modeling is analogous to the standard confidence interval. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22823?source=see_link\">",
"     \"Glossary of common biostatistical and epidemiological terms\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The effect of short- versus long-acting benzodiazepines on the risk of falling is not straightforward. Some studies have suggested a higher risk associated with long-acting drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/81,83\">",
"     81,83",
"    </a>",
"    ], while others have suggested that the dose or recent use, and not the drug half-life of benzodiazepine, is the important risk factor [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/84-87\">",
"     84-87",
"    </a>",
"    ]. However, a significant (55 percent) overall decrease in benzodiazepine prescriptions in New York State, following an administrative measure, did not lead to a change in hip fracture rate and may suggest a weaker association between benzodiazepine use and hip fractures than has been previously considered [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/88\">",
"     88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The selective serotonin reuptake inhibitor (SSRI) antidepressants have been less well studied than older tricyclic drugs, although several reports suggest that they offer no advantage over tricyclic antidepressants in their effects on falls [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/84,89,90\">",
"     84,89,90",
"    </a>",
"    ]. In one report, for example, 2428 nursing home residents who were new users of tricyclic antidepressants, SSRIs, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/0/24584?source=see_link\">",
"     trazodone",
"    </a>",
"    were retrospectively compared with nonusers of antidepressants [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/90\">",
"     90",
"    </a>",
"    ]. The new users of each type of antidepressant had higher rates of falls than the nonusers, with adjusted rate ratios of 2.0, 1.8, and 1.2 for each drug, respectively. The rate ratios increased with the daily dose of the tricyclic antidepressants and SSRIs. Daily use of SSRIs in adults 50 years and older has also been associated with a twofold increased risk clinical fragility fracture, after adjustment for potential covariates [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/91\">",
"     91",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It remains to be established whether the risk for falls related to antidepressants occurs only during drug initiation and dose titration or is seen with stable chronic use.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Antihypertensives and cardiovascular medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vasodilators have been associated with an increased risk of falling [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/64\">",
"     64",
"    </a>",
"    ]. In a meta-analysis of 22 studies involving multiple classes of drugs, there was an association between antihypertensive drugs and risk of falls (OR 1.24, 95% CrI 1.01-1.50), but the association was not significant for beta blockers (OR 1.01, 95% CrI 0.86-1.17) and only marginally significant for diuretics, which could have been given for edema as well as hypertension (OR 1.07, 95% CrI 1.01-1.14) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Alcohol use",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relationship between alcohol use and falls appears to depend on the amount of alcohol consumed. In a study of 6000 men aged 65 years and older, light drinkers (less than 14 drinks per week) had a decreased risk of two or more falls in one year compared to abstainers (RR 0.77, 95% CI 0.65-0.92) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/92\">",
"     92",
"    </a>",
"    ]. However, men with problem drinking had a higher risk of two or more falls than those without problem drinking (RR 1.59, 95% CI 1.30-1.94).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Footwear",
"    </span>",
"    &nbsp;&mdash;&nbsp;Footwear may be an important factor affecting the risk of falls. In one small study evaluating balance and footwear in older men, shoes with thin, hard soles were associated with the best balance, although these shoes were perceived as less comfortable than thick, soft, mid-soled shoes, such as running shoes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast to the results from such gait laboratory studies, a nested case-control study found a lower risk of falls associated with athletic shoes or sneakers and a higher risk of falls with other footwear (RR 1.3, 95% CI 0.9-1.9); going barefoot or in stocking feet appeared to be particularly risky [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/94\">",
"     94",
"    </a>",
"    ]. Although the study adjusted for other factors in a multivariate model, confounding factors may still have affected results, and healthier patients may be more likely to wear athletic shoes or sneakers. In a companion study, footwear with greater heel height was associated with an increased risk of falling, while footwear with greater contact area between the sole and the floor was associated with a lower risk [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/95\">",
"     95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given the conflicting results from laboratory studies and clinical studies, it is uncertain what type of footwear provides the lowest risk of falls, although low-heeled shoes are advisable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Environmental factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Environmental factors frequently interact with intrinsic risk factors, and so their relative importance in fall risk has not been clearly defined. Intervention studies have generally focused upon improving the overall risk factor profile of the individual [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/96\">",
"     96",
"    </a>",
"    ] or have combined individual interventions with environmental manipulation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/97\">",
"     97",
"    </a>",
"    ], making it difficult to partition out the contributions of the environmental factors.",
"   </p>",
"   <p>",
"    One study, for example, investigated the utility of a home visit by an experienced occupational therapist who assessed the home for potential environmental hazards and facilitated any necessary modifications [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/98\">",
"     98",
"    </a>",
"    ]. Patients who were at high risk of falling (history of one or more falls in the year prior to the study) had a significantly reduced risk of falling during the study period compared with controls (RR 0.64). However, this effect may not have been due to home modifications alone, since the therapist visit may also have led to changes in behavior that reduced the risk of falling.",
"   </p>",
"   <p>",
"    The efficacy of hazard reduction was more directly assessed in a study of people ages 70 and older who were randomly assigned to a control group or an intervention group that included a home hazard assessment, information on hazard reduction, and the installation of safety devices [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/99\">",
"     99",
"    </a>",
"    ]. Both groups had a single home visit from a research nurse. The intervention resulted in a small reduction in the mean number of hazards per house, but no reduction in falls compared with the control group [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/100\">",
"     100",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nevertheless, attention to safety hazards in the home environment appears to be worthwhile. Whether a home assessment by a physical or occupational therapist is cost-effective for this purpose is not clear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Institutional settings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Falls in the hospital and nursing home settings occur more frequently and are associated with greater morbidity than falls that occur in the community. In a cross-sectional study of nursing homes in the United States (230,730 patients), 21 percent of newly admitted residents who stayed in the nursing home at least 30 days had at least one fall within 30 days of a post-admission assessment [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/101\">",
"     101",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Use of bed rails has been associated in some reports with an increase in injuries and deaths, and does not appear to significantly reduce the likelihood of falls in nursing homes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/102\">",
"     102",
"    </a>",
"    ]. Reducing the use of bedrails does not appear to change the total number of falls that occur in the hospital, but can decrease the number of serious falls [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/103\">",
"     103",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;In one prospective study, in which 51 hip fractures occurred over nine years, the presence of diffuse white matter lesions on baseline brain MRI study was significantly correlated with increased risk of hip fracture in study participants who were 65 to 80 years old (HR 2.7, 95% CI 1.1-7.1) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/104\">",
"     104",
"    </a>",
"    ]. White matter lesions were not an independent variable for patients over 80 years. Though the clinical significance of white matter lesions is uncertain (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/57/37786?source=see_link&amp;anchor=H16#H16\">",
"     \"Etiology, clinical manifestations, and diagnosis of vascular dementia\", section on 'White matter lesions'",
"    </a>",
"    ), and these findings need to be confirmed by other studies, older people found to have diffuse lesions on incidental brain MRI scanning may benefit from interventions for fall prevention.",
"   </p>",
"   <p>",
"    Men and women over age 65 years with low serum 25-hydroxyvitamin D concentrations (&lt;10",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    [25",
"    <span class=\"nowrap\">",
"     nmol/L])",
"    </span>",
"    are at greater risk for loss of muscle strength and muscle mass [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/105\">",
"     105",
"    </a>",
"    ]. Serum 25-OHD concentrations below 20",
"    <span class=\"nowrap\">",
"     ng/ml",
"    </span>",
"    are also associated with poorer physical performance and a greater decline in physical performance in older men and women [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/106\">",
"     106",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/12/8393?source=see_link&amp;anchor=H6#H6\">",
"     \"Prevention of falls and complications of falls in community-dwelling older persons\", section on 'Vitamin D supplementation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     FALLS RISK ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;An assessment of fall risk should be integrated into the history and physical examination of all geriatric patients, including those not specifically being seen for a problem with falling. Guidelines issued by the American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopedic Surgeons panel on falls prevention include the following (",
"    <a class=\"graphic graphic_algorithm graphicRef69682 \" href=\"UTD.htm?29/50/30496\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/107\">",
"     107",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      All older patients (or their caregivers) should be asked at least once a year about falls, frequency of falling, and difficulties in gait or balance.",
"     </li>",
"     <li>",
"      For persons who report a single fall, gait and balance deficits should be evaluated as a screen for identifying individuals who may benefit from a multifactorial fall risk assessment. A multifactorial fall risk assessment should be performed for community-dwelling older persons who:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Report recurrent (two or more) falls",
"     </li>",
"     <li>",
"      Report difficulties with gait or balance",
"     </li>",
"     <li>",
"      Seek medical attention or present to the emergency department because of a fall",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Guidelines from the US Preventive Services Task Force (USPSTF) recommend against &ldquo;automatically&rdquo; performing a multifactorial risk assessment for all older community-dwelling adults, noting a small likelihood of benefit for interventions targeted to identified risks [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/108\">",
"     108",
"    </a>",
"    ]. The guidelines advise that factors including the circumstances of prior falls, comorbidities, and patient values be taken into consideration in determining the appropriateness of multifactorial risk for individuals. This was corroborated by a study examining risk factors for recurrent fallers, a situation for which multifactorial risk assessment has been recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/109\">",
"     109",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     EVALUATION FOR PATIENTS WITH INCREASED FALL RISK",
"    </span>",
"    &nbsp;&mdash;&nbsp;A targeted history and physical examination can identify patients at risk for falling. In particular, a history of previous fall and a physical finding of lower extremity weakness are important risk factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies report that the most important consideration in the history is a previous fall, which places the patient at increase risk of future falls [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/36,44,63,64\">",
"     36,44,63,64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients presenting with a fall, important components of the history include the activity of the faller at the time of the incident, prodromal symptoms (lightheadedness, imbalance, dizziness), and where and when the fall occurred. Loss of consciousness is associated with injurious falls and should raise important considerations such as orthostatic hypotension, cardiac disease, or neurologic disease.",
"   </p>",
"   <p>",
"    Identification of underlying chronic diseases that increase falls risk is important. Examples of these age-related chronic conditions include Parkinson disease, chronic musculoskeletal pain, knee osteoarthritis, cognitive impairment, dementia, stroke, and diabetes.",
"   </p>",
"   <p>",
"    Information on previous falls should be collected to identify patterns that may help target risk factor modification strategies. A complete medication history should be taken, with specific focus on psychotropic medications, sedative hypnotics, antidepressants, and antihypertensive medications. Alcohol use should be determined. Environmental factors that may have contributed to the fall should also be identified; information on lighting, floor covering, door thresholds, railings, and furniture may add important clues.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Musculoskeletal function",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important aspect of the physical examination in the patient who has fallen is an assessment of integrated musculoskeletal function. This can be obtained by performing one or more tests of postural stability.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2706902\">",
"    <span class=\"h3\">",
"     Performance Oriented Mobility Assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Performance Oriented Mobility Assessment tool (POMA, or Tinetti Assessment Tool) is a scored instrument that assesses balance (nine items) and gait (seven items), using an ordinal scale from zero to two (&ldquo;0&rdquo; for the most impaired performance, &ldquo;1&rdquo; if slight impairment, and &ldquo;2&rdquo; if independent) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/110\">",
"     110",
"    </a>",
"    ].",
"    <a class=\"external\" href=\"file://louisianaqio.eqhs.org/PDF/Patient Safety/TinettiTool.pdf\">",
"     This tool is available here.",
"    </a>",
"    The items range from being able to maintain balance when someone slightly pulls on an individual, to walking normally with assessment of step continuity and path deviation. No reliable cutpoint has been established for the POMA score in the prediction of falls.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     'Get Up and Go' test",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the best known tests is commonly referred to as the \"Get Up and Go\" test, originally described using a graded 1 to 5 scale (where 1 is normal and 5 is severely abnormal) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/111\">",
"     111",
"    </a>",
"    ]. Later versions employed a timed performance approach [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/112\">",
"     112",
"    </a>",
"    ]. A 2013 meta-analysis of 53 studies (n = 12,800) showed that the timed &ldquo;Get Up and Go&rdquo; test in adults &ge;60 years of age did not show a difference in scores between fallers and non-fallers who were living independently [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/113\">",
"     113",
"    </a>",
"    ]. While the test showed a mean difference of 3.59 seconds between institutionalized fallers and non-fallers, cut-off points distinguishing fallers and nonfallers showed considerable variation between studies, and the diagnostic accuracy in most studies was poor to moderate. The &ldquo;Get Up and Go&rdquo; test is best used as part of a global assessment of an individual&rsquo;s fall risk.",
"   </p>",
"   <p>",
"    The test is performed by observing the subject rising from a standard arm chair, walking a fixed distance across the room, turning around, walking back to the chair, and sitting back down. Observation of the different components of this test may help to identify deficits in leg strength, balance, vestibular dysfunction, and gait. The timed part of the test records the mean time (in seconds) from initial getting up to re-seating. Patients are compared to the mean time of adults in their age group, 60-69, 70-79, and 80-99 years of age.",
"    <br/>",
"    <br/>",
"    In practical terms, the observation of deficiencies in various individual components may isolate areas for targeted intervention (",
"    <a class=\"graphic graphic_table graphicRef66046 \" href=\"UTD.htm?5/47/5885\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Functional reach test",
"    </span>",
"    &nbsp;&mdash;&nbsp;The \"functional reach\" test is another practical approach to testing integrated neuromuscular base of support [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/114,115\">",
"     114,115",
"    </a>",
"    ]; it has predictive validity for falls in older males [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/116\">",
"     116",
"    </a>",
"    ]. In its original description, the functional reach correlated with other physical performance measures, including walking speed, tandem walking, and standing on one foot [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/114\">",
"     114",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This test is performed using a leveled yardstick secured to a wall at the height of the acromion. The person being tested assumes a comfortable stance without shoes or socks and stands so that his or her shoulders are perpendicular to the yardstick. The individual makes a fist and extends the arm forward as far as possible without taking a step or losing balance. The total reach is measured along the yardstick and recorded (",
"    <a class=\"graphic graphic_figure graphicRef54071 \" href=\"UTD.htm?31/56/32641\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12527641\">",
"    <span class=\"h3\">",
"     Short Physical Performance Battery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Short Physical Performance Battery (SPPB) characterizes lower extremity function.&nbsp;It includes measures of standing balance (timing of tandem, semi-tandem, and side-by-side stands, four-meter walking speed and ability, and time to rise from a chair five times). The SPPB captures a wide range of functional abilities, and summary scores &lt;9 have independently predicted disability in ADL and mobility at one to six years of follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/117,118\">",
"     117,118",
"    </a>",
"    ]. Components of the SPPB (eg, chair stand, gait speed, and tandem stance) are also predictive of falls [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/119\">",
"     119",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Other tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Berg Balance test is performed easily in the rehabilitation setting or outpatient clinic [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/120\">",
"     120",
"    </a>",
"    ]. The scale predicted risk of multiple falls in older patients in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/121\">",
"     121",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A more comprehensive performance-oriented assessment of balance includes measures of sitting and standing balance, ability to withstand a nudge on the sternum, and ability to reach up, bend down, and extend the back and neck [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/110\">",
"     110",
"    </a>",
"    ]. Each of these performance measures attempts to identify components of postural stability that complement the standard physical examination.",
"   </p>",
"   <p>",
"    Difficulty in performing divided attention tasks (simultaneous manual and cognitive tasks such as walking while talking) may also identify individuals at high risk for falling. A preliminary study in 60 older people found that those who had difficulty walking while reciting the alphabet or walking while reciting every other letter of the alphabet were at significantly increased risk for falls (odds ratio [OR] 7.02 and 13.7, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/122\">",
"     122",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     General physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other aspects of the physical examination in the individual who has fallen should focus upon fall risk factors.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Postural vital signs should be obtained to rule out orthostatic hypotension [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/123\">",
"       123",
"      </a>",
"      ]. The blood pressure and heart rate should be taken supine and after one and three minutes of standing. Some information may be derived from sitting vital signs if the patient is unable to stand.",
"     </li>",
"     <li>",
"      An assessment of visual acuity should be performed; visual acuity should be checked with glasses if the patient was wearing corrective lenses at the time of the fall.",
"     </li>",
"     <li>",
"      Hearing may be assessed using the whisper test or a hand-held audiometer (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/32/39429?source=see_link&amp;anchor=H5#H5\">",
"       \"Evaluation of hearing loss in adults\", section on 'Office hearing evaluation'",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/124\">",
"       124",
"      </a>",
"      ]. Eighth cranial nerve deficits may be associated with vestibular dysfunction.",
"     </li>",
"     <li>",
"      Examination of the extremities may uncover deformities of the feet that contribute to the risk of falling, such as bunions, callouses, and arthritic deformities. Sensory neuropathies also increase the risk of falls [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A targeted neurologic examination (including evaluation of lower extremity strength, gait, and postural stability) may identify persons with an increased risk of falls. Individuals who report a history of falls in the past year tend to have a greater number of abnormalities on a neurologic examination [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/125\">",
"       125",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      One systematic review of 16 studies found that lower extremity weakness had a higher correlation with fall risk than a history of prior falls [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/14\">",
"       14",
"      </a>",
"      ]. In this study, leg weakness increased the risk of falling by more than fourfold and a history of falls by threefold [",
"      <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Diagnostic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic testing may be indicated based upon the history and physical examination, including evaluation of postural stability, gait and mobility. There is no standard diagnostic evaluation of an individual with a history of or at high risk for falls.",
"   </p>",
"   <p>",
"    Laboratory tests such as a hemoglobin concentration and serum urea nitrogen, creatinine, and glucose concentrations can help to rule out causes of falling such as anemia, dehydration, and dehydration and autonomic neuropathy related to diabetes. Serum 25-hydroxyvitamin D levels can identify individuals with vitamin D deficiency who will benefit from vitamin D supplementation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/12/8393?source=see_link\">",
"     \"Prevention of falls and complications of falls in community-dwelling older persons\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is no proven value of routinely performing Holter monitoring in individuals who have fallen [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/6\">",
"     6",
"    </a>",
"    ]. Similarly, the decision to perform echocardiography, brain imaging, or radiographic studies of the spine should not be considered routine, but should be driven by findings during the history and physical examination. Thus, an echocardiogram could be considered for those with heart murmurs believed to contribute to the maintenance of blood flow to the brain, and spine x-rays or magnetic resonance imaging may be useful in patients with gait disorders, abnormalities on neurologic examination, lower extremity spasticity, or hyperreflexia to rule out cervical spondylosis or lumbar stenosis.",
"   </p>",
"   <p>",
"    One study found that carotid sinus massage was helpful in identifying patients with carotid sinus sensitivity as a cause of falls [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/126\">",
"     126",
"    </a>",
"    ]; fall rates were decreased in patients who received pacemakers for carotid massage-induced electrocardiogram pauses of three seconds or longer [",
"    <a class=\"abstract\" href=\"UTD.htm?22/4/22602/abstract/127\">",
"     127",
"    </a>",
"    ]. The subjects in this study had a history of multiple falls (more than seven per year). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/0/18442?source=see_link\">",
"     \"Reflex syncope\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?41/4/42050?source=see_link\">",
"       \"Patient information: Preventing falls (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Between 30 and 40 percent of community-dwelling people over the age of 65 years, and 50 percent of those in long-term facilities, fall each year. Major injuries result from 5 percent of falls in the community and 10 percent of falls in institutions. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Falls in older persons are due to extrinsic stresses working in conjunction with age-related intrinsic factors that increase vulnerability to falls. Multiple risk factors have been identified, including past history of a fall, lower extremity weakness, age, female gender, cognitive impairment, balance problems, psychotropic drug use, arthritis, history of stroke, orthostatic hypotension, dizziness, and anemia. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Medication use is one of the most readily modifiable fall risks. Multiple medications of any type, and psychotropic drugs in particular, are associated with increased falls; benzodiazepine dose is more strongly correlated with risk than short- or long-acting formulation. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Medication use'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All older patients should be asked at least once yearly about falls. Further evaluation is indicated for patients who present with a fall or have a history of recurrent falls. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Falls risk assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Evaluation for fallers should include postural vital signs, assessment of visual acuity, hearing, and muscle function. The value of a complete neurological examination is uncertain. Diagnostic testing may include a CBC, serum BUN and creatinine, glucose level, and vitamin D. Holter monitoring, echocardiograms, and radiologic studies are indicated only when suggested by findings on history of exam. Assessment of carotid sinus sensitivity may be indicated in people with unexplained multiple falls. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Evaluation for patients with increased fall risk'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/1\">",
"      Tinetti ME, Inouye SK, Gill TM, Doucette JT. Shared risk factors for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes. JAMA 1995; 273:1348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/2\">",
"      Salkeld G, Cameron ID, Cumming RG, et al. Quality of life related to fear of falling and hip fracture in older women: a time trade off study. BMJ 2000; 320:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/3\">",
"      Thapa PB, Brockman KG, Gideon P, et al. Injurious falls in nonambulatory nursing home residents: a comparative study of circumstances, incidence, and risk factors. J Am Geriatr Soc 1996; 44:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/4\">",
"      Tinetti ME, Liu WL, Ginter SF. Mechanical restraint use and fall-related injuries among residents of skilled nursing facilities. Ann Intern Med 1992; 116:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/5\">",
"      Nevitt MC, Cummings SR, Hudes ES. Risk factors for injurious falls: a prospective study. J Gerontol 1991; 46:M164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/6\">",
"      Rosado JA, Rubenstein LZ, Robbins AS, et al. The value of Holter monitoring in evaluating the elderly patient who falls. J Am Geriatr Soc 1989; 37:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/7\">",
"      Tinetti ME. Clinical practice. Preventing falls in elderly persons. N Engl J Med 2003; 348:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/8\">",
"      Rubenstein LZ, Josephson KR. The epidemiology of falls and syncope. Clin Geriatr Med 2002; 18:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/9\">",
"      Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988; 319:1701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/10\">",
"      Chang JT, Morton SC, Rubenstein LZ, et al. Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials. BMJ 2004; 328:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/11\">",
"      Centers for Disease Control and Prevention (CDC). Self-reported falls and fall-related injuries among persons aged &gt; or =65 years--United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/12\">",
"      Centers for Disease Control and Prevention (CDC). Public health and aging: nonfatal injuries among older adults treated in hospital emergency departments--United States, 2001. MMWR Morb Mortal Wkly Rep 2003; 52:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/13\">",
"      Nachreiner NM, Findorff MJ, Wyman JF, McCarthy TC. Circumstances and consequences of falls in community-dwelling older women. J Womens Health (Larchmt) 2007; 16:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/14\">",
"      Rubenstein LZ, Josephson KR. Falls and their prevention in elderly people: what does the evidence show? Med Clin North Am 2006; 90:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/15\">",
"      Nickens H. Intrinsic factors in falling among the elderly. Arch Intern Med 1985; 145:1089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/16\">",
"      Oliver D, Connelly JB, Victor CR, et al. Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analyses. BMJ 2007; 334:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/17\">",
"      Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention. J Am Geriatr Soc 2001; 49:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/18\">",
"      Hartholt KA, van der Velde N, Looman CW, et al. Trends in fall-related hospital admissions in older persons in the Netherlands. Arch Intern Med 2010; 170:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/19\">",
"      Tinetti ME, Williams CS. The effect of falls and fall injuries on functioning in community-dwelling older persons. J Gerontol A Biol Sci Med Sci 1998; 53:M112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/20\">",
"      Kiel DP, O'Sullivan P, Teno JM, Mor V. Health care utilization and functional status in the aged following a fall. Med Care 1991; 29:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/21\">",
"      Tinetti ME, Williams CS. Falls, injuries due to falls, and the risk of admission to a nursing home. N Engl J Med 1997; 337:1279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/22\">",
"      Tinetti ME, Mendes de Leon CF, Doucette JT, Baker DI. Fear of falling and fall-related efficacy in relationship to functioning among community-living elders. J Gerontol 1994; 49:M140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/23\">",
"      Close JC, Lord SR, Antonova EJ, et al. Older people presenting to the emergency department after a fall: a population with substantial recurrent healthcare use. Emerg Med J 2012; 29:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/24\">",
"      Tinetti ME, Liu WL, Claus EB. Predictors and prognosis of inability to get up after falls among elderly persons. JAMA 1993; 269:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/25\">",
"      Sattin RW. Falls among older persons: a public health perspective. Annu Rev Public Health 1992; 13:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/26\">",
"      Sattin RW, Lambert Huber DA, DeVito CA, et al. The incidence of fall injury events among the elderly in a defined population. Am J Epidemiol 1990; 131:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/27\">",
"      Spaniolas K, Cheng JD, Gestring ML, et al. Ground level falls are associated with significant mortality in elderly patients. J Trauma 2010; 69:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/28\">",
"      Centers for Disease Control and Prevention (CDC). Fatalities and injuries from falls among older adults--United States, 1993-2003 and 2001-2005. MMWR Morb Mortal Wkly Rep 2006; 55:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/29\">",
"      King MB, Tinetti ME. Falls in community-dwelling older persons. J Am Geriatr Soc 1995; 43:1146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/30\">",
"      Austin N, Devine A, Dick I, et al. Fear of falling in older women: a longitudinal study of incidence, persistence, and predictors. J Am Geriatr Soc 2007; 55:1598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/31\">",
"      Deshpande N, Metter EJ, Lauretani F, et al. Activity restriction induced by fear of falling and objective and subjective measures of physical function: a prospective cohort study. J Am Geriatr Soc 2008; 56:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/32\">",
"      Visschedijk J, Achterberg W, Van Balen R, Hertogh C. Fear of falling after hip fracture: a systematic review of measurement instruments, prevalence, interventions, and related factors. J Am Geriatr Soc 2010; 58:1739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/33\">",
"      Speechley M, Tinetti M. Falls and injuries in frail and vigorous community elderly persons. J Am Geriatr Soc 1991; 39:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/34\">",
"      Graafmans WC, Ooms ME, Hofstee HM, et al. Falls in the elderly: a prospective study of risk factors and risk profiles. Am J Epidemiol 1996; 143:1129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/35\">",
"      Campbell AJ, Borrie MJ, Spears GF. Risk factors for falls in a community-based prospective study of people 70 years and older. J Gerontol 1989; 44:M112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/36\">",
"      Nevitt MC, Cummings SR, Kidd S, Black D. Risk factors for recurrent nonsyncopal falls. A prospective study. JAMA 1989; 261:2663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/37\">",
"      O'Loughlin JL, Robitaille Y, Boivin JF, Suissa S. Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol 1993; 137:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/38\">",
"      Jamal SA, Stone K, Browner WS, et al. Serum fructosamine level and the risk of hip fracture in elderly women: a case-cohort study within the study of osteoporotic fractures. Am J Med 1998; 105:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/39\">",
"      Ho SC, Woo J, Chan SS, et al. Risk factors for falls in the Chinese elderly population. J Gerontol A Biol Sci Med Sci 1996; 51:M195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/40\">",
"      Davis JW, Ross PD, Nevitt MC, Wasnich RD. Risk factors for falls and for serious injuries on falling among older Japanese women in Hawaii. J Am Geriatr Soc 1999; 47:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/41\">",
"      Schwartz AV, Villa ML, Prill M, et al. Falls in older Mexican-American women. J Am Geriatr Soc 1999; 47:1371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/42\">",
"      Bueno-Cavanillas A, Padilla-Ruiz F, Jim&eacute;nez-Mole&oacute;n JJ, et al. Risk factors in falls among the elderly according to extrinsic and intrinsic precipitating causes. Eur J Epidemiol 2000; 16:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/43\">",
"      Penninx BW, Pluijm SM, Lips P, et al. Late-life anemia is associated with increased risk of recurrent falls. J Am Geriatr Soc 2005; 53:2106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/44\">",
"      Ganz DA, Bao Y, Shekelle PG, Rubenstein LZ. Will my patient fall? JAMA 2007; 297:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/45\">",
"      Bergland A, Jarnlo GB, Laake K. Predictors of falls in the elderly by location. Aging Clin Exp Res 2003; 15:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/46\">",
"      O'Loughlin JL, Boivin JF, Robitaille Y, Suissa S. Falls among the elderly: distinguishing indoor and outdoor risk factors in Canada. J Epidemiol Community Health 1994; 48:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/47\">",
"      Li W, Keegan TH, Sternfeld B, et al. Outdoor falls among middle-aged and older adults: a neglected public health problem. Am J Public Health 2006; 96:1192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/48\">",
"      Bath PA, Morgan K. Differential risk factor profiles for indoor and outdoor falls in older people living at home in Nottingham, UK. Eur J Epidemiol 1999; 15:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/49\">",
"      Kelsey JL, Berry SD, Procter-Gray E, et al. Indoor and outdoor falls in older adults are different: the maintenance of balance, independent living, intellect, and Zest in the Elderly of Boston Study. J Am Geriatr Soc 2010; 58:2135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/50\">",
"      Mahoney JE, Palta M, Johnson J, et al. Temporal association between hospitalization and rate of falls after discharge. Arch Intern Med 2000; 160:2788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/51\">",
"      Felson DT, Anderson JJ, Hannan MT, et al. Impaired vision and hip fracture. The Framingham Study. J Am Geriatr Soc 1989; 37:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/52\">",
"      Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995; 332:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/53\">",
"      Lord SR, Dayhew J. Visual risk factors for falls in older people. J Am Geriatr Soc 2001; 49:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/54\">",
"      Lord SR, Dayhew J, Howland A. Multifocal glasses impair edge-contrast sensitivity and depth perception and increase the risk of falls in older people. J Am Geriatr Soc 2002; 50:1760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/55\">",
"      Richardson JK, Hurvitz EA. Peripheral neuropathy: a true risk factor for falls. J Gerontol A Biol Sci Med Sci 1995; 50:M211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/56\">",
"      Scheibel AB. Falls, motor dysfunction, and correlative neurohistologic changes in the elderly. Clin Geriatr Med 1985; 1:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/57\">",
"      Alexander NB. Postural control in older adults. J Am Geriatr Soc 1994; 42:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/58\">",
"      Viljanen A, Kaprio J, Pyykk&ouml; I, et al. Hearing as a predictor of falls and postural balance in older female twins. J Gerontol A Biol Sci Med Sci 2009; 64:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/59\">",
"      Woollacott MH, Shumway-Cook A, Nashner LM. Aging and posture control: changes in sensory organization and muscular coordination. Int J Aging Hum Dev 1986; 23:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/60\">",
"      Maki BE, McIlroy WE. Postural control in the older adult. Clin Geriatr Med 1996; 12:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/61\">",
"      Thelen DG, Schultz AB, Alexander NB, Ashton-Miller JA. Effects of age on rapid ankle torque development. J Gerontol A Biol Sci Med Sci 1996; 51:M226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/62\">",
"      Lang T, Koyama A, Li C, et al. Pelvic body composition measurements by quantitative computed tomography: association with recent hip fracture. Bone 2008; 42:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/63\">",
"      Teno J, Kiel DP, Mor V. Multiple stumbles: a risk factor for falls in community-dwelling elderly. A prospective study. J Am Geriatr Soc 1990; 38:1321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/64\">",
"      Myers AH, Baker SP, Van Natta ML, et al. Risk factors associated with falls and injuries among elderly institutionalized persons. Am J Epidemiol 1991; 133:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/65\">",
"      Kiely DK, Kiel DP, Burrows AB, Lipsitz LA. Identifying nursing home residents at risk for falling. J Am Geriatr Soc 1998; 46:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/66\">",
"      Berry SD, Samelson EJ, Hannan MT, et al. Second hip fracture in older men and women: the Framingham Study. Arch Intern Med 2007; 167:1971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/67\">",
"      Kario K, Tobin JN, Wolfson LI, et al. Lower standing systolic blood pressure as a predictor of falls in the elderly: a community-based prospective study. J Am Coll Cardiol 2001; 38:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/68\">",
"      Sorond FA, Galica A, Serrador JM, et al. Cerebrovascular hemodynamics, gait, and falls in an elderly population: MOBILIZE Boston Study. Neurology 2010; 74:1627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/69\">",
"      Jonsson PV, Lipsitz LA, Kelley M, Koestner J. Hypotensive responses to common daily activities in institutionalized elderly. A potential risk for recurrent falls. Arch Intern Med 1990; 150:1518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/70\">",
"      Wood BH, Bilclough JA, Bowron A, Walker RW. Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry 2002; 72:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/71\">",
"      Leveille SG, Jones RN, Kiely DK, et al. Chronic musculoskeletal pain and the occurrence of falls in an older population. JAMA 2009; 302:2214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/72\">",
"      Schwartz AV, Hillier TA, Sellmeyer DE, et al. Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care 2002; 25:1749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/73\">",
"      Lawlor DA, Patel R, Ebrahim S. Association between falls in elderly women and chronic diseases and drug use: cross sectional study. BMJ 2003; 327:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/74\">",
"      Guo Z, Wills P, Viitanen M, et al. Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol 1998; 148:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/75\">",
"      Srikanth V, Beare R, Blizzard L, et al. Cerebral white matter lesions, gait, and the risk of incident falls: a prospective population-based study. Stroke 2009; 40:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/76\">",
"      Faulkner KA, Cauley JA, Zmuda JM, et al. Is social integration associated with the risk of falling in older community-dwelling women? J Gerontol A Biol Sci Med Sci 2003; 58:M954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/77\">",
"      Cumming RG, Miller JP, Kelsey JL, et al. Medications and multiple falls in elderly people: the St Louis OASIS study. Age Ageing 1991; 20:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/78\">",
"      Buchner DM, Larson EB. Falls and fractures in patients with Alzheimer-type dementia. JAMA 1987; 257:1492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/79\">",
"      Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009; 169:1952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/80\">",
"      Berry SD, Quach L, Procter-Gray E, et al. Poor adherence to medications may be associated with falls. J Gerontol A Biol Sci Med Sci 2010; 65:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/81\">",
"      Ray WA, Griffin MR, Schaffner W, et al. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/82\">",
"      Ray WA, Griffin MR, Malcolm E. Cyclic antidepressants and the risk of hip fracture. Arch Intern Med 1991; 151:754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/83\">",
"      Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989; 262:3303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/84\">",
"      Ensrud KE, Blackwell TL, Mangione CM, et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc 2002; 50:1629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/85\">",
"      Cumming RG. Epidemiology of medication-related falls and fractures in the elderly. Drugs Aging 1998; 12:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/86\">",
"      Wang PS, Bohn RL, Glynn RJ, et al. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 2001; 158:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/87\">",
"      Tamblyn R, Abrahamowicz M, du Berger R, et al. A 5-year prospective assessment of the risk associated with individual benzodiazepines and doses in new elderly users. J Am Geriatr Soc 2005; 53:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/88\">",
"      Wagner AK, Ross-Degnan D, Gurwitz JH, et al. Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med 2007; 146:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/89\">",
"      Liu B, Anderson G, Mittmann N, et al. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 1998; 351:1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/90\">",
"      Thapa PB, Gideon P, Cost TW, et al. Antidepressants and the risk of falls among nursing home residents. N Engl J Med 1998; 339:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/91\">",
"      Richards JB, Papaioannou A, Adachi JD, et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 2007; 167:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/92\">",
"      Cawthon PM, Harrison SL, Barrett-Connor E, et al. Alcohol intake and its relationship with bone mineral density, falls, and fracture risk in older men. J Am Geriatr Soc 2006; 54:1649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/93\">",
"      Robbins S, Gouw GJ, McClaran J. Shoe sole thickness and hardness influence balance in older men. J Am Geriatr Soc 1992; 40:1089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/94\">",
"      Koepsell TD, Wolf ME, Buchner DM, et al. Footwear style and risk of falls in older adults. J Am Geriatr Soc 2004; 52:1495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/95\">",
"      Tencer AF, Koepsell TD, Wolf ME, et al. Biomechanical properties of shoes and risk of falls in older adults. J Am Geriatr Soc 2004; 52:1840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/96\">",
"      Province MA, Hadley EC, Hornbrook MC, et al. The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT Trials. Frailty and Injuries: Cooperative Studies of Intervention Techniques. JAMA 1995; 273:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/97\">",
"      Tinetti ME, Baker DI, McAvay G, et al. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med 1994; 331:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/98\">",
"      Cumming RG, Thomas M, Szonyi G, et al. Home visits by an occupational therapist for assessment and modification of environmental hazards: a randomized trial of falls prevention. J Am Geriatr Soc 1999; 47:1397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/99\">",
"      Stevens M, Holman CD, Bennett N, de Klerk N. Preventing falls in older people: outcome evaluation of a randomized controlled trial. J Am Geriatr Soc 2001; 49:1448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/100\">",
"      Stevens M, Holman CD, Bennett N. Preventing falls in older people: impact of an intervention to reduce environmental hazards in the home. J Am Geriatr Soc 2001; 49:1442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/101\">",
"      Leland NE, Gozalo P, Teno J, Mor V. Falls in newly admitted nursing home residents: a national study. J Am Geriatr Soc 2012; 60:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/102\">",
"      Capezuti E, Maislin G, Strumpf N, Evans LK. Side rail use and bed-related fall outcomes among nursing home residents. J Am Geriatr Soc 2002; 50:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/103\">",
"      Hanger HC, Ball MC, Wood LA. An analysis of falls in the hospital: can we do without bedrails? J Am Geriatr Soc 1999; 47:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/104\">",
"      Corti MC, Baggio G, Sartori L, et al. White matter lesions and the risk of incident hip fracture in older persons: results from the progetto veneto anziani study. Arch Intern Med 2007; 167:1745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/105\">",
"      Visser M, Deeg DJ, Lips P, Longitudinal Aging Study Amsterdam. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003; 88:5766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/106\">",
"      Wicherts IS, van Schoor NM, Boeke AJ, et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 2007; 92:2058.",
"     </a>",
"    </li>",
"    <li>",
"     The American Geriatrics Society Clinical Practice Guideline: Prevention of falls in older person (2010) file://www.americangeriatrics.org/health_care_professionals/clinical_practice/clinical_guidelines_recommendations/2010/.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/108\">",
"      Moyer VA, U.S. Preventive Services Task Force. Prevention of falls in community-dwelling older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 157:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/109\">",
"      Kelsey JL, Procter-Gray E, Berry SD, et al. Reevaluating the implications of recurrent falls in older adults: location changes the inference. J Am Geriatr Soc 2012; 60:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/110\">",
"      Tinetti ME. Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc 1986; 34:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/111\">",
"      Mathias S, Nayak US, Isaacs B. Balance in elderly patients: the \"get-up and go\" test. Arch Phys Med Rehabil 1986; 67:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/112\">",
"      Podsiadlo D, Richardson S. The timed \"Up &amp; Go\": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991; 39:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/113\">",
"      Schoene D, Wu SM, Mikolaizak AS, et al. Discriminative ability and predictive validity of the timed up and go test in identifying older people who fall: systematic review and meta-analysis. J Am Geriatr Soc 2013; 61:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/114\">",
"      Weiner DK, Duncan PW, Chandler J, Studenski SA. Functional reach: a marker of physical frailty. J Am Geriatr Soc 1992; 40:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/115\">",
"      Fleming KC, Evans JM, Weber DC, Chutka DS. Practical functional assessment of elderly persons: a primary-care approach. Mayo Clin Proc 1995; 70:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/116\">",
"      Duncan PW, Studenski S, Chandler J, Prescott B. Functional reach: predictive validity in a sample of elderly male veterans. J Gerontol 1992; 47:M93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/117\">",
"      Guralnik JM, Ferrucci L, Simonsick EM, et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995; 332:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/118\">",
"      Guralnik JM, Ferrucci L, Pieper CF, et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci 2000; 55:M221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/119\">",
"      de Rekeneire N, Visser M, Peila R, et al. Is a fall just a fall: correlates of falling in healthy older persons. The Health, Aging and Body Composition Study. J Am Geriatr Soc 2003; 51:841.",
"     </a>",
"    </li>",
"    <li>",
"     Berg Balance Scale. Available at: www.fallssa.com.au/documents/hp/Berg_Balance_Scale.pdf (Accessed on February 10, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/121\">",
"      Berg KO, Wood-Dauphinee SL, Williams JI, Maki B. Measuring balance in the elderly: validation of an instrument. Can J Public Health 1992; 83 Suppl 2:S7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/122\">",
"      Verghese J, Buschke H, Viola L, et al. Validity of divided attention tasks in predicting falls in older individuals: a preliminary study. J Am Geriatr Soc 2002; 50:1572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/123\">",
"      Lipsitz LA. Orthostatic hypotension in the elderly. N Engl J Med 1989; 321:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/124\">",
"      Lichtenstein MJ, Bess FH, Logan SA. Validation of screening tools for identifying hearing-impaired elderly in primary care. JAMA 1988; 259:2875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/125\">",
"      Ferrucci L, Bandinelli S, Cavazzini C, et al. Neurological examination findings to predict limitations in mobility and falls in older persons without a history of neurological disease. Am J Med 2004; 116:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/126\">",
"      Richardson DA, Bexton RS, Shaw FE, Kenny RA. Prevalence of cardioinhibitory carotid sinus hypersensitivity in patients 50 years or over presenting to the accident and emergency department with \"unexplained\" or \"recurrent\" falls. Pacing Clin Electrophysiol 1997; 20:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/4/22602/abstract/127\">",
"      Kenny RA, Richardson DA, Steen N, et al. Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE). J Am Coll Cardiol 2001; 38:1491.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3012 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-197.136.42.3-430C2FE721-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_4_22602=[""].join("\n");
var outline_f22_4_22602=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Morbidity and mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Fear of falling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Postural control",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Sensory systems",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Muscle activation and composition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      History of falls",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Systemic blood pressure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Chronic diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Cognitive impairment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Medication use",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Drugs affecting the CNS",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Antihypertensives and cardiovascular medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Alcohol use",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Footwear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Environmental factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Institutional settings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      FALLS RISK ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      EVALUATION FOR PATIENTS WITH INCREASED FALL RISK",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Musculoskeletal function",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2706902\">",
"      - Performance Oriented Mobility Assessment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - 'Get Up and Go' test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Functional reach test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12527641\">",
"      - Short Physical Performance Battery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Other tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      General physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Diagnostic testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/3012\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/3012|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?29/50/30496\" title=\"algorithm 1\">",
"      Prevention falls algorithm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/3012|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/9/44190\" title=\"figure 1\">",
"      Causes of falls",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/56/32641\" title=\"figure 2\">",
"      Functional reach test",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/3012|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/47/5885\" title=\"table 1\">",
"      Get up and go test",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/0/30730?source=related_link\">",
"      Drug prescribing for older adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/57/37786?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of vascular dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/32/39429?source=related_link\">",
"      Evaluation of hearing loss in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22823?source=related_link\">",
"      Glossary of common biostatistical and epidemiological terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/41/12951?source=related_link\">",
"      Mechanisms, causes, and evaluation of orthostatic and postprandial hypotension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?41/4/42050?source=related_link\">",
"      Patient information: Preventing falls (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/12/8393?source=related_link\">",
"      Prevention of falls and complications of falls in community-dwelling older persons",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/0/18442?source=related_link\">",
"      Reflex syncope",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_4_22603="Stages of CKD";
var content_f22_4_22603=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F80596&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F80596&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Stages of chronic kidney disease based on 2002 Kidney Disease Outcomes Quality Initiative",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Stage",
"       </td>",
"       <td class=\"subtitle1\">",
"        Description",
"       </td>",
"       <td class=\"subtitle1\">",
"        GFR (mL/min/1.73 m",
"        <sup>",
"         2",
"        </sup>",
"        )",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        Kidney damage with normal or &uarr; GFR",
"       </td>",
"       <td>",
"        &ge;90",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        Kidney damage with mild &darr; GFR",
"       </td>",
"       <td>",
"        60 to 89",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        Moderage &darr; GFR",
"       </td>",
"       <td>",
"        30 to 59",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        Severe &darr; GFR",
"       </td>",
"       <td>",
"        15 to 29",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        Kidney failure",
"       </td>",
"       <td>",
"        &lt;15 (or dialysis)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Chronic kidney disease is defined as either kidney damage or glomerular filtration rate (GFR) &lt;60 mL/min/1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    for&nbsp;three months. Kidney damage is defined as pathologic abnormalities or markers of damage, including abnormalities in blood or urine tests or imaging studies.",
"    <div class=\"footnotes\">",
"     Adapted from: 2002 National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_4_22603=[""].join("\n");
var outline_f22_4_22603=null;
var title_f22_4_22604="Major causes of type 2 RTA";
var content_f22_4_22604=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F68165&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F68165&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major causes of type 2 (proximal) renal tubular acidosis with or without the Fanconi syndrome",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Primary",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Idiopathic (sporadic)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Familial",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Recessive &ndash; proximal tubule cell sodium bicarbonate co-transporter (NBCe1) defect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Recessive &ndash; carbonic anhydrase type 2 deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Cystinosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Tyrosinemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hereditary fructose intolerance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Galactosemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Glycogen storage disease (type I)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Wilson's disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Lowe's syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Acquired disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ifosfamide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Tenofovir",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Carbonic anhydrase inhibitors &ndash; acetazolamide; topiramate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Aminoglycosides",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        M-Protein disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Amyloidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Multiple myeloma/light chain disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Heavy metals",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Lead",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Cadmium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Mercury",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Copper",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Vitamin D deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Renal transplantation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Paroxysmal nocturnal hemoglobinuria",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_4_22604=[""].join("\n");
var outline_f22_4_22604=null;
var title_f22_4_22605="FEV1 and age in females";
var content_f22_4_22605=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F54935&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F54935&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    FEV1 and age in healthy women",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 414px; height: 308px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Growth and decline of lung function in healthy females. Actual values are shown in the top panel and growth velocity in the bottom panel.",
"    <div class=\"footnotes\">",
"     FEV",
"     <sub>",
"      1",
"     </sub>",
"     : forced expiratory volume in one second.",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from: Sherrill DL, Camilli A, Lebowitz MD. Am Rev Respir Dis 1989; 140:638.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_4_22605=[""].join("\n");
var outline_f22_4_22605=null;
var title_f22_4_22606="Glycosylation of proteins";
var content_f22_4_22606=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F80716&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F80716&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 602px\">",
"   <div class=\"ttl\">",
"    Formation of advanced glycosylation end products",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 582px; height: 217px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the formation of advanced glycosylation end products in the presence of persistent hyperglycemia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Bucala R, Vlassara H, Cerami A.&nbsp;Advanced glycosylated endproducts: role in diabetic and nondiabetic vascular disease. Drug Develop Res 1994; 32:77.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_4_22606=[""].join("\n");
var outline_f22_4_22606=null;
var title_f22_4_22607="MDI spacers";
var content_f22_4_22607=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F58957&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F58957&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Spacers used with metered dose inhalers",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 220px; height: 490px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) AeroChamber, (B) AeroChamber with mask, and (C) InspirEase. These devices can make it easier to use a metered dose inhaler and decrease the amount of drug that lands in the mouth and throat.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_4_22607=[""].join("\n");
var outline_f22_4_22607=null;
